Early angiogenic change in dental pulp stromal cells cultured on biomimetic matrices by Russell, Hugh
  
 
 
 
EARLY ANGIOGENIC CHANGE IN DENTAL PULP STROMAL 
CELLS CULTURED ON BIOMIMETIC MATRICES. 
 
 
 
Hugh Russell 
Submitted in accordance with the requirements for the degree of 
PhD. 
 
The University of Leeds 
Dept. of Oral Biology, 
School of Dentistry. 
 
February 2016. 
  
- ii - 
ii 
 
 
The candidate confirms that the work submitted is his/her own and that appropriate 
credit has been given where reference has been made to the work of others. 
 
 
This copy has been supplied on the understanding that it is copyright material and 
that no quotation from the thesis may be published without proper 
acknowledgement. 
 
 
The rights of Hugh Russell to be identified as Author of this work has been asserted 
by him in accordance with the Copyright, Designs and Patents Act 1988. 
 
© 2016 Year of Submission for examination The University of Leeds and Hugh 
Russell. 
- iii - 
iii 
 
Acknowledgements 
I would like to thank my principal supervisor Dr. Xuebin Yang who taught me the 
important fundamentals of dental pulp harvesting and tissue culture; Dr. Howard 
Davies of OralDent for the GenGiGel
®
 samples; Sue Keates for her 
immunohistology training; Jackie Hudson for her unfailing patience at my general 
technological bafflement and SEM training; Yamuna Mohanram and Huiru Zou, the 
backbone of our mutual support group and their superb Asian cuisine; Dr. Sarah 
Myers who looked after my experiments during a prolonged period of illness and 
supervised my FEGSEM images; Dr. Steve Brookes for his unstinting moral 
support; Dr. Jing Kang for statistical guidance; Adam Steele and Greg Baugh for 
their secretarial skills; Claire Godfrey for keeping me away from the University 
ordering system and running the coffee club; Julie McDermott for help during 
Research Days; Dr. Adam Mitchell for advice on PCR; Dr. Scott Finlay for teaching 
me EndNote; Dr. Nigel Bubb, master of the University Thesis template and if I’ve 
forgotten anyone else I apologise for the oversight, but you all know who you are. I 
must again thank Dr. Xuebin Yang for his advice and support throughout this study. 
Finally, two extremely important women! I must give a particularly grateful thank 
you to Professor Jennifer Kirkham, Head of Department and ‘mum’ to us all, for her 
insight, experience and for giving me the chance to pursue this project. Lastly and 
most importantly, my wife Judith, for her help, encouragement and putting up with 
me and all of our travails throughout this, because without her none of it would ever 
have been possible. 
- iv - 
iv 
 
Abstract 
Revascularisation of the devitalised root canal is the Holy Grail of Endodontics and 
is being hotly pursued by many teams of clinicians but has yet to be achieved. The 
overall aim of this work was to attempt to induce early angiogenesis in human 
dental pulp stromal cells (DPSCS) in vitro and in vivo using a biomimetic approach 
based on combining scaffolds comprised of ECM components with DPSCs as a first 
step towards a tissue engineering strategy for dental pulp regeneration. After 
isolating DPSCs using collagenase digest, they were cultured on 1% hyaluronic acid 
(HyA) or Types I and III collagen matrices used either singly or in combination to 
determine the ability of these scaffolds to support/induce early angiogenic change in 
DPSCs both in vitro and in vivo. Angiogenic change was determined using a 
combined approach of DNA quantification, histology, immunohistochemistry to 
detect the angiogenic markers CD31 and CD34 and quantitative RT-PCR. 
DPSCs were shown to attach and proliferate on Type I and III collagen membranes 
in vitro but early angiogenic change in vitro was evidenced only when 1% HyA gel 
was used, including in the absence of the morphogen rhVEGF165 as shown 
immunohistochemically. PCR at two and five days post-seeding showed an up-
regulation of CD31 and CD34 genes dependant on culture conditions, with CD31 
being upregulated early and CD34 later in the culture period. 
A modified tooth slice model containing a combination of HyA/collagen 
scaffold/DPSC constructs within its lumen also showed positive early angiogenic 
change in vitro. SEM examination further confirmed that DPSCs could attach, 
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colonise and proliferate to/on the combined scaffold. The same combined scaffold-
tooth slice model ± DPSCs used in vivo in nude mice showed cellular ingress into 
the lumen with a soft tissue closely resembling dental pulp-like tissues in its 
appearance with new tubule-like material grown on from the dentinal tubules of the 
tooth slice. There was a defined demarcation line between this latter material and the 
dentinal tubules of the tooth slice and the new material closely resembled predentine 
or dentine-like matrix in appearance and stained strongly for CD31 and CD34 
markers. It also had a layer of cells adjacent to and in intimate contact with its 
deposition front, whose cell processes transited the new tubule-like material and 
continued into the dentine tubules of the tooth slice for some distance. Interestingly, 
this neo-tissue was independent of the addition of DPSCs to the construct. The 
results suggest that biomimetic scaffolds based upon components of the pulp 
extracellular matrix may provide a useful platform for future engineering of a 
vascularised replacement dental pulp. 
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Chapter 1: General Introduction 
The dental pulp, commonly but erroneously called ‘the nerve’ is more accurately 
described as a neurovascular bundle forming the living soft tissue component found 
inside every healthy tooth (Luukko et al., 2011). The dental pulp produces dentine 
throughout its lifetime: primary dentine during tooth development, secondary 
dentine thereafter and tertiary, or reactive dentine under pathogenic stimuli (Holland 
and Torabinejad, 2009). It is almost entirely encased by dentine, limiting how much 
it can expand during inflammatory changes and any symptoms, regardless of cause 
arising from within a tooth involve and emanate from this structure which connects 
with the supporting bony tissues of the periodontium, via a periapical foramen or 
multiple foramina in each root (Zavan et al., 2011, Holland and Torabinejad, 2009).  
 
Figure 1. Gross anatomy of the tooth. 
From 3MD marketing (public domain). 
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This constricted vasculature is one of the reasons why dental pulp in the adult tooth 
has very limited powers of healing, particularly when apexification i.e. complete 
formation of the constricted part of the root tip is completed, approximately three 
years following tooth eruption into the oral cavity.  
 
1 Dental pulp embryology 
The dental pulp is derived from the cephalic neural crest. Neural crest cells arise 
from the ectoderm along the lateral margins of the neural plate and begin to migrate. 
Those which migrate down the sides of the head into the maxilla and the mandible 
contribute to the formation of the tooth germs and the dental papilla – from which 
the dental pulp develops – starts as ectomesenchymal cells proliferate and condense 
adjacent to the dental lamina at the sites where the teeth will develop (Pashley and 
Liewehr, 2006). The migratory potential of ectomesenchymal cells continues to 
persist in the ability of pulp cells to move into areas of injury and replace dead 
odontoblasts. Tooth formation of the primary dentition begins around the sixth week 
of embryonic life when the proliferation of ectodermal cells gives rise to two 
horseshoe shaped structures, one on the mandible, the other on the maxilla. These 
structures are called the primary dental laminae and each divides into a vestibular 
and a dental lamina. Cells in the dental epithelium and adjacent ectomesenchyme 
divide rapidly at this stage and the dental lamina can induce tooth formation by its 
influence on the underlying ectomesenchyme (Mina and Kollar, 1987). 
 3 
 
Tooth formation is a continual process, but for convenience is usually divided into 
three stages: (i) bud, (ii) cap and (iii) bell (Lumsden, 1988, Nanci, 2012, Orban, 
1928). The bud stage is the initial stage, where the epithelial cells of the dental 
lamina proliferate and produce a budlike projection into the ectomesenchyme. 
Figure 2. Bud stage (the tooth at 8 weeks embryonic life). 
1. The Dental Lamina. 2. The Oral Epithelium. 3. The Tooth Bud. 4. The 
Jaw Mesenchyme. 
The cap stage occurs when the cells of the dental lamina have proliferated to form a 
concavity. At the transition from bud to cap, enamel knot formation initiates cuspal 
patterning, an important stage in tooth morphology (Jernvall et al., 1994). The outer 
cells of the cap are cuboidal and form the outer enamel epithelium. The inner cells 
are more elongated and form the inner enamel epithelium. Between them is a 
network of cells called the stellate reticulum. The rim of the enamel organ (where 
the two layers of cells meet) is called the cervical loop (Parikh, 2004, Pannese, 
1962). 
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Figure 3. Cap Stage the tooth at 10 weeks embryonic life. 
1. The Inner Enamel Epithelium. 2. The dental Papilla. 3. The Outer 
Enamel Epithelium. 4. The Dental Lamina. 
As they continue to proliferate, there is further invagination of the enamel organ into 
the mesenchyme and the organ assumes a bell shape. During this stage, the 
ectomesenchyme of the dental papilla becomes partly enclosed by the invaginating 
epithelium and the blood vessels become established in the dental papilla (D'Souza, 
2002). The condensed ectomesenchyme surrounding the enamel organ and dental 
papilla forms the dental sac and ultimately becomes the periodontal ligament. 
Differentiation of epithelial and mesenchymal cells into ameloblasts and 
odontoblasts respectively, occurs during the bell stage. 
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Figure 4. Bell stage (the tooth at 12 weeks embryonic life). 
1. Stellate Reticulum. 2. Odontoblasts. 3. Ameloblasts. 4. Dental Sac. 5. 
Dental Papilla. 
By about the sixth month of development, many more of the tooth’s structures have 
become established, including the calcified tissues and the beginning of root 
formation is about to commence. 
 
Figure 5. Advanced Bell Stage (about 24 weeks of embryonic life). 
1. Stellate Reticulum. 2. Ameloblast layer. 3. Early Enamel formation. 4. 
Epithelial Root Sheath. 5. Odontoblast Layer. 6. Early dentine formation. 
7. Dental Pulp. 
As the odontoblast layer differentiates, the cells elongate and take on the ultra-
structural characteristics of protein-secreting cells. Cytoplasmic processes extend 
from the cells and increasing numbers of collagen fibrils (Von Korff fibres) appear 
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in the extra-cellular matrix (ECM). Both Type I and Type III collagen messenger 
Ribonucleic Acid (mRNA) can be found in developing odontoblasts (D'Souza et al., 
1995) but most of the collagen produced by mature odontoblasts is Type I. 
Dentinogenesis begins where tooth cusp tips or incisal edges will eventually be and 
as odontoblasts reach full maturity they become tall columnar cells of up to 50 µm 
but with a fairly consistent width of about 7 µm. As predentine matrix is laid down 
the odontoblasts move inwards at between 4 to 8 µm per day leaving matrix behind. 
In the matrix, an accentuated process from each odontoblast remains to form the 
primary odontoblast’s process and the dentinal tubules are formed around these 
(Pashley and Liewehr, 2006). 
 
Under the microscope, dental pulp is usually described as having four regions or 
zones (Zach et al., 1969). 
1) The odontoblast layer around the periphery of the pulp, in intimate 
contact with the tooth dentine. 
2) The so-called ‘cell free’ zone, which has fewer cells than the odontoblast 
layer but containing capillaries and nerve fibres. 
3) The ‘cell-rich’ zone populated by fibroblasts and undifferentiated 
mesenchymal cells with a rich vascular supply. 
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4) The central pulp zone. This region contains the pulp’s larger blood 
vessels and innervative structures. The main cell types are fibroblasts. 
Figure 6. Regions in the Dental Pulp. From Oral Histology Digital Lab (public 
domain). 
1. (white in above image) Odontoblast Layer. 2. ‘Cell free’ 
zone. 3. ‘Cell Rich’ zone. 4. Central Zone. 
A: Dentine. B: Nerve Fibril. C. Blood vessel. 
Dental pulp is a tissue of ectomesenchymal origin with specialised odontoblasts 
placed peripherally in intimate contact with dentine. This closeness of this pairing, 
embryologically, developmentally, anatomically and functionally, has led to them 
being termed as the pulp-dentine complex and is a reason why the two tissues can be 
regarded as a single functional entity although made up of histologically distinct 
components (Pashley, 1996). The pulp has an extensive blood supply (Kishi et al., 
1995) but constraints are imposed on the pulp by its rigid mineralised surroundings 
which limit its ability to expand during periods of vasodilation, inflammation and 
increased tissue pressure, resulting in an increase in tissue pressure instead of 
volume (Heyeraas and Berggreen, 1999). As the total volume of fluid in the pulp 
chamber cannot be greatly increased (although volume changes can occur between 
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venules, arterioles, lymphatics and extra-vascular tissue) careful regulation of blood 
flow is crucial to pulp health, with shunting occurring mainly in the apical half of 
the pulp (Meyer and Path, 1979). Being limited in volume, the microcirculatory 
system of the pulp contains no true veins or arteries, only venules and arterioles 
(Zhang et al., 1998). Also there is no collateral system and the vascularity of the 
pulp decreases progressively with age as the dental pulp shrinks and becomes 
progressively more fibrous (Bernick and Nedelman, 1975). The pulp contains a 
mixture of tissues including nerve fibres, vascular tissue, connective tissue, ground 
substance, interstitial fluid, odontoblasts, fibroblasts and immunocompetent cells. 
However, its special characteristics and ability to remodel mean that even a mature 
dental pulp bears a resemblance to embryonic connective tissue and is therefore a 
fairly good source of stem cells (Pashley and Liewehr, 2006). Odontoblasts continue 
to lay down matrix and deposit dentine throughout the lifetime of the tooth. 
 
1.1 Extracellular matrix components of the dental pulp 
ECM comprises the predominantly non-cellular elements present in all organs and 
tissues. ECM has been described as the ideal biologic scaffold material and can be 
divided into two compartments, namely ground substance and fibrous proteins 
(Badylak, 2007). The ECM is not passive. It supports the blood vessels, nerves and 
lymphatic tissues and also permits the diffusion of nutrients from the blood to the 
adjacent cells (Badylak, 2007). As each tissue has its own tailor-made ECM 
manufactured by its own cells (Badylak, 2007) it provides the necessary physical 
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and mechanical support medium for the cellular (mostly fibroblasts) constituents. 
Physiologically, it initiates important biomechanical and biochemical prompts for 
differentiation, homeostasis and morphogenesis (Frantz et al., 2010). Its importance 
can be seen by syndromes arising from conditions such as Type IV Ehlers-Danlos 
syndrome as well as other genetic abnormalities deriving from genetic mutations in 
ECM proteins (Jarvelainen et al., 2009). Its two main macromolecular components 
comprise of proteoglycans (PGs) and fibrous proteins (Schaefer and Schaefer, 
2010). 
 
1.1.1 Proteoglycans 
Proteoglycans (PGs) are a principal component of the tissue ground substance. 
Ground substance also acts as a molecular sieve, able to exclude large proteins and 
urea and it can exclude osmotically active molecules, helping to determine the 
physical characteristics of the pulp. Ground substance can be degraded in the 
presence of lysosomal enzymes, proteolytic enzymes, hyaluronidases and 
chondroitin sulphatases. The pathways of inflammatory and infective reactions are 
strongly influenced by the level of polymerisation of the ground substance 
components (Pashley and Liewehr, 2006). 
PGs are the main component contributing towards the ground substance properties. 
and are formed of glycosaminoglycan (GAG) polymer chains, covalently attached to 
a specific protein core (Schaefer and Schaefer, 2010). Hyaluronic Acid (HyA) is 
also a GAG but is found free in tissues or non-covalently associated with PG 
aggregates (Iozzo and Murdoch, 1996, Sakamoto et al., 1981). One of their 
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functions is to act as adhesive molecules binding cell surfaces to other molecules in 
the ECM (Uitto and Larjava, 1991). Proteoglycans have a net negative charge which 
attracts water molecules. Thus, within a tissue, PGs can fill most of the extracellular 
and interstitial spaces giving it the form of a hydrated gel, or hydrogel (Badylak, 
2002) with a wide variety of roles reflecting their buffering, force resistance, binding 
and hydration capabilities (Jarvelainen et al., 2009). PGs are classified by their 
glycosaminoglycan (GAG) composition, core proteins and localisation, with the 
main three types being small leucine rich PGs (SLRPs), cell surface proteoglycans 
and modular proteoglycans. GAG chains bound to the protein cores of PGs comprise 
of unbranched polysaccharides, of repeating disaccharide units (sulphated N-
acetylglucosamine or N-acetylgalactosamine, L-iduronic or D-glucuronic acid) and 
galactose (N-acetylglucosamine-β1 3-galactose-β1) which are subdivided into 
sulphated (keratin, chondroitin, dermatan and heparan sulphate) and non-sulphated 
(hyaluronic acid) GAGs (Schaefer and Schaefer, 2010). Their extreme hydrophilic 
nature gives them highly extended conformations enabling them to absorb high 
compressive forces and they have been implicated in tooth eruption mechanisms 
(Dean and Cole, 2013, Picton, 1989). SLRPs have involvement in many signalling 
pathways including binding to and activating low density lipoprotein related protein 
1 (LRP1), regulation of inflammatory response reactions, binding to and activating 
transforming growth factor β (TGFβ), binding to and activating insulin-like growth 
factor 1 receptor (IGFIR) and also epidermal growth factor receptor (EGFIR) 
(Goldoni and Iozzo, 2008) and binding to and directing collagen fibrillogenesis and 
fibre orientation. Some (but not all) of the actions of modular PGs involve 
modulating cell adhesion, proliferation and migration (Schaefer and Schaefer, 2010). 
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Basement membrane modular PGs such as agrin, perlecan and collagen Type XVIII 
function dually as both pro and anti-angiogenic factors (Iozzo et al., 2009). Cell 
surface PGs such as syndecan and glypicans facilitate ligand binding with signalling 
receptors by acting as co-receptors (Schaefer and Schaefer, 2010). 
In the pulp, the principal GAGs include dermatan sulphate, heparan sulphate and 
chondroitin sulphate. The PG content of the pulp reduces greatly following tooth 
eruption (Linde, 1985). During active dentinogenesis, chondroitin sulphate 
predominates (Linde, 1973) especially in the odontoblast and predentine layer where 
it may have a role in the mineralisation process (Bouvier et al., 1990). Predentine 
contains several types of GAGs and PGs, whereas dentine predominantly contains 
chondroitin sulphate-containing PGs (Takagi et al., 1990). Following tooth eruption, 
hyaluronic acid and dermatan sulphate increase and chondroitin sulphate reduces 
greatly. 
 
1.1.2 Non-collagenous proteins 
The ECM of dentine also contains non-collagenous proteins (NCPs) active in 
controlling collagen fibre mineralisation and crystal growth in predentine as part of 
its’ transition into dentine proper. Mutations in these proteins are manifested by 
marked phenotype changes in dentine mineralisation and in other calcified tissues 
such as bone (Feng et al., 2002, Sreenath et al., 2003, Xiao et al., 2001, Xu et al., 
1998, Zhang et al., 2001). NCPs such as the small integrin binding ligand, N-linked 
glycoproteins (SIBLINGs) include osteopontin (OP), bone sialoprotein (BSP), 
matrix extracellular phosphoglycoprotein (MEPE), dentine sialophosphoprotein 
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(DSPP) and dentine matrix protein 1 (DMP1) (Fisher et al., 2001). Principally found 
in bone and dentine, SIBLING proteins are secreted into the ECM as part of the 
formation and mineralisation of these two tissues although the expression of DMP1, 
OPN, DSPP and BSP are similar qualitatively but differ quantitatively between these 
two tissues (Qin et al., 2001). 
Fibronectin (FN) is a non-collagenous protein with roles in managing the 
organisation of interstitial ECM as well as mediating cell function and attachment. 
Secreted as a dimer joined by two C-terminal disulphide bonds, FN has binding sites 
to heparin and other FN dimers. It also binds to cell-surface integrin receptors 
(Pankov and Yamada, 2002). It is able to be stretched by a factor of several times its 
resting length by cellular traction forces (Smith et al., 2007). This force-dependant 
unfolding results in the exposure of secret or ‘cryptic’ binding sites for integrins 
resulting in pleiotropic changes altering cell behaviour and hint at FN having a role 
as an extracellular mechano-regulator. 
 
1.1.3 Fibrous proteins 
The most commonly found fibrous protein within the ECM is collagen which can 
comprise up to 30% of the total protein found in a multicellular animal (Frantz et al., 
2010). The majority of interstitial collagen is secreted by the fibroblasts residing in 
the ECM stroma or which are recruited into it from adjacent tissues (De Wever et 
al., 2008). 
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1.1.3.1 Collagen 
Thus far, twenty eight types of collagen have been identified in vertebrate animals 
(Gordon and Hahn, 2010). Most collagen molecules form a triple helix which, 
depending on the collagen type, can subsequently be assembled into supramolecular 
complexes like fibrils and networks. The importance of Type I collagen structure is 
evident when seen in patients with osteogenesis imperfecta which is caused by 
mutations in the Type I collagen gene (Cole, 2002) and in dentinogenesis imperfacta 
type 1 where there are mutations in the genes encoding collagen Type I, COL1A1 
and ICOL1A2 (Barron et al., 2008). Network collagens are incorporated into 
basement membranes and fibrous collagens form the basis of collagen fibril bundles 
within the interstitial tissue stroma (Frantz et al., 2010). Type I collagen synthesis 
includes several enzymatic post-translational modifications (Myllyharju and 
Kivirikko, 2004), predominantly the hydroxylation of lysine and proline residues, 
the cleavage of N- and C- terminal propeptides and the glycosylation of lysine. Post-
secretion, lysyl oxidases (LOX) convert the side chains of lysine and hydroxylysine 
residues of the collagen molecules to their aldehyde forms. These can then go on to 
react to form covalent inter-molecular cross links, strengthening the collagen fibrils 
(Robins, 2007). Collagens provide the main structural element for the ECM, where 
they can direct tissue development, aid chemotaxis and cell migration, help regulate 
cell adhesion and give tensile strength (Rozario and DeSimone, 2010). Fibroblasts 
are able to exert tension on the ECM, organising collagen fibrils into sheets and 
fibres or cables influencing the alignment of the resultant collagen fibres. Normally 
within any one specific tissue the collagen fibres are a mixture of several types, but 
one type usually comprises the majority (Frantz et al., 2010). Dental pulp ECM 
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consists of 56% Type I collagen, 41% Type III collagen, 2% Type V collagen and 
0.5% Type VI collagen associated with microfibrillin (Goldberg and Smith, 2004). 
 
1.1.3.2 Elastin 
Elastin is another ECM fibre frequently co-expressed with collagen. Elastin fibres 
are secreted as a precursor tropoelastin which is assembled into fibres, becoming 
highly crosslinked to each other by their lysine residues. This is carried out by 
members of the LOX enzyme group which includes LOX and lysyl oxidase like 
(LOXL) (Lucero and Kagan, 2006). Elastin fibres allow stretch and recoil in tissues 
subjected to these forces on a repeated basis with the elastin stretch being crucially 
constrained by its intimate association with collagen fibrils (Wise and Weiss, 2009). 
The maintenance of the integrity of the elastin fibres is due to their covering of 
predominantly fibrillin glycoprotein microfibrils (Wise and Weiss, 2009). 
 
1.2 Connective tissue fibres of the pulp 
Dental pulp, in common with all connective tissues contains both major and minor 
fibres within the ECM. Two principal types of structural proteins can be found in the 
pulp, namely elastin and collagen (see above). Initially during tooth formation thin 
microfibres called oxytalan fibres are formed (Bradamante et al., 1980) comprised 
of fibrillin glycoprotein microfibrils, then elastin protein is deposited within them, 
forming elastic fibres. Elastic fibres are associated with the walls of larger blood 
vessels and are also part of the ECM. However, collagen Type 1 is by far the most 
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abundant fibrous protein present in the pulp. By dry weight the amount of total 
collagen in the dental pulp is approximately 26% in premolars and 32% in third 
molars (van Amerongen et al., 1983) which is higher than that reported for other 
mammalian species such as rabbit (Uitto and Antila, 1971). The content is higher in 
the radicular part of the pulp than the coronal. Collagen Types I and III are both 
present throughout the majority of pulp collagen, with Type I predominating 
(Shuttleworth et al., 1978) but with the proportion of Type III collagen also being 
relatively high at about 43% of the total collagen in human dental pulp (van 
Amerongen et al., 1983) and over 40% of the total collagen in bovine dental pulp 
(Lechner and Kalnitsky, 1981) which may contribute to its elasticity (Shuttleworth 
et al., 1980) enabling it to better adapt during periods of hyperaemia. In the pulp, 
Type III collagen forms finely branched filaments distributed similarly to reticular 
fibres (Magloire et al., 1982) and is distributed densely in both the cell rich and cell 
poor zones (Karjalainen et al., 1986). Dentine and predentine collagens are almost 
totally Type I (Ruch, 1985) although some investigators have detected Type III 
collagen (Karjalainen et al., 1986) and Type V collagen in predentine (Lukinmaa 
and Waltimo, 1992). Pulp fibroblasts can produce both Types I and III collagen but 
the majority of collagen produced by odontoblasts is Type I (D'Souza et al., 1995). 
Collagen Types III and V (Tsuzaki et al., 1990) and VI (Hillman and Guertsen, 
1997) have been noted in pulp tissue forming a dense, microfibrillar network 
throughout the stroma of the connective tissue of the pulp. Fibres of Type VI 
collagen have been found between odontoblasts toward the predentine suggesting 
they are a component of Korff fibres (Hillman and Guertsen, 1997). Also, collagen 
Type IV is a component of basement membrane in the pulpal blood vessels (Fried et 
 16 
 
al., 1992). Turnover of collagen in the dental pulp is high, compared to other tissues 
and is associated with the fibroblasts which are able to both synthesise and degrade 
collagen (Orlowski, 1977). Inflammation consequent to bacterial infection may 
accelerate collagen degradation as seen in pulps with suppurative pulpitis which 
show elevated collagenolytic activity (Morand et al., 1981) and in vitro studies have 
suggested that production of collagenolytic enzymes is up-regulated in fibroblasts in 
response to infection and inflammation. 
 
1.3 Metabolism of the dental pulp 
The metabolic activity of dental pulp tissues has been studied by measuring the rate 
of O2 consumption by the bovine dental pulp and the production of CO2 or lactic 
acid. Their production was found to be low in comparison to other tissues 
(Biesterfeld et al., 1979, Fisher, 1967, Fisher et al., 1957, Hamersky et al., 1980, 
Sasaki, 1959) with one study finding that odontoblasts consumed O2 at the rate of 
3.2 ± 0.2 mL/minute/100grams of pulp tissue (Yu et al., 2002) with others showing 
it to be much higher, in the region of 40-50 mL/minute/10 grams of tissue as 
estimated using radioactive microsphere techniques (Kim, 1985, Meyer, 1993, Path 
and Meyer, 1977). During active dentinogenesis, metabolic activity is higher than 
after crown development, with the greatest metabolic activity found in the 
odontoblast layer (Bhussary, 1968, Fisher, 1967). Also, the pulp can produce energy 
via a phosphogluconate (i.e. pentose phosphate) shunt type of metabolism (Fisher 
and Walters, 1968), which may be how it survives periods of relative ischaemia 
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induced by vasoconstrictive anaesthetic agents (Kim et al., 1984). Some dental 
materials such as amalgam, eugenol, zinc oxide and eugenol and calcium hydroxide 
appear to reduce O2 consumption by dental pulp tissue suggesting that they could be 
able to down-regulate the metabolic activity of dental pulp cells (Jones et al., 1979, 
Fisher et al., 1957) and it has been shown that sufficient force to elicit orthodontic 
movement for three days can reduce respiratory activity in dental pulp tissue by 27% 
(Hamersky et al., 1980). 
 
1.4 Vascular Supply of the dental pulp 
The dental pulp has an extensive vascular supply (Kishi et al., 1995). The vessels 
pass through the apical foramen and accessory foramina in other areas of the root 
surface, as part of the neurovascular bundle with smaller vessels entering via lateral 
canals. The arterioles pass up the centre of the pulp, giving off lateral branches 
which spread towards the odontoblast layer, forming a plexus beneath them. 
Capillary blood flow in the coronal pulp is nearly twice that in the root area (Kim, 
1985). Also, blood flow is greater in the pulp horn regions than elsewhere (Meyer 
and Path, 1979). From the capillary bed, venous drainage is via progressively larger 
venules and in multirooted teeth the principal venous drainage may be 
predominantly down one root (Kramer, 1968). Arteriovenous anastomoses are found 
in the radicular and coronal pulp, especially the former. It is thought they perform an 
important regulatory function in shunting blood flow away from areas of 
inflammation or injury. The blood flow is regulated by sympathetic adrenergic 
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vasoconstriction (Kim et al., 1989), β-adrenergic vasodilation (Tonder, 1976), a 
sympathetic cholinergic vasoactive system (Aars et al., 1993) and an antidromic 
vasodilation system involving sensory nerves including axon reflex vasodilation 
(Sasano et al., 1994). Despite numerous studies, blood circulation in an inflamed 
pulp involves complex pathophysiologic mechanisms which have yet to be fully 
elucidated (Heyerass and Kvinnsland, 1992, Kim et al., 1983). Lymph vessels are 
also present in the pulp, smaller ones being located on the periphery and larger 
vessels located in the central pulp, being suggestive of drainage starting from the 
periphery and progressing to the centre of the pulp (Sawa et al., 1998). 
 
1.5 Innervation of the dental pulp 
During the bell stage of development nerve fibres follow the path of blood vessels 
into the papilla. The sensory innervation of the teeth terminates primarily in the 
coronal odontoblast layer, predentine and inner dentine. Morphologically, it is made 
up of at least six types of nerve fibre, each having a preferred location, one example 
of which being the medium sized Aß myelinated fibres innervating mainly dentine 
near the pulp horn tip. They are the most sensitive fibres to 
mechanical/hydrodynamic stimulation of dentine (Chudler et al., 1985, Dong et al., 
1985). Between 25% and 50% of dental nerve fibres are small myelinated AΔ fibres 
containing the neuropeptide calcitonin gene-related peptide (CGRP) and express 
receptors for nerve growth factor (NGF). Predominantly, they innervate dentine, 
predentine and the odontoblast layer in the coronal dentine region underlying 
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enamel (Byers and Narhi, 1999). The majority of nerve fibres in teeth are 
unmyelinated slowly conducting C-fibres, with most being regulated by NGF in the 
adult and about half requiring NGF during their development while others use brain-
derived neurotrophic factor (BDNF) or glial-derived neurotrophic factor (GDNF) 
(Byers and Kish, 1976). They terminate in peripheral pulp and are mostly activated 
by pulpal damage. It is known that nerve fibres are dynamic and continually adjust 
their association with pulpal cells and dentine (Hattyasy, 1961). This has been 
further explained by studies showing growth-associated protein-43 in dental nerve 
fibres and endings (Maeda and Byers, 1996). Ultrastructural and 
immunocytochemical data show a close association between nerve fibres and 
odontoblasts, fibroblasts, blood vessels and immunocompetent cells (Ibuki et al., 
1996) but specific synaptic or gap junctional connections between pulpal cells and 
clearly identifiable nerve fibres do not exist (Byers and Kish, 1976). Vasodilatory 
functions of the sensory innervation of teeth are opposed by vasoconstriction from 
the sympathetic fibres (Olgart, 1996), which are located mainly in the deeper pulp 
and around blood vessels (Pohto and Antila, 1972). Parasympathetic activity can 
affect pulpal blood flow but it is unclear if this is from intradental or periodontal 
sites and is considered to be of less importance than sympathetic activity (Sasano et 
al., 1995). Interestingly, it has been shown that a single nerve fibre can innervate 
multiple tooth pulps (Hikiji et al., 2000). Broadly speaking, the nerve bundles pass 
through the radicular pulp with the blood vessels and on reaching the coronal pulp 
they fan out forming the plexus of Raschow. The fibres branch prolifically giving 
rise to a vast overlap of receptor fields (Harris and Griffin, 1968). 
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1.6 Dental pulp morphology 
In a mature, healthy pulp, the outermost layer consists of odontoblasts. These are 
found immediately adjacent to and in intimate contact with the layer of predentine, 
which is in turn in contact with the dentine itself. The odontoblast cell’s processes 
(see Figure 7) extend through the predentine and into the dentine and between each 
odontoblast there is a gap of 30 to 40 nanometres width. The odontoblast cell bodies 
are connected by both tight and gap junctional complexes (Bishop and Yoshida, 
1992). Odontoblasts are typically columnar in the coronal part of the tooth, cuboidal 
in the radicular pulp region (Couve, 1986) and flattened in the apical region of the 
pulp (Kramer, 1968, Nanci, 2012). Immediately adjacent, there is a layer of 
comparatively few cells approximately 40 µm wide, known as the cell-free zone. 
Blood capillaries, unmyelinated nerve fibres, and the cytoplasmic processes of 
fibroblasts cross this area, which may or may not be obvious and sometimes absent, 
depending on the level of activity the pulp is undergoing e.g. in young pulps, where 
reparative dentine is being formed, or where dentine is being rapidly laid down 
(Couve, 1986). Adjacent to this is the cell-rich zone, which contains a relatively high 
proportion of fibroblasts when compared to the central zone of the pulp. This zone is 
more prominent in the coronal part of the pulp than elsewhere and also contains 
varying numbers of lymphocytes, macrophages and dendritic cells. It is thought that 
this zone arises from the peripheral migration of cells originally found in the central 
regions of the pulp, which then migrate around the time of tooth eruption 
(Gotjamanos, 1969). Irreversibly injured odontoblasts are thought to be replaced by 
cells migrating from the cell-rich zone (Fitzgerald et al., 1990) and their mitotic 
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activity is likely the first stage in the formation of new odontoblasts (Murray et al., 
2000). 
 
Figure 7. Representation of the odontoblast layer and subodontoblastic layer of 
the pulp. 
Adapted from Pathways of the Pulp 10
th
 edition 2011. Editors K.M. 
Hargreaves, S. Cohen & L.H. Berman. 
 
Cell division in this zone is uncommon in healthy pulps but odontoblast death 
causes an increase in the rate of mitosis. Cells migrate from the cell-rich zone to the 
inner surface of the dentine to replace irreversibly injured odontoblasts and this 
mitotic activity is the first stage in forming a new odontoblast layer (Fitzgerald et al., 
1990). The ‘body’ or main central mass of the pulp contains the larger blood vessels 
and nerves and here, the connective tissue cells consisting of fibroblasts and pulpal 
cells predominate. 
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1.7 Cells of the Dental pulp 
1.7.1 Odontoblasts  
These cells are responsible for dentinogenesis throughout the lifetime of a tooth and 
are the most readily identifiable cells within the pulp with the fully developed 
odontoblast found in the coronal pulp being a tall columnar cell (Couve, 1986). 
They form the dentinal tubules and their presence makes dentine a living, vital 
tissue, responsible for the hydrodynamic theory of pain transduction (Brannstrom, 
1966(a), Brannstrom, 1966(b), Gysi, 1900). They share many general similarities 
with osteoblasts and cementoblasts, such as producing a matrix of collagen fibres 
and proteoglycans capable of being mineralised (Charadram et al., 2012, Goldberg 
et al., 1995, Qin et al., 2004). Ultrastructurally, they all exhibit a highly ordered 
Rough Endoplasmic Reticulum, prominent Golgi complex, secretory granules and 
numerous mitochondria, reflecting their role as secretory cells. 
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Figure 8. Representation of a fully differentiated odontoblast, showing cell 
organelles. 
Adapted from Pathways of the Pulp 10th
th
 edition 2011. Editors K. M. 
Hargreaves, S. Cohen & L. H. Berman. 
 
Odontoblasts are rich in RNA and have nuclei with one or more prominent nucleoli. 
The major differences between odontoblasts, osteoblasts and cementoblasts are their 
morphology and relationship with the structures they ultimately produce. 
Osteoblasts and cementoblasts are polygonal to cuboidal in form, whereas the fully 
mature coronal odontoblast is a long columnar cell (Marion et al., 1991). In bone 
and cementum some osteoblasts and cementoblasts become trapped in the matrix as 
osteocytes or cementocytes (Li et al., 2011). Odontoblasts, however, leave behind 
cellular processes to form the dentinal tubules (Andrew and Matthews, 2000). 
Lateral branches link the major odontoblastic processes via canaliculi (Mjor and 
Nordahl, 1996) just as cementocytes and osteocytes link together via the canaliculi 
in cementum and bone. This provides avenues for inter-cell signalling, circulation of 
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fluid and metabolites through the mineralised tissues. An active odontoblast has a 
prominent nucleus, basally situated within a nuclear envelope with up to four 
nucleoli. A well-developed Golgi complex, numerous evenly distributed 
mitochondria and prominent rough endoplasmic reticulum (RER) for protein 
synthesis are also found. Mature odontoblasts mainly secrete Type I collagen, 
although small amounts of Type V collagen are also found in the ECM. As well as 
collagen and proteoglycans, odontoblasts secrete alkaline phosphatase (ALP, an 
enzyme closely linked to mineralisation), dentine sialophosphoprotein (DSPP), a 
highly phosphorylated phosphoprotein which is involved in extracellular 
mineralisation and is unique to dentine (D'Souza et al., 1995). Originally thought not 
to occur in many other mesenchymal cell lines (Butler et al., 1992) it has since been 
shown to be present in brain, kidney, liver, cartilage and salivary glands, but absent 
from the heart and spleen. It has also been shown to be expressed at higher levels in 
salivary glands, cartilage, kidney and liver than in bone and has also been found in 
the pericytes of dental pulp blood vessels (Prasad et al., 2011). Post secretion, DSPP 
is rapidly cleaved to produce dental sialoprotein (DSP) (Butler et al., 1992), dentine 
glycoprotein (Yamakoshi et al., 2005) and dentine phosphoprotein (MacDougall et 
al., 1997). 
Resting odontoblasts have reduced numbers of organelles and may become shorter 
as seen in the apical region of the pulp, following root completion (Couve, 1986). 
The odontoblast process forms the template for the dentinal tubule and is responsible 
for laying down peritubular dentine. Associated with its lateral branches are 
microtubules and microfilaments. There is much debate as to how far the process 
extends along the tubule with studies claiming it goes a third of the way into the 
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dentine (Holland, 1976, Holland, 1985, Thomas and Payne, 1983), up to the 
amelodentinal junction in some cases (Grossman and Austin, 1983, Kelley et al., 
1981) and the amelodentinal junction in all cases (Sakurai et al., 1999, Sasaki and 
Garant, 1996). Odontoblasts are considered to be fixed postmitotic cells that, once 
fully differentiated, cannot undergo further cell division. 
 
1.7.2 Dental pulp fibroblasts 
Dental Pulp fibroblasts are the most numerous cells within the pulp and seem to be 
tissue specific, capable of giving rise to cells which are committed to differentiation 
e.g. odontoblast-like cells, if given the appropriate signal (Luukko et al., 2011). 
They synthesise Types I and III collagen as well as PGs and GAGS and maintain the 
matrix proteins of the ECM as well as being responsible for collagen turnover in the 
pulp (Luukko et al., 2011). Fibroblasts are to be found throughout the pulp but are 
particularly abundant in the cell-rich zone (Nanci, 2012). In their immature stage, 
their organelles are rudimentary and inconspicuous with sparse RER. As they 
mature they become more stellate in form, the RER proliferates, the Golgi complex 
enlarges and they take on more of the characteristics of protein-secreting cells. With 
the increase in numbers of blood vessels and nerve fibres in the body of the pulp, the 
number of fibroblasts becomes relatively reduced. Compared with the fibroblasts of 
other tissues, pulp fibroblasts remain in a relatively undifferentiated state (Han, 
1968) and it has been demonstrated that mitotic activity preceding the differentiation 
of replacement odontoblasts seems to occur primarily among fibroblasts (Fitzgerald 
et al., 1990). Cells from the dental pulp with mesenchymal stem cell properties have 
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been shown to be capable of various types of functional differentiation dependant on 
the environmental clues provided under the culture conditions, such as neuronal 
(Arthur et al., 2008), angiogenic (d'Aquino et al., 2007) and osteoblastic 
(Ramamoorthi et al., 2015). 
 
1.7.3 Macrophages 
These are monocytes which have left the bloodstream, entered the tissues and 
differentiated into various subpopulations. One subpopulation is active in 
endocytosis and phagocytosis; the other in processing antigen for presentation to T 
memory cells (Okiji et al., 1992) binding it to major histocompatibility complexes 
(MHCs) - formerly known as class II antigen molecules - on the macrophage (Hahn 
et al., 1989) and is an essential part of T cell-dependant immunity. 
 
1.7.4 Dendritic cells 
These are accessory cells of the immune system similar to the Langherhans’ cells of 
the epidermis and mucous membranes (Jontell et al., 1987). They are antigen-
presenting cells, characterised by dendritic cytoplasmic processes or filopodia and 
the presence of cell surface MHCs. They are primarily found in lymphoid tissues but 
also distributed in connective tissues, including the pulp (Sakurai et al., 1999). Their 
purpose is engulfing proteins and presenting the peptide fragments for T cells to 
recognise prior to their activation with the majority of the cells co-expressing 
coagulation factor XIIIa, a marker for antigen-presenting cells of the dermis (Okiji 
et al., 1997). They are particularly prevalent in the periphery of the pulp, in and 
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subjacent to the odontoblast layer where their processes sometimes extend into the 
dentinal tubules (Sakurai et al., 1999). They are also found in the perivascular area 
arranged parallel to the endothelial cells (Okiji et al., 1997). 
 
1.7.5 Lymphocytes 
T lymphocytes are a normal finding in human dental pulp (Hahn et al., 1989) with 
CD8
+
T (suppressor) lymphocytes outnumbering the CD4
+
T cells subset. During 
tooth decay, the induction of the cellular immunoresponse is started by T lineage 
cells and as the lesion progresses this humoral immunoresponse is bolstered by B 
lineage cells and is accompanied by pulp tissue destruction as a result of the release 
of proteolytic enzymes by infiltrating macrophages and neutrophils (Izumi et al., 
1995). The presence of human immunodeficiency virus (HIV) has also been 
reported in human dental pulp tissue (Glick et al., 1989). B-lymphocytes and plasma 
cells are rarely found in the normal human pulp but have been observed in the pulps 
of impacted teeth (Langeland and Langeland, 1965). 
 
1.7.6 Mast cells 
Distributed widely in connective tissues, mast cells are seldom found in the dental 
pulp although they are a common finding in chronically inflamed pulps (Sakurai et 
al., 1999). 
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1.7.7 Dental pulp stem cells 
Modern dental pulp cell biology dates from the work originally done by Stanley 
(Stanley, 1962) and the subsequent culture methods (Pomerat and Contino, 1965) 
which regarded them as fibroblasts (Kawashima, 2012) along with them being a 
candidate source for regenerated odontoblasts (Fitzgerald, 1979). Other investigators 
have also thought them capable of differentiation into odontoblasts (Yamamura, 
1985). 
The identification of a postnatal mesenchymal stem cell population of dental pulp 
stem cells (DPSCs) has been a more recent occurrence (Gronthos et al., 2000) and 
corresponds with the identification of stem cell populations in other tissues 
(Gronthos et al., 2002). Predominantly neural crest derived cells, they express some 
of the genes found in embryonic stem cells but don’t express mesodermal genes 
(Dimitrova-Nakov et al., 2014) and despite their obvious existence their precise 
origin is still uncertain (Dimitrova-Nakov et al., 2014). DPSCs have been compared 
to other stem cell populations such as bone marrow stem cells (BMSCs) which are 
the most studied stem cell type and although there are similarities, they express 
different panels of surface markers from those characteristic of haematopoietic stem 
cells from bone marrow (Huang et al., 2010) and have never been shown to aid 
haematopoiesis in transplantation assay experiments (Gronthos et al., 2002). DPSCs 
are able to regenerate tissues closely resembling the dentine-pulp complex, made up 
of a mineralised tubule-like matrix aligned with odontoblasts and with a fibrous 
tissue component containing vasculature similar to that of human teeth (Gronthos et 
al., 2002). The precise percentage of pulp cells which are definitively stem cells is a 
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subject of contention but most authors put the number as less than 1% of the total 
population with an age variation of 0.4% diminishing to 0.1% when comparing 
young and old rats (Kenmotsu et al., 2010). The multipotency of DPSCs and their 
ability to exhibit osteoblastic, neuronal and adipogenic differentiation shows them to 
be different to the pulpal fibroblasts which exhibit monopotency by only being able 
to differentiate into odontoblasts (Kawashima, 2012). 
 
1.8 Function of the dental pulp 
The dental pulp is responsible for several functions. Ironically, a tooth can function 
perfectly well without one (Yu and Abbott, 2007) as the supply of blood and 
nutrients to the apparatus of attachment (i.e. the periodontal ligament and the tooth 
cementum) is unaffected by the pulps’ absence. However, the pulp renders a tooth 
less liable to bacterial ingress as a tooth with a healthy pulp is much more able to 
resist bacterial invasion than one without (Nagaoka et al., 1995). The dentinal tubules 
are occupied by the odontoblast processes and pressurised fluid which can in concert 
act like a positively charged hydrogel (Linden et al., 1995, Vongsavan and Matthews, 
1992). The positive outward flow of the dentinal fluid provides an important barrier 
against the rate at which noxious substances can diffuse into dentinal tubules 
(Matthews et al., 1996, Vongsavan and Matthews, 1992). Antibodies and other 
antimicrobial agents can also be present in dentinal fluid as a response to bacterial 
stimuli (Trowbridge and Kim, 1998). Immune complex build up and the precipitation 
of higher molecular weight proteins e.g. fibrinogen, carried in the dentinal fluid can 
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reduce the functional radius of a tubule and slow down the rate and volume of fluid 
shift potentially reducing dentine permeability and sensitivity (Pashley et al., 1984). 
Pulp has the cellular constituents necessary to recognise and process antigens, 
leading to its ability to mount an immune response reaction (Jontell et al., 1988). The 
major immune cells in a healthy pulp are peripheral T cells of the 
cytotoxic/suppressor and the helper/inducer types, while the main antigen presenting 
cells in a healthy pulp are the dendritic cells which are located mainly in association 
with the odontoblastic layer (Okiji et al., 1997). Pulp also has sensory functions with 
its sensitivity to differing thermal and osmotic stimuli being obvious (Holland, 
1994), in fact regardless of the stimulus whether it be mechanical deformation, 
thermal or pulp trauma, pulp interprets them all as pain (Yu and Abbott, 2007). 
Dental pulp tissue contains both autonomic and sensory nerves, enabling it to carry 
out its defensive and vasomotor roles (Avery et al., 1980, Heyeraas et al., 1993, 
Inoue et al., 1994, Okamura et al., 1995, Pohto and Antila, 1972). Numerous theories 
abound regarding the exact mechanism of dental pain transmission such as 
odontoblastic transduction, dentine innervation and the hydrodynamic theory, with 
the hydrodynamic theory being the most popular (Matthews and Vongsavan, 1994, 
West et al., 2013). 
Odontoblasts are a cell unique to the dental pulp and are end-differentiated post 
mitotic cells (Kim and Simmer, 2007) responsible for the deposition of dentine in its 
various forms throughout the lifespan of a tooth (Yu and Abbott, 2007). The cell 
resides in the periphery of the pulp at the predentine margin with its process 
extending into the dentine matrix, possibly all the way to the amelo-dentinal 
junction (Grossman and Austin, 1983, Holland, 1985, Kelley et al., 1981, Sigal et 
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al., 1984(a), Sigal et al., 1984(b), Yamada et al., 1983), although other authors 
dispute this, claiming that it is limited to the inner third (Byers and Sugaya, 1995, 
Garberoglio and Brannstrom, 1976, Narhi, 1985, Thomas, 1979, Weber and Zaki, 
1986). Odontoblasts are also implicated in sensory transduction (Matthews et al., 
1996) with the presence of adhering, tight and gap junctions inferring cell to cell 
communication, with the gap junctions also existing between nerve fibres and 
odontoblasts (Matthews and Holland, 1975, Sasaki and Garant, 1996). The O2 
uptake of odontoblasts is high with its uptake being significantly higher in the 
periphery of bovine dental pulps (Fisher, 1967) and the O2 consumption of rat 
odontoblasts has been shown to be 3.2 mL of O2/minute/100grams of tissue, a rate 
comparable to that of the brain (Chien, 1987). Transmission electron microscope 
studies have shown that odontoblasts are particularly sensitive to ischaemia (Chen, 
1987) and an electron microscope study has shown ultrastructural changes including 
mitochondrial swelling, chromatin clumping and irregular nuclear membrane in 
odontoblasts (Torabinejad et al., 1993). 
The pulpal circulation’s purpose is to provide nutrients and oxygen to its constituent 
cells and is defined as a microcirculation and given the physical constraints it 
operates under careful regulation of blood flow is important with alterations in the 
pulpal microcirculation occurring early during pulpal inflammation (Baumgardner et 
al., 1996, Kim, 1985). As previously stated, the blood flow in the dental pulp of a 
mature tooth is comparable to that in the brain and can be in the region of 40-50 
mL/minute/10 grams of tissue as estimated using radioactive microsphere 
techniques (Kim, 1985, Meyer, 1993, Path and Meyer, 1977). Furthermore, one 
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study has shown pulp vessels in monkeys to be unaffected by atherosclerosis (Krell 
et al., 1994). 
 
1.9 Historic dental treatment and the current status of endodontics 
Human teeth have been the subject of restorative attempts since prehistory, with 
evidence of prepared cavities being found in teeth from what is now Pakistan dated 
to between 8,000 to 9,000 years ago (Cohen, 2001). There is also evidence that 
prehistoric man may have used beeswax as a filling material after a mandible found 
in what is now modern Slovenia was found to have had a cracked left mandibular 
canine filled with the material (Barras, 2012). Coming more up to date, prostheses 
from Etruscan tombs from between the sixth and fourth century B.C. are common 
archaeological findings and prostheses from Roman cemeteries have been recovered 
dated from around the first to second century A.D. (Minozzi et al., 2007) that were 
found to have used gold wire to retain lost or replacement teeth. 
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Figure 9. Scanning electron microscope image of a tooth with beeswax filling 
(left) and Roman prosthodontics (right). 
Tooth filled with beeswax (left image, courtesy of New Scientist magazine) 
and Roman dental prosthesis (right image, courtesy of Dr. Franchesco 
Coschino, University of Pisa, Italy). 
 
The practice of Endodontics has been attempted for at least two millennia with the 
oldest bona fide root canal filling being a piece of copper wire, discovered inside the 
upper right lateral incisor found in the excavated skull of a Nabatean warrior dating 
from around 200 BC, the tooth having been X-rayed out of curiosity to see why it 
was green. This root filling came from a time when the prevailing theory of the 
cause of tooth diseases was that of a worm burrowing inside the tooth (Zias and 
Numeroff, 1987). Earlier than this, the Chinese had also subscribed to the worm 
theory of dental caries and an inscription excavated from the 14
th
 century BC (Ying 
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Dynasty) shows a character clearly designed and intended to mean dental caries, by 
combining the two characters for worm and tooth.  
 
Figure 10. Ancient Chinese characters for worm, tooth and tooth decay. 
Adapted from Tsai-Fang 1984. 
 
Some fifteen hundred years later, arsenicals were being used by the Chinese to treat 
pulpitis, some sixteen hundred years before their first use by Europeans and they 
were also using an amalgam-like material to restore cavities in teeth circa 659 AD 
(Tsai-Fang, 1984). 
The traditional and still current method of rectifying a badly diseased, painful or 
necrotic pulp is either by tooth extraction or endodontic treatment i.e. pulp removal, 
followed by instrumentation and the use of medicaments to clean and disinfect the 
root canal, then obturation of the resulting space using gutta percha cones or points, 
with a sealing cement followed by definitive restoration such as a crown. 
Although endodontic success is high in the hands of a skilled practitioner (West, 
2006), the procedure can be technically difficult with the potential at every stage for 
something to go wrong, with some clinical textbooks even devoting chapters to 
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‘Procedural Accidents’ (Holland and Torabinejad, 2009). Even after successful 
endodontic therapy, the tooth remains liable to fracture and reinfection (Goto et al., 
2009, Torabinejad and Lemon, 2009). 
Teeth in which the dental pulp has become necrotic and consequently non-vital, 
through whatever process, traditionally suffer one of three fates: 
1). They are left untreated because they are symptomless. 
2) They are extracted when they eventually initiate pain and sepsis. 
3). They undergo endodontic (i.e. root canal) treatment in order that the 
tooth be retained as a functioning masticatory unit within the oral cavity (Yu 
and Abbott, 2007). 
For several reasons i.e. what the patient desires, operator technical ability or 
expertise and technical reasons such as ease of access or compromised anatomy, 2 
often follows on from 3, despite the best intentions and efforts of the Dental 
Surgeon. 
Orthograde endodontics is usually described as “root canal filling” by conventional 
methods i.e. sealing the canal hermetically from the inner ends of the dentinal 
tubules and completely filling and sealing the canal from there, to the floor of the 
root chamber (Blaney, 1928, Orban, 1930). 
The techniques for this have been more accurately expounded as: 
1) The isolation of the appropriate tooth, 
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2.) The removal of organic and inorganic debris from the root canal 
system and the elimination of any bacteria, 
3). Shaping and filling of the resultant non-vital tooth with the 
appropriate obturation materials to form a hermetic three-dimensional seal (Schilder, 
1967). 
 Endodontic surgery, an extension of these techniques, and usually carried out when 
conventional therapies have failed, has been considered part of the remit of oral 
surgery but is now considered to be within the field of specialist endodontics in 
accordance with the regulations of the American Association of Endodontists 
(Endodontists., 1994). 
More recently, the scope of endodontics has broadened to encompass procedures 
designed to safeguard and maintain the health of all or part of the dental pulp. This 
has evolved gradually with the recognition that the pulp has definite powers of 
recuperation and recovery given the appropriate circumstances and supportive 
therapy. Procedures such as pulpotomy and pulp capping (Cvek, 1978) are now 
commonplace. Hence, the aim now when a pulp is diseased or injured is to preserve 
as much of the normal healthy pulpal tissue as can be retained, wherever possible. 
Historically, it could be argued that modern endodontics began with the gold foil 
capping of cariously exposed pulps by Pfaff about two hundred and fifty years ago 
(Dammaschke, 2008). It is likely this treatment, or something similar, had been 
widespread previously before being rediscovered, as there is evidence of attempted 
endodontic work in countries around the Mediterranean and Middle East (Zias and 
Numeroff, 1987). 
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Figure 11. Images of Dental Treatment from Antiquity.  
Hesi-Re (left) “Chief of the Toothers”. Unknown Arab dentist (right).  
Internet images from public domain. 
The conventional methods of root canal therapy have been around for decades and a 
wide variety of materials have been tried including asbestos, silk, cotton, wool, 
paper, fiddle string in creosote, orange wood dipped in phenol, gold thread, copper 
thread, ivory cones, beeswax and numerous others (Gethro, 1919). 
There is evidence that Asa Hill (1847) developed the first gutta percha root canal 
filling material, known as “Hill’s Stopping” which was composed of powdered 
quartz, carbonate of lime and bleached gutta-percha and patented it the following 
year (Thorpe., 1909), thus heralding the beginning of gutta-percha as an endodontic 
filling material although in some instances it was only placed over the canal orifice 
and not within the canal (Grossman, 1976). Later in 1867, G. A. Bowman, a St. 
Louis dentist was attested to have used gutta-percha points to pack root canals 
(Grossman, 1976) and gutta-percha points began to be marketed to the dental 
profession in 1887 by S.S. White Co. (Keane, 1944). 
Silver points became available in the 1930s but have increasingly fallen out of 
favour after it was demonstrated that it was virtually impossible to produce round 
canals to match the diameter of the silver points (Schneider, 1971) and round apical 
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root canal orifices are only found in a certain percentage of root canals, with other 
canal orifice shapes being defined as oval, asymmetric, semilunar, hour glass-shaped 
and serrated (Green, 1956). It was further observed that silver points corrode in the 
root canal, resulting in toxic corrosion products and leakage (Brady and del Rio, 
1975). 
Currently, the material most widely used for root canal obturation is gutta percha, a 
naturally occurring form of rubber (either cis, or trans-polyisoprene), along with 
sealing cement, or a softening agent, depending on the technique being employed 
(Goodman et al., 1974). It is generally accepted not to be the perfect material for this 
purpose as it doesn’t fulfil the three main criteria of the ideal endodontic filler 
namely: entomb any bacteria remaining within the root canal system; prevent the 
influx of any serum or bodily fluids back into the root canal system to nourish the 
aforementioned bacteria and prevent coronal leakage of bacteria into the root canal 
system (Hovland and Dumsha, 1985), but the least bad of those available, as 
ultimately any material will eventually leak to some degree and can potentially 
reinfect (Ainley, 1970). Chemically pure gutta percha exists in two different 
crystalline forms, alpha and beta. These are interchangeable depending on the 
temperature of the material with both the alpha and beta forms used clinically, 
usually mixed with other materials such as zinc oxide to produce a material which 
can be readily used within the root canal. 
1). Although the claimed success rates for endodontic treatment can 
reach as high as 97% after an eight-year period there are still drawbacks in 
what might appear to be an otherwise successful therapy (Freire and 
Archegas, 2010, Salehrabi and Rotstein, 2004, Sedgley and Messer, 1992). 
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2). Endodontically treated teeth often discolour and darken  
3). They are more brittle and prone to fracture, especially in the molar 
region where occlusal forces are higher  
4). The increased brittleness requires more extensive restorative 
procedures in order to ‘protect’ the tooth leading to further tooth substance 
loss. 
5). Any decay which occurs progresses much more rapidly than in a vital 
tooth. 
6). Removal of dentine bulk can weaken the tooth. 
7). Endodontically treated teeth with post-retained restorations have less 
bone supporting them. 
8). Insertion of post-retained restorations can act like a wedge, splitting 
the tooth during masticatory function. 
9). Because of the lack of tissue pressure and immune response, 
endodontically treated teeth can re-infect and cause abscess formation. 
10). If unsuccessful, revision endodontics or further surgery such as 
apicectomy may be necessary. 
In short, the present ‘gold standard’ root filling materials impart few if any of the 
tooth’s physiological requirements and a new, replacement, tissue engineered dental 
pulp would be a much better therapeutic option (Aptekar and Ginnan, 2006, Eliasson 
et al., 1995, Murray et al., 2007). 
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1.10 Dental pulp tissue engineering 
The first usage of the term ‘Tissue Engineering’ in its current context as opposed to 
its previous usage to describe prosthetic devices and surgical manipulation of tissues 
was in an article entitled ‘Functional Organ Replacement: The New Technology of 
Tissue Engineering’, published in Surgical Technology International in 1991 
(Vacanti, 2006). The first publication to broadly describe the technology behind 
tissue engineering (in its current usage) was published earlier in 1988 (Vacanti, 
2006). 
There are many definitions of the term Tissue Engineering, for example ‘an 
interdisciplinary field applying the principles of engineering and life sciences toward 
the development of biological substitutes that restore, maintain or improve tissue 
function’ (Langer and Vacanti, 1993). Others have defined it as ‘understanding the 
principles of tissue growth and applying this to produce functional replacement 
tissue for clinical use’ (MacArthur, 2005) and it has further been defined as ‘the 
employment of biologic therapeutic strategies aimed at the replacement, repair, 
maintenance and/or enhancement of tissue function (Murray et al., 2007). Not to be 
outdone, it has also been described as ‘the application of principles and methods of 
life sciences and engineering combining towards the fundamental understanding of 
structural and functional relationships found in normal and pathological mammalian 
tissues and the development of biological substitutes to restore, maintain or improve 
tissue function’ (Shalak, 1988). This has been further expanded as the application of 
scientific engineering principles to the design, construction, modification, growth 
and maintenance of living tissue and organs from native or synthetic sources for the 
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human body to restore function based on principles of molecular developmental 
biology, cell biology and biomaterial sciences (Boyan et al., 1999). Overall, the goal 
of tissue engineering is to surpass the limitations of conventional treatments based 
on organ transplantation and biomaterial implantation (Langer and Vacanti, 1993) 
and its basic premise is that the repair and regeneration of biologic tissues can be 
guided through application and control of cells, materials, and the microenvironment 
into which these cells are delivered (Vacanti and Vacanti, 2000). The normal 
protocols of tissue engineering require cells, a scaffold for them to attach to, 
morphogenetic cues and/or growth factors along with nutrients in order to 
recapitulate the developmental events which served to grow the tissue or organ ab 
origine (Chan and Leong, 2008, Murphy et al., 2013, O'Brien, 2011). 
One other avenue of investigation could be gene therapy to convey genes for 
morphogens/growth factors, transcription factors and extracellular matrix molecules 
on a local level to somatic cells, with a therapeutic effect. Theoretically, the gene 
conveyed can stimulate or induce the desired natural biological process by 
expressing the necessary molecules involved in a regenerative response for the 
desired tissue (Bonadio et al., 1999). Either viral or non-viral vectors are used for 
the gene uptake and expression. Presently, adenoviral, retroviral, herpes simplex 
virus and lentivirus are being developed to eliminate their disease potential for 
therapeutic gene transference (Jullig et al., 2004, Naldini et al., 1996). Non-viral 
systems include electroporation, sonoporation, deoxyribonucleic acid (DNA) -ligand 
complex and gene gun applications to address the safety concerns associated with 
the viral methods. Most risk from gene therapy seems to arise from the vector used 
rather than the gene expressed (Jullig et al., 2004). Consequently, widespread 
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clinical application is unlikely until safe, affordable, simple and efficient vectors are 
available which can express the required level of transgene for an adequate length of 
time (Parikh, 2004). 
 
1.11 The model for dental pulp regeneration in nature 
In nature there already exists a well-studied model for dental pulp regeneration and 
the commonest ‘naturally-occurring’ human model for pulp regeneration occurs 
when upper incisor teeth are either avulsed or subluxed out of their sockets during 
facial trauma and then replaced. It has been shown (Kling et al., 1986) that there are 
several factors that need to be taken in to account for the successful 
revascularisation of teeth after reimplantation. 
1) Time the tooth has spent out of the socket. 
2) Interim storage conditions. 
3) The state of maturity of the tooth i.e. the width of the apical foramen and the 
apical-coronal length of the pulp. 
Andreasen and Andreasen (Andreasen, 1994) reported that “The relationship 
between the diameter of the apical foramen and the chance of pulpal 
revascularisation apparently is an expression of the size of the contact area at the 
pulpo-dental interface….whereas the length of the root canal probably reflects the 
time necessary to repopulate the ischaemic pulp. With a favourable ratio (i.e. a broad 
apical foramen and short canal as opposed to a narrow apical foramen and a long 
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root canal), the odds for an intervening pulpal infection are reduced. A limiting 
factor in pulpal revascularisation appears to be an apical diameter of less than 
1mm”. Thus it would appear that any method of tissue engineering a new dental 
pulp could require an apical opening of 1mm or greater. However, this could also be 
described as a simplistic view as most reimplantation studies are done on young or 
adolescent children who are still growing and have a much better healing response 
potential. Alternatively, it might also be argued that in a mature adult, the amount of 
materials and nutrients necessary for a purely soft tissue pulp - as opposed to one 
which is still involved in laying down large amounts of dentine, root formation and 
pulp tissue formation - wouldn’t be as great, so this might be the more advantageous 
situation. Other individual case histories support the younger patient. In one case 
(Iwaya et al., 2001) the 13-year-old female patient had a lower premolar tooth with 
an open apex and a draining sinus which, following the appropriate washing out of 
necrotic tissue, double antibiotic therapy and sealing of the access cavity, continued 
to grow and complete apexification. In another case, an 11-year-old boy with a tooth 
similar to the above had a similarly successful outcome using a slightly different 
treatment protocol where the immature apex of the tooth was instrumented to make 
it bleed in a controlled fashion back up the root canal. The tooth was then sealed 
with MTA and a temporary dressing, followed by a definitive bonded composite 
resin restoration two weeks later (Banchs and Trope, 2004). In the former case, there 
does appear to be radiographic evidence in the article that the pulp space was 
continuing to calcify and sclerose following the successful apexification of the tooth, 
which could suggest that any remaining pulp tissue and blood clot which in effect 
became the scaffold for the soft tissue ingrowth, initiated a repair process as opposed 
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to a regeneration process following the application of calcium hydroxide to the 
remaining pulp tissue and that conventional endodontics might be necessary to 
retain the tooth for the future. When comparing the above two protocols 
(apexification cf. revascularisation) revascularisation has been shown to increase 
radicular reinforcement and root length extension (Diogenes et al., 2013) when 
compared with teeth treated via the apexification protocol using CaOH2 (Jeeruphan 
et al., 2012, Moreno-Hidalgo et al., 2014). 
 
1.12 Requirements for dental pulp tissue engineering 
The dental pulp has recognised, definite powers of repair and regeneration 
(Nakashima, 1994) and the bridge of reparative dentine produced is biologically 
superior to any restorative material yet available (Smith and Lesot, 2001). As with 
any projected tissue engineering construct, any regenerated pulp will need stem 
cells, morphogens and a scaffold for the cells to attach and differentiate upon into 
functional tissue (Demarco et al., 2011). 
 
1.12.1 Cells 
DPSCs can self-renew and have multi-lineage capacity in vitro and it has been 
suggested that DPSCs are closely associated with pulpal blood vessels, especially 
pericytes and smooth muscle cells (Shi and Gronthos, 2003). The demonstration of 
specific markers in DPSC differentiation pathways is still uncertain, as there is as 
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yet no single definitive marker for odontoblasts or DPSCs. Also, DPSCs would be 
available in a partially-vital pulp, but would be absent in a completely non-vital 
pulp, so it is possible that other cells e.g. from the gingival tissues or periodontal 
ligament cells might have to be used as source cells to regrow a new pulp into an 
empty pulp canal and chamber system (Rutherford and Gu, 2000). However, DPSCs 
are capable of long-term cryopreservation and retain their capability to differentiate 
and their differentiated cytotypes proliferate, produce woven bone tissue and express 
all their respective surface antigens, confirming cellular integrity (Papaccio et al., 
2006). 
 
1.12.2 Scaffold 
Following pulp capping with calcium hydroxide, pulp cells eventually adhere to an 
osteodentine layer before differentiation into odontoblasts (Schroder, 1985). Other 
studies (Anneroth and Bang, 1972, Nakashima, 1990, Nakashima, 1994, Tziafas and 
Kolokuris, 1990) suggest that there is a requirement for an appropriate 
physicochemical surface for odontoblast differentiation. The mechanisms involved 
in this are still unclear (Nakashima and Reddi, 2003). Fibronectin plays a role in the 
interactions between ECM and cells to reorganise the cytoskeleton of the polarising 
odontoblasts overall pulpal wound healing process and also facilitates the binding of 
signalling molecules. Collagen facilitates arrangement of preodontoblasts and binds 
newly matured odontoblasts to pulp tissue, thereby supporting a reparative 
dentinogenesis network (Kitasako et al., 2002). Synthetic extracellular matrix may 
also be a likely scaffold candidate for reparative dentinogenesis and pulp 
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regeneration (Bohl et al., 1998). Mineral trioxide aggregate (MTA) – a well-
established pulp capping agent - while unlikely to be a scaffold in its present form, is 
likely to be a good ‘lid’ to seal any access cavity into the tooth and also to promote 
odontoblast differentiation and reparative dentine formation on the surface of any 
regenerated dental pulp (Torabinejad and Chivian, 1999), as would Biodentine, a 
combination of tri and dicalcium silicate, calcium carbonate and oxide filler, iron 
oxide shade and zirconium oxide (Malkondu et al., 2014). Previous animal studies 
have shown that high molecular weight HyA can be used to facilitate reparative 
dentine formation in amputated rat molar pulps (Sasaki and Kawamata-Kido, 1995). 
 
1.12.3 Morphogens 
Morphogens produce inductive signals which function as growth and differentiation 
factors in odontoblast differentiation. Originally isolated from demineralised bone 
matrix, bone morphogenic proteins (BMPs) (Urist, 1965) such as BMP2 can have 
various effects on pulp cells, e.g. adult pulp cells are stimulated to differentiate into 
odontoblasts in monolayer cultures under the influence of recombinant human 
BMP2 (Nakashima, 1994, Saito et al., 2004) and also in three dimensional pellet 
cultures (Iohara et al., 2004). Millipore filters with human TGFβ implanted 
intrapulpally induced odontoblast differentiation and reparative dentine formation in 
close proximity to the implants (Tziafas et al., 1998) showing the efficacy of this 
morphogen for odontoblast differentiation in the pulp (Tziafas, 2004). It is not yet 
clear what controls the abrupt transition of stem and progenitor cells from quiescent 
to active state regarding differentiation, proliferation, migration and matrix secretion 
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as the sequelae of pulp tissue injury and the molecular mechanisms of control for 
morphogen release require further elucidation to be useful in regenerative 
endodontics. 
 
1.12.4 Vascular regeneration 
The dental pulp vascular system is vital for nutrient supply and removal of waste 
metabolites. Its contribution to any pulp regeneration would be immense as the 
importance of vasculature to any tissue repair and regeneration is well known. 
Vascular endothelial growth factor (VEGF) is a regulator of angiogenesis and 
increases vascular permeability. It also induces chemotaxis, proliferation and 
differentiation of dental pulp cells (Artese et al., 2002, Matsushita et al., 2000) and 
is present in dentine matrix (Roberts-Clark and Smith, 2000). VEGF’s presence in 
dentine suggests there might be endothelial progenitor cells in the pulp tissue 
alongside the progenitors for neuronal cells and odontoblasts (Gronthos et al., 2002) 
and it is likely that VEGF and vascular endothelial cells are crucial for dentine 
regeneration. 
 
1.12.5 Neural regeneration 
Firstly, we must remember that were predictable peripheral sensory and motor nerve 
regeneration possible, spinal cord injuries involving severance would not result in 
their current sequelae. The rich innervation of the dental pulp includes both sensory 
and sympathetic nerves (see previous section on innervation). Their interactions, 
location and function with pulp tissue, vasculature and immune cells all differ 
 48 
 
(Byers et al., 2003) and the cytochemical location of neurofilaments, NGF, GDNF 
and CGRP vary with the type of nerve fibre (Byers et al., 2003). Embryologically, 
the temporal sequence of pulp innervation depends on gradients of neurotrophic 
growth factors coming from the pulp cells. Dental pulp expresses NGF, BDNF and 
GDNF (Nosrat et al., 2004). As already stated, the pulpal innervation is crucial in 
the homeostasis of the dental pulp. Sensory nerves stimulate invasion of immune 
and inflammatory cells into sites of injury (Fristad, 1997). Sensory denervation 
gives rapid necrosis of any exposed pulp cells because of impaired blood flow and 
extravasation of immune cells (Byers and Taylor, 1993, Fristad, 1997, Holland et al., 
2001, Olgart, 1996) and reinnervation leads to recovery in coronal dentine, which 
Schwann cells seem to play a role in by releasing neurotrophic growth factors and in 
recruiting sensory and sympathetic nerves during the process. Some members of the 
BMP family also have effects on neurogenesis (Mabie et al., 1999) possibly 
enabling them to have a dual role in pulp regeneration. There is also the intriguing 
possibility that nerve tissue may not be a requirement for functional pulp 
regeneration, as there is at least one claimed example of mammalian dental pulp 
tissue which doesn’t contain nerve tissue (Fagan et al., 1999) although this has been 
contradicted by later investigators (Boy and Steenkamp, 2004). 
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1.13 Dental pulp tissue engineering: Current Status 
At present, there is keen interest in the development of a protocol for the tissue 
engineering of a dental pulp, primarily to encourage better formation of a calcific 
barrier in the case of cariously or traumatically exposed dental pulps (Hermann, 
1952), in the case of immature apex formation to develop apical closure (Damle et 
al., 2012) or completion of root formation (Diogenes et al., 2013). To this end, there 
have been numerous studies, usually involving the application of BMPs 
(Nakashima, 1994) onto exposed pulp tissue and investigation of the resultant 
calcific barrier. The success of these procedures was probably just as equally 
attributable to the germ-free conditions as the technique. This had been shown much 
earlier in tests which showed that any pulp capping material would give rise to a 
calcific barrier if used in germ-free conditions (Paterson, 1976) and also using no 
material whatsoever would still give rise to a calcific barrier in germ-free conditions 
(Kakehashi et al., 1965). However, in another study, exposed dental pulps that had 
been treated with a bacterial lipopolysaccharide were able to develop little or no 
reparative dentinogenesis (Rutherford and Gu, 2000). This would potentially 
seriously limit the clinical applications of BMPs and patient usefulness as most pulp 
exposures are as a result of involvement with caries with all the concomitant 
bacterial infection, inflammatory sequelae and resultant complications, often with 
the added complication of salivary contamination. Currently, there is no uniform 
protocol for these studies but many investigators use the tooth slice model in 
immunodeficient rodents as it has a proven track record of success and enables 
investigators to control desired parameters such as cell types, scaffolds and 
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morphogens with others using the canine model (Goncalves et al., 2007, Magloire et 
al., 1996, Mullane et al., 2008, Sakai et al., 2011, Sakai et al., 2010, Sloan et al., 
1998, Nakashima and Iohara, 2014). 
 
1.14 Potential clinical problems in dental pulp tissue engineering 
Bacterial invasion and colonisation of a devitalised tooth and how to prevent it is a 
continual complication for all clinicians and patients. One study (Nagaoka et al., 
1995) compared the rates of bacterial ingress along dentinal tubules in cervical 
cavities prepared in vital and non-vital teeth at 30 and 150 days and found that there 
was a significant difference in the bacterial invasion rate between the two groups of 
teeth, with the non-vital teeth having much higher levels of bacterial infiltration 
along the dentinal tubules. This would suggest that any pulpal regeneration would 
have a finite time to become established, or at least give rise to a positive pulpal 
pressure, before becoming infected from bacterial ingress along the dentinal tubules 
of the coronal and radicular sections of the root canal. There would also be the 
necessity for a good coronal seal preventing leakage as this has a bearing on the 
success of conventional endodontics (Ray and Trope, 1995) although other authors 
have elucidated several other factors to be taken into consideration when assessing 
the success or failure of endodontic treatment (Ng et al., 2011). There is potential, 
however, to perhaps at least partially negate these effects by inclusion of 
antimicrobials to diffuse along the tubules far enough to halt or slow down bacterial 
ingress until any new pulp graft becomes established and this has been successful in 
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the past (Banchs and Trope, 2004) although antimicrobial levels sufficient to inhibit 
bacterial ingress may have deleterious effects on new pulp cell growth. 
As discussed above, the ideal three-dimensional scaffold has yet to be established 
and while some researchers have used ground substance components in 
experimentation (Ferroni et al., 2015, Smith et al., 2015) no one has yet fully 
expounded its role and relative importance in embryonic pulp development and 
growth. 
The main problem however, would be the re-establishment of a new blood supply 
into the nascent pulp tissue as no cells would be able to survive without one and it is 
unlikely that a normal sized mature apical foramen would be large enough to 
accommodate a blood vessel of sufficient diameter to supply a growing pulp. The 
likely adopted method to enlarge an apical foramen would be patency filing 
(Buchanan, 1989) which is to this day a contentious area of both endodontology 
thought and practice, totally contradicting many areas of teaching and clinical 
practice promoted by both teachers and practitioners. Addressing the issue of blood 
vessel construction, since the production of the first tissue engineered blood vessel 
(Weinberg and Bell, 1986) improvements in static patency (L'heureux et al., 1997), 
vessel wall thickness, improved suture retention, physiological smooth muscle cell 
density and patency achieved in pulsed growth conditions (Niklason, 1999) and 
grafts have all been grown in the recipient’s own peritoneal cavity (Campbell et al., 
1999). However, the replication of small diameter blood vessels of < 6mm still 
eludes researchers (Sarkar et al., 2005) and this is still vastly larger than the size of 
those required for the dental pulp, so not only access to the regenerating pulp would 
be impossible, the diffusion of nutrients and O2 limits the distance from blood 
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vessels to a 500 μm maximum (Sachlos and Czernuszka, 2003) although later 
studies have made progress in the field of in vitro capillary matrices (Montano et al., 
2010). Until this most fundamental aspect of regeneration is solved, perhaps by the 
combined use of proteins more often found in higher levels in the foetus as a 
microscaffold used down to the nanotopographical level and VEGF, encapsulated in 
microbead delivery vessels, the risk of necrosis in the centre of any newly grown 
pulp would be high. 
Endodontic treatment of teeth is ripe for change away from a therapeutic protocol 
and train of thought allied to materials and techniques available and originating in 
the 19
th
 Century and gradually modified since, in an attempt to alleviate any inherent 
shortcomings. Tissue Engineering is the logical future pathway to explore and 
Endodontic regeneration the logical method by which to achieve the re-
establishment of a vital living tissue inside a previously wholly or partly devitalised 
tooth, mimicking what can occur spontaneously when an immature incisor for 
example, suffers trauma such as sub-luxation and re-establishes vital pulp tissue, 
continuing root formation and apexification, and there have and continue to be 
strong calls from Academia to that effect (Murray et al., 2007). 
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1.15 Angiogenic markers 
Cell surface markers of angiogenesis provide useful tools with which to characterise 
cell populations when investigating tissue engineered constructs where angiogenesis 
is an important end result. CD 31 and CD34 were chosen because of their 
conservation between different species, enabling them to be easily accessible for 
immunohistochemistry purposes and also as they are early markers of angiogenesis, 
again across most species. 
 
1.15.1 CD31 Angiogenic marker 
Cluster of Differentiation 31 (CD31, also known as platelet endothelial cell adhesion 
molecule-1, or PECAM-1) is a 130-kDa transmembranous glycoprotein and a 
member of the immunoglobulin (Ig) superfamily. It comprises of six extracellular Ig 
domains, a cytoplasmic domain and a transmembrane domain (Newman, 1997). 
CD31 has been shown to contain intracytoplasmic immunoreceptor tyrosine 
inhibitory motifs (ITIMS), which, following phosphorylation, are able to mediate an 
inhibitory function via recruitment and activation of protein-tyrosine phosphatases 
(PTPs), mainly Src homology region 2 domain containing phosphatase 1 (SHP-1) 
and SHP-2, which are crucial for T cell response (Hua et al., 1998, Jackson et al., 
1997, Lorenz, 2009). CD31 is found expressed in leukocytes, monocytes, 
neutrophils, macrophages (Pusztaszeri et al., 2006), concentrated at the lateral 
junctions of endothelial cells and obviously, platelets. It was firstly identified as a 
cell to cell adhesion molecule which mediated cellular adhesion through self-
association (Pinter et al., 1997). As a bioactive molecule, CD31 has been shown to 
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be involved in numerous biological processes such as platelet aggregation and 
homeostasis, thrombosis, maintenance of the vascular endothelial barrier function, 
mechanosensing of endothelial cell response to fluid shear stress (Woodfin et al., 
2007), leucocyte migration during the inflammatory response to sites of injury and 
bacterial ingress and development of the vasculature (DeLisser et al., 1997, Ferrero 
et al., 1995, Thompson et al., 2001). As such, CD31 has been described as more than 
a marker for endothelial cells (Liu and Shi, 2012). 
CD31 has been shown to have an important role in the inhibition of tumour-induced 
angiogenesis by the use of anti-CD31 antibodies in several animal models and it has 
been demonstrated that CD31 has a role in the cell to cell association of endothelial 
cells which is a prerequisite for endothelial tube formation which itself is a precursor 
to blood vessel formation (Cao et al., 2002, Pinter et al., 1997, Thompson et al., 
2001). 
1.15.2 CD34 Angiogenic marker 
CD34 is a transmembrane glycoprotein initially identified on haematopoietic stem 
and progenitor cells (Civin et al., 1984), having a molecular weight of 
approximately 115 kDa with a heavily sialylated, O-linked glycosylated 
extracellular domain which also contains some N-linked glycosylated sites (Sidney 
et al., 2014). The commonest ligand for CD34 is L-selectin (or CD62L) but the 
adapter protein CrkL (Crk-like), a phosphorylated tyrosine, which is involved in 
adhesion regulation also binds to it (Baumheter et al., 1993, Felschow et al., 2001). 
It is found in many multipotent precursor cells of the haematopoietic system, hair 
follicle stem cells, mast cells, embryonic fibroblasts, eosinophils and vascular 
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endothelial cells (Brown et al., 1991, Fina et al., 1990, Nielsen and McNagny, 
2008). The complete functionality of this molecule has not yet been fully elucidated, 
but amongst others, it has been reported to stimulate proliferation and block 
differentiation of progenitor cells and to enhance the migration and trafficking of 
haematopoietic cells (Nielsen and McNagny, 2008). It has been used for the 
isolation of haematopoietic stem and progenitor cells and as a marker to identify 
some tissue specific stem cell such as muscle satellite cells and epidermal cell 
precursors. Thus, it has been widely used both as a haematopoietic stem cell marker 
and a vascular endothelial cell marker (Fina et al., 1990, Hristov and Weber, 2008, 
Sato et al., 1999). Peripherally circulating CD34
+
 cells have been examined for 
utilising in neovascularisation therapies (Mackie and Losordo, 2011) and can 
differentiate into osteoblasts (Tondreau et al., 2005) and cardiomyocytes (Zhang et 
al., 2004). There is also a subset of CD34
+
, noncirculating adult endothelial cells 
predominantly found within smaller blood vessels, whereas the majority of 
endothelial cells in larger arteries and veins are CD34
-
 (Fina et al., 1990). 
Endothelial cells typically have a ‘cobblestone’ morphology, whereas CD34+ cells 
have a more pronounced elongated morphology and are lacking in tight junctions 
(Siemerink et al., 2012). Predominantly found on the luminal membrane of cellular 
processes, CD34 expression can also be detected on the abluminal membrane of 
cells situated at the tip of vascular sprouts (Fina et al., 1990, Schlingemann et al., 
1990). Additionally, CD34
+
 endothelial cells are quiescent and considered to be 
involved in adhesion and migration (Fina et al., 1990). 
Human umbilical vein endothelial cells (HUVECs) are CD34
+
 in vivo but after 
several passages of culture CD34 expression is lost and only a relatively small 
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population of CD34
+
 cells are left (Fina et al., 1990). They have distinctive 
morphological characteristics such as numerous filopodia (Siemerink et al., 2012). 
Migration of these cells is started by angiogenic stimuli and it has been proposed 
that this CD34
+
 subpopulation is analogous to sprouting tip cells which are a 
specialised type of endothelial cell found at the leading edge of in vivo angiogenesis 
(Siemerink et al., 2012). At sites of active angiogenesis, CD34 is strongly expressed 
on the filopodia of angiogenic tip cells showing the important functional role for 
CD34 in progenitor cell activity (Sidney et al., 2014). 
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Chapter 2: Aims and Objectives 
The clinical need for a reliable, effective, Dental Surgeon user-friendly method of 
dental pulp regeneration that is also acceptable to patients is apparent from 
examining the literature (Murray et al., 2007). The hypothesis to be tested in this 
thesis is that constructs comprising of DPSCs together with a scaffold suited 
structurally and physiologically to that found in a dental pulp could be used to 
regenerate dental pulp-like tissue in vitro and in vivo. Such a scaffold would ideally 
comprise of a mixture of the main constituents of dental pulp, incorporating Types I 
and III collagen and HyA, which are already licenced for therapeutic use in humans 
and which can incorporate nutrients and if necessary, morphogens. 
The overall aim of this work was to induce early angiogenic change in DPSCS in 
vitro and in vivo using a biomimetic approach based on combining scaffolds 
comprised of ECM components with human dental pulp stromal cells as a the first 
steps towards a tissue engineering strategy for pulp regeneration. 
The specific objectives are summarised as follows: 
 To determine whether DPSCs can be cultured on biomimetic scaffolds 
comprising of hyaluronic acid and Types I and III collagen (either singly or 
in combination) both in vitro and in vivo. 
 To investigate if either hyaluronic acid or Types I and III collagen matrices 
used either singly or in combination can support/induce early angiogenic 
change in DPSCs both in vitro and in vivo. 
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Chapter 3: Materials and Methods 
3.1 General Materials 
Cell culture flasks, plates and other plastics were purchased from Corning 
(Amsterdam, Netherlands). Alpha-modified minimum essential medium (α-MEM), 
phosphate buffered saline solution (PBS) and foetal calf serum (FCS) were 
purchased from Lonza (Slough, U.K.). Antibiotics, enzymes, and other reagents 
were purchased from Sigma (Poole, U.K.). Growth factors and antibodies were 
purchased from AbCam (Cambridge, U.K.). Other laboratory supplies were obtained 
as indicated in the text. 
DPSCs were isolated from teeth donated for research purposes immediately post-
extraction in the Department of Oral Surgery, School of Dentistry, Leeds Dental 
Institute (LDI) with full written consent from the patient and appropriate ethical 
approval (LDI Research Tissue Bank: LREC 07/H1306/93; Tissue Bank reference 
number: 180808/HR/12) and in accordance with the Human Tissue Act. The age and 
sex of the patient were recorded along with the tooth notation wherever possible for 
record-keeping purposes but all teeth were anonymised prior to distribution to the 
researcher. 
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3.2 Harvesting of the dental pulp organ 
Teeth obtained as described above from the Research Tissue Bank were 
predominantly unrestored upper and lower third molars which were being removed 
due to their causing cheek trauma and/or pericoronitis, or premolar teeth extracted 
for orthodontic purposes. The dental pulp organ was harvested in accordance with 
an established departmental protocol (El-Gendy et al., 2015) as follows. The teeth 
were transported to the tissue culture laboratory and placed in a sterile petri dish 
inside a laminar flow hood. Teeth were initially cleaned by scalpel to remove any 
gross debris such as calculus, obvious food and plaque deposits, blood clots and 
adherent soft tissues. The teeth were then washed 2 to 3 times with sterile 1x PBS to 
remove any remaining stubborn debris, sprayed externally with 70% ethanol which 
was allowed to evaporate, then picked up coronally by a gloved hand (after spraying 
the glove with 70% ethanol and allowing it to evaporate) between the thumb and the 
forefinger. The glove was then everted placing the tooth inside the thumb tip which 
was then wrapped in paper towel, taken to a workshop vice and crushed. After 
returning to the tissue culture hood and cutting off the thumb tip into a sterile petri 
dish, the pulp tissue was dissected out using a combination of scalpels, dental 
explorers and fine tweezers (see Figure 12). After this it was sectioned by scalpel for 
explant culture or collagenase digest. 
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Figure 12. In situ  image of a dissected dental pulp from a lower left first molar. 
 
Image displaying an intact complete dissected dental pulp, with the entire 
dental pulp contents: coronal pulp and pulp horns (indicated by the green 
arrows), the distal root canal dental pulp (indicated by the white arrow) 
and the two mesial root canal dental pulps (mesio-buccal indicated by the 
left yellow arrow; mesio-lingual indicated by the right yellow arrow). The 
two blue coloured arrows indicate the apical blood vessels. The other scuff 
marks on the dish surface (bottom left) were caused by instruments 
during dissection and positioning of the sample during image taking. 
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3.3 Isolation of DPSCs via the pulp explant method 
Following the above initial dissection process, the pulp was then transferred into a 
sterile petri dish and segmented, usually into six pieces comprising of the upper 
coronal pulp, the lower coronal pulp, the coronal section of the root-canal pulp, the 
radicular root-canal pulp, the apical root-canal pulp and any extraneous pulpal soft 
tissue such as the dental papilla beyond the tooth root which came with the tooth 
during extraction of teeth with open apices (see Figure 14). These sections of pulp 
were cultured in either a 6 well plate or T25 flasks with αMEM/10% FCS at 37°C in 
5% CO2/air until outgrowth of cells from the explants became observable. If no 
outgrowth of cells was visible after three weeks, or if the pulp tissue sample had 
failed to attach to the plate or flask, the sample was discarded. The cells were 
passaged at 80% confluence until passage 3 then either used for experimentation or 
frozen for future use. For alkaline phosphatase (ALP) staining, the explant samples 
were fixed in 98% ethanol overnight prior to use (see Appendix A for complete 
protocol). 
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Figure 13. Dissected lower premolar pulp in DMEM/10%FCS. Scale in 
millimetres  
1) Coronal Pulp; 2) Lower Coronal Pulp; 3) Lower Coronal/Upper 
radicular Root Canal Pulp; 4) Radicular Root Canal Pulp; 5) Apical Root 
Canal Pulp; 6) Extraneous Pulp Tissue (Apical Papilla – potential source 
of stem cells from the apical papilla (SCAP) cells). 
Figure 14. Pulp tissue cut into 3 mm sections. 
Site specific culture of dental pulp: 1. Upper coronal pulp. 2. Lower 
coronal pulp. 3. Upper coronal part of the root canal pulp. 4. Radicular 
root canal pulp. 5. Apical root canal pulp. 6. Dental papilla in adjacent 
flask. 
 
For ALP staining, the cell explants were first stopped in 98% ethanol overnight in 
their 6 well plate. Next day the 98% ethanol was drained off and replaced with PBS 
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for 10 minutes, during which the following reagent was made up in these 
proportions: 9.6 mL of distilled water was added to 0.4 mL of Naphthol A5-MX 
phosphate alkaline solution (Sigma-Aldrich), to which was added 2.4 mg of Fast 
Violet B salt. This was mixed thoroughly, the PBS was removed from the explant 
samples and enough reagent was added to cover the explants. It was then left for a 
minimum of 30 minutes for the reaction to take place. After obvious colour change 
had occurred, the solution was drained off and images were taken of the explants.  
The DPSCs from T175 flasks for cryostorage were collected at passage 3, 4 or 5 by 
detaching with 10 mL. of 1x trypsin/edta solution. Five millilitres of FCS were 
added and then they were spun down at 600g for ten minutes. The supernatant was 
carefully drawn off then the cells were resuspended in FCS/10% dimethyl 
sulphoxide (DMSO) in cryotubes and placed into the insert of a Mr. Frosty™ 
freezing container (Thermo Scientific™) containing isopropyl alcohol around the 
insert holding the cryotubes and placed in a minus 80°C freezer to cool at minus 1°C 
per minute until frozen, thereby giving optimal cell preservation.  
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3.4 Isolation of DPSCs by the collagenase digest method 
The following method of DPSC isolation was used for all other investigations 
described in this thesis from Section 3.11.3 onwards. Pulp explants, harvested as 
described above in section 3.3 were treated with collagenase P (Roche, Pensberg, 
Germany) to allow release of the cells from the intact tissue. This was a 
modification of the collagenase/dispase method used by other authors in previous 
studies (Gronthos et al., 2002, Huang et al., 2006). The collagenase digest method 
was adopted as it gave a greater and much more rapid release of cells from each pulp 
sample between the second and third passage, thus giving better yield in comparison 
to the pulp explant method (see Results section 4.1.2). Following its retrieval from 
the tooth, the pulp tissue was finely chopped using two scalpels fitted with no. 15 
blades (Swann Morton Ltd., Sheffield, England) in the base of a sterile Petri dish. 
This was done quickly in the laminar air flow hood to avoid dehydration of the 
tissues, with any small fragments being ‘parked’ in αMEM/10% FCS or in PBS, in a 
separate Petri dish until required for the next stage of the protocol. The resultant 
fragments were placed into a sterile 5 mL test tube and immersed in a solution of 
collagenase P diluted to a concentration of 5 mg/mL in PBS (with no added Mg
2+
 or 
Ca
2+
) for at least 30 minutes at 37°C and 5% CO2 in a tissue culture incubator, with 
the test tube lid being ’cracked open’ half a turn to allow for gas exchange. Every 5-
10 minutes, the test tube was removed from the incubator, its lid secured and then 
vortexed for one minute at full power to ensure even mixing and exposure of the 
tissues to the collagenase, then returned to the incubator as before. When the minced 
fragments of dental pulp were adjudged by eye to have dissociated as far as possible 
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at a time never greater than 60 minutes, 50% FCS (per volume) was added to the 
mixture to halt the reaction. The cell suspension was centrifuged at 600 g for 10 
minutes, the supernatant carefully pipetted off and the resultant cell pellet 
resuspended in αMEM. This was then passed through a 70 µm cell strainer (BD 
Falcon™ California, USA) to obtain a single cell suspension. The cells were then 
cultured in T75 flasks in αMEM/10% FCS, supplemented with 200 mM L-
glutamine and 100 units/mL penicillin/streptomycin at 37°C and 5% CO2 with 
weekly changes of medium. 
 
3.5 Counting and passaging DPSCs 
After reaching 80-90% confluence (confirmed by light microscopy), the 
αMEM/10% FCS medium was discarded and the cell layer was washed twice with 
5-10 mL of 1× PBS to remove any extraneous FCS (FCS interferes with the serine 
protease function of the trypsin/EDTA solution). The PBS was drained off, then 10 
mL of 1x 0.25 mM trypsin/ethylenediaminetetracetic acid (EDTA) was added to the 
T 175 flask for approximately 5-10 minutes to detach the cells. Periodic observation 
by microscope was used to monitor this process. Once all the cells were detached 
and in solution, the reaction was then halted by adding 2.5 mL of FCS and 5 mL of 
αMEM to re-suspend the cells, the whole then being placed in a test tube and 
centrifuged at 1100 rpm for 5 minutes. The supernatant was carefully removed 
without disturbing the pellet and the pellet was re-suspended in plain (i.e. no FCS) 
αMEM. This was vortexed to ensure even distribution in the liquid. A 30 µL sample 
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from this was then applied to the central groove of the haemocytometer and a cover 
slip applied. Under a microscope, the cells were counted in five demarcated fields 
with the numbers being added up. This number was then averaged (i.e. divided by 
five) and multiplied by the haemocytometer constant and again by the volume of the 
suspension to give the total cells in the suspension. After this the desired volume 
containing the required number of cells could be calculated in microlitres. No 
Trypan Blue reaction was recorded. In this way, the cells could be seeded at 
different densities dependent upon the conditions and requirements of the relevant 
experiment or split and passaged on into new tissue culture flasks for further culture 
and expansion. 
 
3.6 Cryopreservation of DPSCs
 
After the appropriate number of passages cultured in αMEM/10% FCS plus L-
glutamine supplement and having achieved 80% confluence in a T175 flask, the 
cells were then trypsinised, detached and spun down at 1000 rpm for 5 minutes to 
form a pellet, which was re-suspended in a solution of 90% FCS/10% DMSO 
(Sigma. Poole, Dorset) in cryotubes and stored in the insert of a Mr Frosty
™
 freezer 
box containing isopropanol which would lower the temperature at 1 degree 
centigrade per minute in a minus 80°C freezer. Then the cells were kept at minus 
80°C until required. This same method of cryopreservation was adopted for cells 
obtained via the collagenase digest method and all other types of cell used during the 
study. 
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3.7 Dental pulp explants and DPSCs for alkaline phosphatase 
staining 
Where pulp explants or DPSCs were to be used for alkaline phosphatase staining, 
following examination under light microscopy to ascertain their suitability, they 
were fixed in 98% ethanol until required (see Section 3.3). If used the same day, the 
explants/DPSCs were first stopped in 98% ethanol overnight in their 6 well plate. 
Next day the ethanol was drained off and replaced with PBS for 10 minutes. Then 
0.4 mL of Naphthol A5-MX solution was added to 9.6 mL of distilled water. To this 
mixture 2.4 mg of Fast Violet B salt was added and mixed thoroughly. The PBS was 
removed from the samples and sufficient reagent mixture was added to cover the 
samples. The lid was kept on for at least 30 minutes or longer if necessary until no 
further colour change was apparent. The liquid was drained off and images taken. 
 
3.8 In vitro expansion of control cells 
G292 cells 
G292 cells were used as a control cell line in some of these studies. The cells are a 
human osteosarcoma cell line and were obtained from stock held within the 
Department either from the minus 80°C freezer, or held in cryostorage in liquid 
nitrogen. These cells had originally been obtained from the European Collection of 
Cell Cultures (ECACC) and were G292 cells clone A141B1, passage 20 at the time 
of use. The cells were thawed rapidly, suspended in α-MEM in a 15 mL test tube 
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then centrifuged for 5 minutes at 1100 rpm. Following removal of the supernatant 
the pellet was re-suspended in αMEM/10% FCS and cultured in tissue culture flasks 
until required for experimental purposes, being passaged as and when necessary at 
approximately 80% confluence. For cryostorage, the cells were treated as per the 
DPSCs in section 3.6. 
 
3.9 In vitro culture of Human Umbilical Vascular Endothelial Cells 
(HUVECs) as control 
HUVECs were obtained from PromoCell GmbH (Cat. No. C-12203; Heidelberg, 
Germany) and were derived from a pooled donor source. On arrival, the cells were 
removed from the transportation dry ice and quickly thawed. They were then 
suspended in 30 mL of basal endothelial growth medium (EGM) (PromoCell 
catalogue no. C-22210) to which a supplied supplemental mixture had been added 
(PromoCell catalogue no. C-39210), giving the following concentrations per 
500 mL: 
 
 
 
 
 
 
 69 
 
 
TABLE 1: Total amounts of supplement reagents in 500 mL of EGM. 
 
REAGENT AMOUNT 
FCS 20 µL/mL 
Endothelial Growth Supplement 4 µL/mL 
Epidermal Growth Factor 0.1 ng/mL 
Basic Fibroblastic Growth Factor (rh) 1 ng/mL 
Heparin 90 µg/mL 
Hydrocortisone 1 mg/mL 
The initial 500,000 cells received from the supplier were firstly split between two 
T175 flasks and cultured in EGM to between 80-90% confluence as adjudged by 
light microscopy. They were then passaged by EGM removal, washing with 30 mL 
of 1x PBS for thirty minutes and detached with 10 mL of 1 × 0.25 mM 
trypsin/EDTA solution. Then the cells were either re-suspended to continue 
passaging, or for experimental use, or stored in FCS/10% DMSO at minus 80°C to 
build up a working stock. One vial of HUVECs was kept back at each passage and 
stored in FCS/10% DMSO in case of contamination. A working stock was obtained 
from cells at passages 3 to 5 with passage 4 being used experimentally. When 
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required, these were retrieved from the -80°C freezer, rapidly thawed, re-suspended 
in EGM and cultured for experimental use. 
3.10 Culture of G292 cells on GenGiGel
®
 HyA scaffolds 
Preliminary work for this thesis was conducted using G292 cells and DPSCs (see 
below) as a preliminary study of biocompatibility. 
 
3.10.1 Preparation of GenGiGel
® 
 
GenGiGel
®
 is a commercial product (OralDent U.K.) made from high molecular 
weight fractions of HyA which is a constituent of ground substance. It is available in 
several forms e.g. a low viscosity mouthwash and at higher, more viscous gel 
concentrations of 0.2 % and 0.8 %, depending on its intended clinical use, which can 
vary from periodontal application following surgery, soft tissue healing after 
titanium implant placement and in the management of mouth ulcers. Given that 
GenGiGel
® 
is already licensed for clinical use
 
in dental applications and in 
promotion of wound healing, together with the fact that HyA exists within the 
ground substance of pulp, GenGiGel
® 
was evaluated as a candidate scaffold in pulp 
tissue engineering.  
Differing amounts of granular GenGiGel
®
 powder were autoclaved at 120
o 
C for 15 
minutes in 10 mL Pyrex containers with foil lids. After cooling, 10 mL of 
Dulbecco’s modified eagles medium (DMEM, Sigma)/10% FCS was added to the 
powders and mixed using a magnetic stirrer to final GenGiGel
®
 concentrations of 
0.2%, 0.4%, 0.6% and 0.8%. The gels were then left overnight at 4°C. After the 
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initial experiments were completed it was decided to continue with a concentration 
of 1% HyA gel as this handled better, shrank less during cooling and its increased 
viscosity resisted being removed by the Pasteur pipettes during medium changes. 
 
3.10.2 Preliminary study of G292 cells cultured on GenGiGel
®
 HyA gel 
G292 human osteosarcoma cells obtained from departmental frozen stock as 
described in section 3.9 were used in this preliminary study exploring the use of 
GenGiGel as a possible biomimetic scaffold. The cells were cultured in tissue 
culture flasks in DMEM supplemented with penicillin and streptomycin (5,000 units 
per mL penicillin and 5,000 µg per mL streptomycin) and 10 % FCS (Harlan Sera 
Lab s-0001 AE) at 37
o
C and under 5 % CO2/air. The medium was changed weekly 
until at 70 -80 % confluence, normally after two to three weeks. The cells were then 
detached by adding 5 mL of 1x trypsin (0.5 g/L trypsin 1:250, 0.2 g/L EDTA 
(Versene) prior to seeding at a density of 2 x 10
5 
cells per mL (300 L) onto the 
GenGiGel
® 
preparations (0.2 %, 0.4 %, 0.6 % and 0.8 % GenGiGel
®
 prepared as 
described above). The cultures were maintained in an incubator for one week at 
37°C in a 5% CO2/air mixture prior to being examined in the light microscope.  
One millilitre (mL) of each GenGiGel
 
concentration was placed into a well of a 24 
well plate sealed with Parafilm
™
 and incubated overnight in a tissue culture 
incubator to allow settling. The gels were then seeded with G292 cells at a 
concentration of 2 x 10
5
 cells in 1 mL of DMEM/10% FCS and cultured for one 
week prior to image acquisition. 
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3.10.3 Culture of HPDLCs in EGM on 1% HyA gel ± 5 ng/mL rhVEGF165 
HPDLCs (Tissue Bank number: D0613673) were suspended in EGM and seeded 
onto 1% HyA gel at 2 × 10
5
 cells per mL in a 6 well plate. To this was added enough 
EGM with additional rhVEGF165 to give a final concentration of 5 ng/mL rhVEGF165 
in 3 mL of EGM. After 48 hours the plates were stopped by fixing in 10% NBF for 
30 – 40 minutes at room temperature, washed twice with PBS for 10 minutes then 
stained for CD31 and CD34 biomarkers. 
 
3.11 Culture of DPSCs on other scaffolds 
In addition to GenGiGel, further scaffold materials were evaluated for use in these 
studies in order to investigate the attachment and growth of human dental pulp 
stromal cells (DPSCs). These included: elephant ivory blocks (obtained with 
permission from HM Customs & Excise) and poly (DL) -lactic acid 
(PDLLA)/Bioglass
® 
(45 % SiO2, 24.5 % Na2O, 24.5 % CaO and 6 % P2O5) foams 
(provided by Dr Aldo Boccaccini, Imperial College, London, UK) which contain 
45S5 Bioglass
®
 particles (0, 5 and 40 wt. %) (Lu et al., 2014, Yang et al., 2006). 
 
3.11.1 Culture of DPSCS on 3-D ivory scaffolds 
The ivory blocks (5 x 5 x 5 mm
3
) cut from the body of the tusk dentine, were 
sterilised in 70 % ethanol overnight and washed twice in DMEM for thirty minutes. 
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Then 20 mL of DMEM was added to the blocks for 4 hours to condition the surface 
of the substrate. Half of the block samples were placed into 10 mL of 4% 
GenGiGel/10% FCS/DMEM gel in the base of the test tubes prior to the addition of 
the ivory blocks and the seeding of the DPSCs, the remainder being kept for future 
use. 
DPSCs (passage 4) were detached using 1 x trypsin/EDTA solution (Sigma, Poole, 
UK). The cells were then re-suspended in 6 mL of DMEM/10% FCS and 2 x 10
5 
cells were seeded onto the conditioned ivory blocks in GenGiGel using a static 
seeding method in sterile test tubes. The test tubes were then incubated overnight at 
37°C and 5 % CO2 to allow cell attachment. The ivory blocks and GenGiGel were 
then transferred to a 6 well plate and cultured for a further three days in 
DMEM/10% FCS prior to being labelled with a live cell fluorescent marker, 
5-chloromethylfluorodiacetate (5-CMFDA) (Thermo Fisher Scientific) prior to 
imaging (see Appendix A for full protocol). The cells growing on the ivory scaffolds 
were labelled with 5-CMFDA (see Section 4.6) which is taken up by live cells and 
fluoresces under an excitation wavelength of 497 nm with an emission spectrum of 
517 nm producing a green colouration. Briefly, the culture medium was drained off 
and the cells cultured in plain DMEM for 45 minutes. At the same time, 5-CMFDA 
was dissolved in 10 µL of DMSO. The DMEM was drained off again and replaced 
by fresh DMEM with the 5-CMFDA/DMSO added to it. The flask was then 
wrapped in aluminium foil to exclude light and incubated at 37°C in the tissue 
culture CO2 incubator for a further 30 minutes, then viewed at 497 nm wavelength in 
a fluorescent light microscope. See full staining protocol is given in appendix A.  
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3.11.2 Culture of DPSCs on 45S5 Bioglass
®
 scaffolds 
Scaffold 45S5 poly (DL) -lactic acid (PDLLA)/Bioglass
® 
(45 % SiO2, 24.5 % Na2O, 
24.5 % CaO and 6 % P2O5) foams were provided by Dr Aldo Boccaccini (Imperial 
College, London). Different amounts of 45S5 Bioglass
®
 particles (0, 5 and 
40 wt. %) were used for this study to examine the adhesion, growth and 
differentiation potential of DPSCs on synthetic scaffolds. 
Scaffolds (S5 Bioglass
® 
or ivory) of 5mm
3 
were sterilised under type C ultraviolet 
(UV) light (wavelength 250 – 260nm) for 30 minutes in 10 mL universal tubes in an 
aluminium foil tray. The tubes were turned at regular 5 minute intervals to ensure 
uniformity of exposure. DPSCs (2 x 10
5
) obtained by the cell explant method (see 
Section 3.1.2), were suspended in 1 mL DMEM and were seeded onto the 45S5 
BioGlass
®
 samples and left overnight to allow the cells attach to the scaffolds. The 
following morning, the 45S5 cell-BioGlass
®
 constructs were transferred to a 24 well 
plate and cultured in DMEM/10% FCS for up to 12 weeks. At weekly intervals the 
cultures were stopped for assessment by staining with Sirius Red and Alcian Blue 
stain. Briefly, after fixing in 10% NBF the sections on the slides were stained with 
Weigart haematoxylin, using a plastic Pasteur pipette to gently wash the Weigart 
haematoxylin over each section and left for 10 minutes. Each slide was rinsed gently 
through a water bath then replaced in the staining rack. The rack was placed into a 
water bath and rinsed for 10 minutes. The rack of slides was dipped 3x in 
acid/alcohol (20 mL HCl added to 2 litres 50% methanol) then rinsed in the water 
bath for one minute. The slides were then stained in molybdophosphoric acid for 30 
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minutes followed by a one minute rinse in the water bath. The slides were then 
stained with Sirius Red for one hour, followed by a one minute immersion in water, 
then immersed in 100% ethanol for 30 minutes then fresh 100% ethanol for a further 
30 minutes. They were then mounted in DPX and ready for viewing. 
 
3.11.3 Examination of micro and ultrastructure of unseeded Osseoguard
®
 and 
BioGide
®
 membranes 
Unseeded Type I and III collagen membranes were either coated with gold (Au) in 
an inert argon gas atmosphere under vacuum, prior to obtaining scanning electron 
microscope (SEM) images with a Hitachi S-3400N SEM or coated with platinum 
(Pt) for imaging with a FEI Quanta 650 Field Emission Gun Scanning Electron 
Microscope (FEGSEM), to provide comparator control images to the seeded 
samples and higher resolution images of the membrane structure. 
 
3.11.4 DPSCs on Osseoguard
®
 and BioGide
®
 collagen Type I and III 
membranes in vitro 
Biomimetic scaffolds containing both collagen Types I and III, (Osseoguard
®
 and 
BioGide
®
) were chosen because they have long proven clinical usage in both 
hospital and private practice. They consist of Types I and III collagen and are 
readily available commercially. They were either purchased, donated as a gift by 
commercial representatives or came from the spare pieces left over from my dental 
practice during implant placement and Guided Bone Regeneration procedures, 
which were then re-sterilised using UV radiation in a BIO-RAD GS Gene Linker
®
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UV Chamber, using the sterilisation for UV Resistant Material setting for 90 
seconds on each side before experimental use. To ascertain whether DPSCs obtained 
via the collagenase digest method could attach and proliferate on collagen Type I 
and III membranes, 25 mm
2
 sections of Osseoguard
® 
and BioGide
®
 were 
conditioned as follows: each membrane was first treated by immersion in DMEM 
for 1 hour in a 6 well plate at 37°C in air/5% CO2 mixture. This was done to modify 
the surface chemistry and condition the surface of the scaffold to promote cell 
attachment. This was followed by 2 x 10 minute changes of PBS, liquid removal by 
aspiration via a Vacuubrand vacuum pump unit with two Pasteur pipettes (one to 
hold the sample in place, the other for evacuation of any liquid) to remove any 
excess liquid still retained, then seeded with DPSCs at 2 x 10
5
 cells per mL in 
DMEM/10% FCS. These were left for a minimum of four hours to facilitate cell 
attachment, then transferred to a new 6 well plate and cultured in DMEM/10% FCS 
for up to 28 days at 37°C in a 5% CO2/air mixture. 
 
3.11.4.1 5 CMFDA and TOPRO staining 
To determine cell viability on the scaffolds, the medium was removed and the 
samples were then stained with 5-CMFDA and TOPRO-3 iodide (Thermo Fisher 
Scientific) as follows: the 5-CMFDA was applied as in section 3.11.1. The TOPRO-
3 was diluted to 1:100 in PBS to give a working solution. Any culture medium or 
fluid was removed and the sample lightly fixed in 10% Neutral Buffered 
Formaldehyde (NBF) for 15 minutes maximum. The samples were then washed for 
3 x 5 minutes in PBS, then permeabilised in 0.1% Triton-X in PBS for 20 minutes. 
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They were then washed in 3 x PBS for 5 minutes and incubated at 37°C for 20 
minutes in TOPRO. They were then washed in PBS for 1 x 5 minutes, following 
which they were examined under confocal microscopy. TOPRO excitation was at 
642 nm, emission at 661 nm, 5-CMFDA excitation at 497 nm and emission at 517 
nm. 
 
3.11.4.2 Acridine Orange and HCS CellMask
™
 Deep Red staining 
Acridine Orange stain has previously been used for assessing viability of dental pulp 
tissues (Sloan et al., 1998) so for staining with Acridine Orange/HCS CellMask
™
 
Deep Red, the constructs were fixed by immersion in 10% NBF for 30 minutes at 
room temperature prior to staining as follows: three washes (10 minutes each) in 1× 
PBS prior to being stained with a 2 ng/mL working solution of HCS CellMask
™
 
Deep Red stain (Thermo Fisher Scientific) in PBS made up from the stock HCS 
CellMask
™ 
solution (10 µg/mL). The samples were stained for 30-40 minutes. Then 
the samples were washed a further three times (10 minutes each) in PBS and stained 
with 0.01% Acridine Orange working solution for 40 minutes. Whole membrane 
samples were examined under a scanning electron microscope and confocal laser 
scanning microscope (Acridine Orange: excitation at 488 nm, emission at 520 nm. 
HCS CellMask
™
 Deep Red: excitation at 633 nm, emission at 680 nm). Images were 
recorded as snapshots or Z-stacks thereof. 
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3.12 Histochemistry and immunohistochemistry of DPSCs on Type 
I and III collagen membranes 
To assess the ability of DPSCs to attach and proliferate on Osseoguard
®
 and 
BioGide
®
 collagen Type I and III membranes, DPSCs obtained by the collagenase 
digest method (see Section 3.4) were seeded onto template-derived 25 mm
2
 sections 
of Osseoguard
®
 and BioGide
®
 Types I and III collagen membranes (see below for 
seeding protocol). 
Each of the membranes was first treated as described in Section 3.11.4. This was 
done to modify the surface chemistry and condition the surface of the membrane to 
promote cell attachment. This was followed by 2 changes of PBS (10 minutes in 
each), then the membrane was subjected to suction using two Pasteur pipettes (one 
to hold it in place, the other for evacuation) to remove excess liquid, then seeded 
with DPSCs at 2 x 10
5
 cells per mL in DMEM/10% FCS. These were left for a 
minimum of four hours to facilitate cell attachment, then transferred to a new 6 well 
plate and cultured in DMEM/10% FCS for up to 15 days at 37°C in a 5% CO2/air 
mixture. They were fixed in 10% NBF for 45 minutes to 1 hour at room 
temperature. They were then tissue processed in an Excelsior ES Tissue Processor 
(Thermo Shandon), where they were dehydrated in a series of graded alcohols up to 
100% ethanol, infiltrated with 100% xylene and then infiltrated with wax before 
being further wax embedded before being sliced into 5µm sections using a JUNG 
BIOCUT 2035 microtome and histological evaluation such as H&E staining (see 
Section 3.12.1 and Appendix A) or immunohistochemistry (see section 3.1.12 and 
Appendix A). 
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3.12.1 Immunohistochemistry for CD31, CD34 and STRO-1 
DPSCs were seeded onto BioGide
®
 Type I and III collagen membranes (see Section 
3.11.4). They were then cultured in αMEM/10% FCS in a 6 well plate in a tissue 
culture incubator for 14 days then stopped by draining off the αMEM/10% FCS, 
washing twice in 1× PBS for 30 minutes each, drained, then fixed in 10% neutral 
buffered formalin for one hour at room temperature. The membrane samples were 
tissue processed in an Excelsior ES Tissue Processor (Thermo Shandon), where they 
were dehydrated in a series of graded alcohols up to 100% ethanol, infiltrated with 
100% xylene and then infiltrated with wax before being further wax embedded (by 
hand) in tissue cassettes, then 5 µm sections were cut using a JUNG BIOCUT 2035 
microtome. Sections were wetted with 20% ethanol and floated on warm water onto 
3-aminopropyltriethoxysilane (APES) coated slides, then dried overnight in an air 
incubator at 37°C before horseradish peroxidase (HRP) immunohistochemistry 
staining. This protocol was carried out for CD31, CD34 and STRO-1 markers, or 
H&E staining (see Section 3.12.1 and Appendix A for full protocol details), with the 
protocol being common to all CD31, CD34 and STRO-1 samples, only the first 
antibody differing. Briefly, HRP-immunohistochemistry staining involves use of a 
primary antibody raised (in this case) in rabbits and directed against a specific 
antigen molecule (such as CD31, CD34) and normally used at a concentration of 1 
in 100 in accordance with the manufacturers data sheet having been further 
optimised previously by test samples at different serial dilutions ( 1 in 50; 1 in 100; 
1 in 250; 1 in 500) to detect the presence and location of the antigen within a tissue 
or sample. The sections to be investigated were prepared as described above onto 
APES (3-aminopropyltriethoxysilane) coated slides (the APES coating gives a 
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negative charge which improves the attachment of the sections to the surface of the 
slide). They were then immersed in two stages of 100% xylene, for 20 minutes each, 
followed by two stages of absolute alcohol for five minutes each and one stage of 
2% hydrogen peroxide and absolute methanol for 20 minutes. After washing, the 
antigenic epitopes were exposed by a process of antigen retrieval. The sample was 
warmed in a 0.01M citrate buffer for 60 minutes at 60°C in a plastic Copling jar in a 
covered water bath. The sections were then washed again in PBS and then 150 µL of 
20% normal goats serum (NGS) was applied for 5 minutes minimum as a blocking 
agent. Primary antibody (anti-CD31 Abcam ab 28364, anti-CD34 Abcam 81289, 
anti-STRO-1 Abcam 102969) used at 1 in 100 dilution in PBS was applied and 
incubated overnight in a controlled humid environment at room temperature, with 
the 20% NGS being used for any negative control samples such as the experimental 
samples themselves. For positive control samples, human or animal tissue (e.g. 
dental pulp) which should test positive to the primary antibody were used. After 
leaving overnight, the samples are then washed again in PBS for 5 minutes and then 
two drops of solution A from the EnVision™ kit was applied for 30 minutes to each 
slide. A 5 minute wash with PBS was then applied. While this was happening, 
enough amounts of solutions B and C were mixed in the ratio of 1 mL B to 20 µL C, 
the slides rapidly moved onto a flatbed and 120 µL of the B and C mixture applied 
to each slide to develop the brown colouration indicative of the horseradish 
peroxidase staining. This stage was monitored closely by checking under the 
microscope and repeated if necessary. The samples were then washed in tap water 
for a minimum of 5 minutes, counterstained with H&E for 1 minute, washed in tap 
water for 5 minutes, immersed in Scotts tap water for 1 minute, washed again in tap 
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water, dried in two changes of absolute alcohol for two minutes each, then washed 
in two changes of xylene for two minutes each. Finally, a drop of dibutylphthalate in 
xylene (DPX) was used to exclude any air over the sample, then a coverslip applied 
prior to viewing and imaging. 
 
3.12.2 Haematoxylin and Eosin (H&E) staining 
For H&E staining protocol, as in Section 3.12.1, the sections were firstly dewaxed in 
xylene twice for 5 minutes each, then immersed in two changes of absolute ethyl 
alcohol for 5 minutes and then washed under running tap water for 5 minutes. They 
were then immersed in Harris’ haematoxylin solution for 3 minutes, washed under 
running tap water for 5 minutes, given 3 quick dips (literally) in 1% acid alcohol 
with a quick look under the light microscope to check the nuclear staining, washed 
under tap water again for 5 minutes, then immersed in Scott’s tap water for 2 
minutes, washed again under tap water for 5 minutes, then counterstained in 1% 
aqueous eosin for 30 seconds and finally given a tap water wash for 5 minutes. This 
was followed by two changes of absolute ethyl alcohol for 5 minutes each, then 
clearing in xylene for 5 minutes and then mounting under DPX with a coverslip. 
Sections of human dental pulp which had been dissected from teeth and fixed in 
10% NBF and tissue processed as described in the previous paragraph and stained 
exactly the same as the experimental samples were used as positive or negative 
controls during this process. 
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3.13 Biochemical assay using PicoGreen
® 
for determination of total 
DNA content of DPSCs 
To determine the proliferation rate for DPSCs on BioGide
® 
Type I and III collagen 
membranes following seeding on both sides, total DNA content was measured using 
a PicoGreen
®
 assay. Firstly, the membranes were marked with a fine dot on one side 
with a black Sharpie permanent marker and allowed to dry inside a petri dish in a 
tissue culture incubator for 30 minutes. This was done so as not to seed the same 
side twice. Double sided seeding increases the numbers of cells attached and 
maximises DNA retrieval. DPSCs were seeded onto the 25mm
2
 samples of collagen 
membranes using a modified technique to increase the numbers of cells attaching in 
the absence of a dynamic-seeding alternative. The membranes were conditioned by 
application of αMEM for 4 hours followed by three changes of PBS for 30 minutes. 
Following this, each membrane was skewered onto a sterile hypodermic needle and 
placed into the base of a 15 mL test tube in which was a 5 mL suspension of 2 x 10
5
 
DPSCs in αMEM. Each test tube was then placed in a rack with the lids lightly 
closed to enable air circulation and the rack was then placed in a tissue culture 
incubator at 37°C in 5% CO2/air mixture. The samples were left for 4 hours then 
removed into a tissue culture hood, the cell suspension agitated, the membranes 
were taken out of the test tube, turned over the other way, placed back on the end of 
the needle and left for another 4 hours in the cell suspension in a similar fashion. 
After that, they were placed in a 6 well plate and cultured in 3 mL of αMEM/10% 
FCS and stopped at days 5, 10 and 15. The samples were stopped by washing in 2 x 
PBS for 30 minutes then the PBS was removed by suction until the Type I and III 
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collagen membrane and cell samples were visibly dry. These were then snap-frozen 
in the 6 well plate at minus 20°C, following which they were then assayed for DNA 
content via the PicoGreen
®
 assay method to measure the proliferative capacity of the 
cells (Yang et al., 2006). The membrane samples were placed in 1 mL of 1% triton-
X 100 in a 1.5 mL Eppendorf tube to thaw, then completely refrozen. Following 
defrosting for the first time, the samples were finely minced with sharp pointed 
scissors in the Eppendorf tube then refrozen. This freeze/thaw cycle was repeated 
five times in total to ensure as complete membrane disruption as possible. To 
prepare the solution for measurement, briefly, a stock solution of 10 mM Trizma 
hydrochloride and 1 mM EDTA buffer (TE) was made up in 500 mL of sterile 
DNase free water. To make the working solution, 10 mL of the 20 x TE buffer was 
diluted in 190 mL of DNase free water. To generate a standard curve, a 2 µg/mL 
stock solution of dsDNA (double stranded Deoxyribonucleic acid) was prepared in 
TE buffer. Sample fluorescence was measured against standards made up to 5, 10, 
25, 50 and 100 ng/mL of salmon sperm DNA (Sigma-Aldrich) using a 2 µg/mL 
solution of diluted in TE buffer to the desired concentrations. Total dsDNA was 
measured in the cell lysates by placing 100 µL aliquots of each standard, test 
samples (15 µL of sample plus 85 µL of TE buffer) and blanks (TE buffer only) 
were added to 96 well plates in triplicates. Then, 100 µL of PicoGreen
®
 (diluted 
1:40 in TE buffer) was added to each well and the plates were incubated in the dark 
at room temperature for 5 minutes. The fluorescence of the samples was measured 
using a Thermoscientific (ELISA) microplate reader (Fluoroskan Ascent) with an 
excitation wavelength of 480 nm and an emission wavelength of 520 nm. 
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Statistical analysis of the results was carried out with IBM SPSS version 22 using a 
one way ANOVA test with a post hoc Bonferroni correction. 
 
3.14 Culture of DPSCs and HUVECs on 1% Collagen gel + 
rhVEGF165 
3.14.1 Culture of DPSCs and HUVECs 
A 1% sterile mixture of Type I collagen gel was prepared by autoclaving 1 gram of 
collagen gel powder (gelatine) and dissolving it in 100 mL sterile water, then storing 
it in a sterile bottle at 4°C. It was then warmed to 70°C in a water bath and 100 µL 
was pipetted into the base of a 12 well plate and allowed to set and cool in a tissue 
culture incubator at 37°C. DPSCs or HUVECs suspended in EGM were then seeded 
with 1 mL of cell suspension at a density of 10
4
 cells per mL per well with each well 
receiving another 2 mL of medium along with the appropriate amount of 
recombinant human Vascular Endothelial Growth Factor165 (rhVEGF165) next, to 
give a final concentration of 5 ng/mL (Matsushita et al., 2000). This was incubated 
over 48 hours in a tissue culture incubator at 37°C in a 5% CO
2 
and air mixture. 
 
3.14.2 Immunohistochemistry of DSPCs and HUVECs 
Plates were stopped by draining off the EGM very carefully using a disposable 
Pasteur pipette, so as not to disturb the gel and given a light fix by immersion in 
10% NBF for 30 minutes at room temperature. This was then carefully drained off 
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and washed twice with PBS. They were then immunostained for CD31 or CD34 
markers in a modified technique from section 3.1.1 where the antigen exposure step 
was omitted as the samples were not paraffin embedded and the protocol ended at 
the second alcohol stage with no final xylene steps as these would have dissolved 
the 12 well plate plastic. After draining, a round coverslip was placed into each well 
to retain the gel and the plate lid was sealed with parafilm after which the plates 
were ready for image recording and inverted onto the microscope stage to enable 
focussing. This methodology was used for all the samples in sections 3.14 and 3.15. 
 
3.15 Culture of DPSCs and HUVECs on 1% Hyaluronic Acid gel ± 
rhVEGF165 
3.15.1 Culture of DSPCs and HUVECs 
A 50 mL sterile mixture of 1% HyA gel was prepared using the method described 
earlier in section 3.1.8 and stored in a sterile Schott bottle. The bottle was placed in 
a water bath and warmed to 70°C. One hundred microlitres of warm 1% HyA gel 
were pipetted into the base of each well of a 12 well plate which had been pre-
warmed in the tissue culture incubator at 37°C and the plate turned to ensure even 
coverage in the base of each well. The plate was then incubated at 37°C for 
approximately one hour until needed. DPSCs suspended in EGM were then seeded 
onto the 1% HyA gel at a density of 10
4
 cells per well with each well receiving 2 mL 
of medium along with the appropriate amount of recombinant human Vascular 
Endothelial Growth Factor165 (rhVEGF165) next, to give a final concentration of 
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5 ng/mL. This was placed for 4 hours in a tissue culture incubator at 37°C in a 5% 
CO
2 
and air mixture and the plates incubated over 48 hours in a tissue culture 
incubator. 
 
3.15.2 Immunohistochemistry of DSPCs and HUVECs 
Samples were treated using the same protocol as described in section 3.14.2. 
HUVECs were used as controls for this part of the study and subjected to identical 
conditions. 
This procedure was then repeated, with DPSCs and HUVECs this time with no 
rhVEGF165 being added to the cells and the cultures stained for CD31 and CD34 cell 
markers as before. As further controls, G292 cells were also cultured and tested 
using the same methodology, again with no rhVEGF165 
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3.16 In Vitro culture of DPSCs on Type I and III collagen 
membranes and 1% HyA gel in endodontically prepared tooth slices 
 
3.16.1 Preparation of Type I and III collagen membranes and 1% HyA gel 
To combine the two elements of culture so far, DPSCs were cultured on Type I and 
III collagen membranes which had been infiltrated by 1% HyA gel under gentle 
vacuum overnight. Type I and III collagen membranes were prepared by immersion 
in a 1% HyA gel in a Schott bottle under a vacuum for one hour in a vacuum vessel 
with the bottle lid slightly open to allow the vacuum to have an effect on the 
penetration of the gel. The bottle was then closed and placed in a fridge at 4°C until 
required. 
 
3.16.2 Preparation of tooth slices 
The tooth slice and scaffold model (Sakai et al., 2011) used for dental pulp tissue 
engineering (Cordeiro et al., 2008) was in turn derived from a combination of the 
tooth slice organ culture model (Sloan et al., 1998) and the SCID (severe combined 
immunodeficient) mouse model used in the study of human angiogenesis (Nor et al., 
2001). This has been used to study angiogenesis-based therapeutic methods for pulp 
regeneration and revascularisation (Goncalves et al., 2007, Mullane et al., 2008). 
The protocol was modified for use in this study. Slices of tooth, 3 mm thick, were 
cut horizontally from the cervical region of premolar teeth on a Struers Accutom
®
 5 
water-cooled cutting machine to give a ring shaped sample. The rationale behind 
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this was that anatomically, the pulp chamber is usually largest in this region of the 
tooth and can be further enlarged by endodontic instrumentation (see figure 15). 
 
  
Figure 15. a premolar tooth prior and post-sectioning. 
A: The two parallel black lines indicate the cervical region of the tooth 
from where the slices were sourced. B: resulting tooth slice instrumented 
up to a size 140 file. 
 
The resultant annular slices were then filed/instrumented to increase the lumen of 
the root canal with sterile Kerr endodontic files up to a size 140. The tooth slices 
were then sterilised by placing them in 70% ethanol inside a sealed bijoux container 
which was then placed in an ultrasonic bath for 30 minutes and sonicated. The 
ethanol was then removed inside a tissue culture hood, replaced with PBS with 
added Penicillin/Streptomycin (Pen/Strep) at a concentration of 100 units of each 
per mL and sonicated again. Lastly this solution was replaced with 1 x PBS and 
again sonicated. Following this, the tooth slices were incubated overnight in 5 mL of 
αMEM/10% FCS in a tissue culture incubator to check for contamination before 
being removed, washed three times for 30 minutes each in PBS then used. 
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The collagen Type I and III membranes were removed from the 1% HyA gel and 
placed on a sterile surface inside a tissue culture hood. The tooth slices were 
removed from the PBS and placed alongside. The tooth slices were then gripped in a 
pair of locking forceps and the collagen Type I & III membrane was inserted into 
and pulled through the enlarged root canal using tissue forceps until it jammed 
whereupon the excess was cut off at both ends with a scalpel. Each tooth sample 
with the treated membrane in the enlarged canal lumen was then placed into a well 
in a 6 well plate then seeded with 2 x 10
5
 DPSCs suspended in the appropriate 
volume of EGM. Cells were allowed to attach for four hours in a tissue culture 
incubator at 37°C in a 5% CO2/air mixture after which the wells were topped up 
with 3 mL of EGM then incubated at 37°C in a CO2/air mixture for two weeks with 
the medium being changed every three days in accordance with the manufacturer’s 
instructions. After this, the samples were drained, fixed in 10% NBF overnight and 
radiographs taken using a Phillips Oralux X-ray machine and AGFA size 2 intra-oral 
films. They were then demineralised in 10% TRIS/EDTA solution, radiographed at 
weekly intervals and the demineralising solution changed weekly until the slices 
appeared radiolucent on the radiographs and the dentine showed no difference in 
radiolucency from the Type I and III collagen membrane. The tooth slices were then 
prepared for manual embedding by sequential dehydration in a series of alcohols 
under vacuum in a Dry-Seal desiccator: 70% ethanol for 20 minutes; 95% ethanol 
for 20 minutes × 2; 100% ethanol for 20 minutes × 2; xylene for 20 minutes × 2 
before being placed in tissue cassettes and wax embedded in Gurr
®
 Paramat 
embedding wax at 40°C under 1000 m bar of vacuum for 40 minutes. The samples 
were then slowly brought up to atmospheric pressure and placed into a new wax 
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bath for a further 40 minutes then embedded in fresh paraffin wax. Sections of 5µm 
thickness were prepared using a microtome and floated onto APES slides before 
immunohistochemistry staining for CD 31 and 34 markers and H&E staining as 
described in section 3.12 (see Appendix 1 for full protocol details). Unseeded 
membrane samples were used as negative controls and subjected to the same 
histological procedures. 
 
3.16.3 Cold stage SEM imaging of tooth slice-DPSCs/scaffold constructs 
Samples for SEM cold stage imaging were stopped in 10% NBF prior to imaging. 
They were washed twice in PBS for thirty minutes, blotted dry then placed in the 
SEM cold stage for imaging under vacuum at minus 20 °C. 
 
3.17 Determination of CD31 and CD34 gene expression at 2 and 5 
days by DPSCs using qRT-PCR 
DPSCs were seeded at 2 × 10
5
 cells per well and cultured under the following four 
different conditions in 6 well plates for 2 and 5 days. This was to examine the 
change in gene expression of the angiogenic marker genes CD31 and CD34 in 
comparison to the housekeeping gene Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta polypeptide (YWHAZ) which acts in signal 
transduction. 
 
 91 
 
 
TABLE 2: Culture conditions for DPSCs to determine CD31 and CD34 expression. 
 
Groups 2D/3D Culture conditions 
A 1%HyA gel EGM  
B 1% HyA gel αMEM/10% FCS 
C monolayer EGM 
D monolayer αMEM/10% FCS 
As a pre-requisite to carrying out qRT-PCR, RNA was isolated from the cell culture 
lysates, following which it was reverse-transcribed into cDNA. Initially, cells were 
disrupted by adding 1.5 mL of RLT buffer, to which had previously been added β-
mercaptoethanol at a concentration of 10 µL per mL. The RNA was extracted from 
the cell lysates using an RNeasy Mini Kit (50) (Cat. No. 74104) with additional 
DNase digestion (Qiagen, Crawley, UK) in accordance with the manufacturer’s 
instructions. RNA concentrations were quantified using a NanoDrop 
spectrophotometer (Thermo Scientific, Wilmington, USA). The RNA obtained was 
then processed, with the amount being used dependant on its concentration, into 
single stranded cDNA samples using a High Capacity RNA-to-cDNA Kit (Applied 
Biosystems, Carlsbad, USA) to obtain 200 ng of cDNA in 20 µL reaction volumes 
in accordance with the manufacturer’s instructions. These were then run on an MJ 
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Research PTC-100 Thermo Cycler for 1 hour at 37°C and then at 95°C for five 
minutes and were stored at minus 20°C until required. 
Amplification and analysis of the angiogenic markers was carried out using 
Taqman
® 
probe assays in a 20 µL reaction volume in the Roche light cycler as 
follows: 
10 µL of gene expression master mix supplied by Applied Biosystems, UK (ABI, 
UK) were combined with 9 µL of cDNA template and 1 µL of Taqman
®
 assay probe 
(ABI, UK). This mixture was added in triplicates to 96 well plates which were 
sealed and centrifuged for 10 seconds then placed into the light cycler. The 
amplification program comprised of three steps (as recommended by ABI) for the 
Taqman
®
 probes: 
 A pre-incubation cycle for 5 minutes at 95°C; 
 45 amplification cycles comprising of two steps:1. 95°C for 5 seconds, 
followed by 2. 65°C for 1 minute. 
 This was followed by a final cooling cycle with the temperature being 
dropped to 40°C for 30 seconds. 
This experiment was repeated three times, with the results being analysed using the 
ΔCT method. Details of the Taqman® gene expression assays used follow in the next 
table. A sample from DPSCs on day 0 was used to provide a baseline. 
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TABLE 3: Details of Taqman
® 
gene expression assays used in qRT-PCR. 
 
Gene name Gene group Taqman
®
 gene expression 
assay number 
YWHAZ Binds phosphoserine and 
phosphothreonine 
proteins. Active during 
signal transduction, 
apoptosis, tumour 
suppression. 
Hs00237047 
CD31 Cell adhesion 
molecule/protein binding 
molecule/angiogenic 
marker/gene of interest 
Hs01065279-m1 
CD34 Cell adhesion 
molecule/protein 
binding/angiogenic 
marker/gene of interest 
Hs00990732-m1 
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3.18 In vivo study 
3.18.1 Preparation of DPSCs-scaffold constructs for in vivo implantation 
Tooth slices were prepared as in section 3.16 for use in an in vivo study to determine 
the ability of the cell-scaffold constructs to develop vascular-like structures under 
physiological condition in vivo, when implanted subcutaneously in four MF1 Nu/Nu 
nude mice. These albino mice were selected as they have normal B cell function but 
have a rudimentary dysfunctional thymus and so are T cell deficient. They are 
phenotypically hairless, generate no cytotoxic effector cells and show no graft 
versus host response. 
The tooth slices and HyA/Type I and III collagen membrane constructs were 
prepared in the same manner as described  in sections 3.16.1 and 3.16.2. DPSCs 
were seeded on these scaffolds at a density of 2x10
5 
cells
 
per sample and cultured for 
two weeks in 6 well plates. Four different scaffold constructs were examined: (a) 
Tooth slice with Type I and III collagen membrane and HyA gel in situ but with no 
DSPCs; (b) Tooth slice and Type I and III collagen membrane seeded with 2x10
5
 
DPSCs. (c) Tooth slice and 1% HyA gel seeded with 2x10
5
 DPSCs and (d) Tooth 
slice and Type I and III collagen membranes infiltrated with 1% HyA gel and seeded 
with 2x10
5
 DPSCs as described in section 3.16.1. Each sample was incubated 
initially in EGM for 2 weeks with the medium being changed every three days, to 
allow the cells to attach and proliferate before being inserted subcutaneously into the 
dorsal surface of four MF1 Nu/Nu nude mice.  
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3.18.2 In vivo implantation  
Four MF1 Nu/Nu athymic mice (five weeks old, male) were used for this study. The 
procedure was conducted under general anaesthetic (Project license: PPL40/3361) 
and carried out by Dr. Xuebin Yang from the Dept. of Oral Biology. After an 
incision was made on the dorsal surface of the mouse, four subcutaneous pockets 
were made via blunt dissection (16 sites in total). A scaffold only, or DPSCs-
scaffold construct was implanted in this pocket and the wound was closed by non-
resorbable suture. The implantation locations (see Figure 17) were in the following 
order for each of the animals: (a) was inserted into the shoulder area above the left 
forelimb; (b) was inserted into the shoulder area above the right forelimb; (c) was 
inserted into the lumbar area above the right rear limb and (d) was inserted into the 
lumbar area above the left rear limb. 
 
Figure 16. Diagram of incision sites for subcutaneous implantation of 
constructs. 
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The mice were housed in the Central Biological Service with normal food and drink 
available under a 12 hours day/night cycle. Each wound was checked daily for the 
first week post operation. After four weeks, the four animals were euthanized and 
the samples (16 in total) dissected out, immersed in 10% NBF for one week then 
decalcified. They were then tissue processed for histological and 
immunohistochemical analysis by the same method as described in section 3.16.2. 
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Chapter 4: Results 
4.1 Cell outgrowth from dental pulp explants and cell growth 
following the collagenase digest method 
4.1.1 Cell growth and proliferation from the pulp explant method 
Dental pulp explants normally stick onto tissue culture plastic surfaces after a few 
minutes, although overnight incubation was necessary in some cases. After being 
cultured for between 1 to 14 days, the cell explants began to show DPSC outgrowth 
from discreet areas or ‘nodes’ of their periphery (see Figure 17). Generally, the 
sooner this happened the better it predicted cell proliferation but it varied between 
explants as some which had attached showed no growth whatsoever. Donor 
variation was also seen, with some donor tissue showing early, vigorous growth with 
rapid proliferation and others proliferating very slowly. This correlates with other 
investigators’ findings in the literature (Moule et al., 1995). Figure 17 (A), shows a 
pair of DPSCs after 24 hours of attachment, (B) shows a cluster of DPSCs 
emanating from a single growth node, again at the 24 hour time point, while (C) 
shows another larger cluster of DPSCs at 24 hours and (D) shows a single DPSC 
growing out of a dental pulp explant at the 7 day time point. Images of this nature 
highlighted the donor variability of the procedure, making the predictability of cell 
proliferation and therefore availability of cells for experimental purposes impossible 
to predict. It is also possible that the DPSCs grow out of areas where vascular 
structures have been in contact with the tissue culture plastic as the perivascular 
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niche has been postulated as the source of DPSCs which differentiate into 
odontoblasts (Bianco and Cossu, 1999, Senzaki, 1980). In addition, DPSCs 
associated with “stemness” express surface markers such as CD44, CD106, CD146, 
3G5 and STRO-1. See Figure 35 (A), for an example of this latter marker. 
 
  
  
Figure 17. Single cell outgrowth from a dental pulp growth node. 
A-D: dental pulp explants are all designated by the blue arrows. DPSCs 
are indicated by the yellow arrows. The vertical white line in (C) is a 
scratch on the tissue culture plastic surface and the black arrow in (D) 
indicates a dentine fragment adhering to the pulp explant. 
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4.1.2 Comparison of DPSC proliferation from pulp explant and collagenase 
digest at days 14 and 15 
As stated before, cell proliferation from a growth node from pulp explants was 
unpredictable and could be extremely slow or extremely rapid (see Figure 18). 
Figures 18 (A) and (B) show cell outgrowth from the same coronal region of a pulp 
explant at days 14 and 15. Normally, the DPSC numbers would have been much 
higher than this, further illustrating the variability in between donor samples. Cell 
counting showed approximate doubling of cell numbers over a 24 hour period. The 
piece of fibrous/extraneous tissue attached to the dental pulp explant on the right 
side of the image was used to accurately locate where the DPSC outgrowth was 
occurring (the view was moved slightly to accommodate the extra cells on the 
second day). Figure 18 (C,D) shows cell proliferation data obtained after using the 
collagenase digest method at days 14 and 15 after original dental pulp collagenase 
digestion. The cells had undergone an additional passage in that time, one week 
previously. It can be seen that many more cells were present compared to the 
explant method and that some of the cells had arranged themselves into circular/oval 
patterns reminiscent of vascular structures. As a result of the obvious increased 
proliferation rate of the DPSCs obtained via the collagenase digest method and in 
accordance with the findings of other authors (Gronthos et al., 2000, Huang et al., 
2006) it was decided to adopt this as the method of choice for DPSC harvesting and 
proliferation for future experiments. 
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Figure 18. Comparing the proliferation of DPSCs obtained following the dental 
pulp explant method (A and B) and collagenase digest method (C and D) 
at the same time points. 
Image A: DPSCs outgrowth from a dental pulp explant at day 14. 
Image B: DPSCs outgrowth from same dental pulp explant at day 15 (24 
hours later). 
Image C: DPSCs proliferation following the collagenase digest method 
one week following P1, at day 14 
Image D: DPSCs proliferation following the collagenase digestion method 
at day 15 (24 hours later). Note the circular/oval pattern of the DPSCs 
indicated by the white arrows, suggestive of vascular structures. 
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4.2 Site-specific expression of alkaline phosphatase activity by 
DPSCs in vitro 
As part of a general characterisation of the DPSCs harvested from dental pulp 
explants, pulp explants from three donors were assessed to determine ALP staining 
as an indication of their osteogenic/calcification potential. Data from one individual 
is reported here. Again, there was variability in DPSC outgrowth from explants seen 
between donors and also between different regions of the dental pulp explants. 
Figure 19 shows site-specific ALP activity for cells outgrowing from different 
regions of the pulp sections. ALP positive staining was found in the lower coronal 
region of the pulp and the upper coronal region. Weak staining was observed in the 
corono-radicular, radicular and apical regions, with this last pulp fragment 
expressing no staining whatsoever. Figure 19 (A and B) shows obvious red-brown 
staining. Some weak staining was also visible in C and virtually no DPSC ALP 
activity towards the tooth apex (D and E). The sample consisting of the apical 
papilla tissue had proliferated so rapidly that the cells had become over-confluent 
during the culture period and were unusable. The rapidity of this proliferation was 
consistent with the findings of other investigators (Sonoyama et al., 2008) where 
SCAP cells were found to proliferate at a 2 to 3 fold greater rate than those from 
pulp organ cultures. 
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Figure 19. Site - specific ALP staining for cells growing out from the different 
regions of pulp tissue sections (size = approximately 3 mm each). 
A = upper coronal pulp; B = lower coronal pulp; C = upper radicular 
pulp; D = radicular pulp; E = apical pulp. ALP activity was highest at the 
growth nodes seen in (B) (yellow arrows), followed by (A), then (C) which 
was very weak (red arrows), then (D) then (E) with these latter two images 
showing virtually no positive staining for ALP. White arrow indicates the 
dental pulp explant in all images. 
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4.3 Cytocompatability of HyA scaffolds 
4.3 1 Cytocompatability of HyA scaffolds with G292 cells as control 
G292 cells were cultured on different concentrations of HyA gel as a positive 
control to ensure scaffold cytocompatibility. After one week of culture in 
αMEM/10%FCS, G292 cell growth on GenGiGel® scaffolds was examined using 
light microscopy. Crystalline-like nodule formation, which could represent 
mineralise deposition (see below) was observed at the two higher GenGiGel
®
 
concentrations (0.6 % and 0.8 %) but not in the two lower concentrations of gels 
(0.2 % and 0.4 %, data not shown). The more obvious nodular growth in 0.8% HyA 
is shown in Figure 20. Figure 20 (A) shows a group of three nodules, the upper two 
are out of the plane of focus but a more detailed image of the colony can be seen in 
the lower right of the image (see white arrows). Figure 20 (B) shows the larger more 
obvious colony from (A), with fine hair-like growth in the bottom left (see white 
arrow) and the rest of the colony gradually moving out of focus, indicating a 3D 
growth pattern within the GenGiGel
®
 structure. 
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Figure 20. G292 osteosarcoma cell growth on/in 0.8% GenGiGel
®
. 
 
White arrow shows the crystal-like nodule formation in both images. 
Image A: magnification: x100. Image B: magnification x400. 
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4.3.2 DPSCs grown on 2% and 4% HyA gel 
Following the data obtained from the G292 cells’ culture on HyA gel which 
indicated good biocompatibility, further experiments using DPSCs were carried out 
(see Figure 21A and B). There were morphological differences visible between the 
DPSCs grown on each gel concentration with the 2% gel showing cells exhibiting a 
more elongated morphology (Figure 21 A) and the higher 4% concentration 
resulting in cells with shorter cell bodies. This was possibly associated with the 
increased viscosity of the HyA gel acting in a motility inhibiting fashion, a higher 
sodium concentration (the HyA was of the sodium salt) or simply a higher 
concentration of higher molecular weight molecules being present in the gel 
structure, given that GenGiGel is a high MW gel. This might suggest that higher 
concentrations of high MW HyA could have an effect on DPSC morphology. 
Intriguingly, some cells at the periphery of the culture, away from the main cell 
colony, exhibited a columnar phenotype with long processes, but still with much 
shortened cell bodies. However, other cells away from the main colony also 
exhibited a fibroblastic morphology (Figure 21(B)). This is similar to results by 
other authors (Couble et al., 2000) who noted differences in DPSC phenotype in the 
presence of βGP in the culture medium, with polygonal cells present centrally and 
elongated cells present on the periphery of the culture. This could imply that the 
HyA gel not only has an effect related to its MW but that it could also be 
concentration and therefore dose-dependent. 
 
 
 106 
 
 
  
 
Figure 21. DPSCs grown on different concentrations of HyA (GenGiGel). 
 
A: DPSCs showed fibroblast-like phenotype when cultured for one week 
on 2% GenGiGel in DMEM/10% FCS based upon their morphological 
appearance under light microscopy. Elongated cell bodies and multiple 
processes were present throughout all fields of view. 
B: DPSCs cultured on the stiffer, more rigid 4 % gels showed a much 
more rounded/polygonal cell phenotype after 7 days (Figure 22 (B)). 
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4.4 DPSCs grown on ivory block scaffolds 
It was intended to eventually adopt the tooth slice model (Goncalves et al., 2007, 
Mullane et al., 2008, Sloan et al., 1998) incorporating other elements of scaffold 
material, as the experimental model of choice within this thesis. For initial studies, 
ivory blocks were utilised to overcome a short term shortage in tooth availability 
from the Tissue Bank as ivory has a very similar chemical composition to dentine 
(Locke, 2008). DPSCs were seeded at a density of 10
5
 cells per block onto sections 
of ivory block scaffolds which had been prepared as described in section 3.11.1. 
As can be seen in Figure 22, the DPSCs were seen to attach, colonise and proliferate 
successfully on the surface of the ivory blocks after 7 days of culture in 
DMEM/10% FCS. The cells appeared to be aligned on the ivory surface, with the 
alignment most likely reflecting the micro or nanotopography of the scaffold 
substrate. The strong green background staining evident in Figure 22 was seen 
whenever a collagen-based scaffold of any type was used and stained with 5-
CMFDA (see also Figures 25 (A) and (B), section 4.6). However, DPSCs were 
clearly visible against the background. 
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Figure 22. Fluorescent image of DPSCs, labelled with 5-CMFDA, grown on 
ivory blocks. 
 
The image shows viable DPSCs apparently aligned on the ivory surface, 
after 7 days of culture in DMEM/10%FCS.  Arrows show the 
approximate direction of the alignment. 
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4.5 DPSCs grown on biodegradable 45S5 Bioglass
®
 matrices 
Following culture to assess ALP activity, DPSCs were cultured on three different 
concentrations of Bioglass
®
 scaffolds to examine their potential for collagen and 
glycosaminoglycan/aggrecan deposition on these scaffolds using histological 
methods. DPSCs were examined after 12 weeks, experiments of shorter time span 
having failed to show any histological changes. After being stopped and stained as 
described in section 3.11.2, Sirius Red and Alcian Blue staining showed that more 
extensive red staining was observed in the 0% and 40% Bioglass
®
 scaffolds 
compared to that of the 5% Bioglass
® 
scaffold (see Figure 23), although evidence of 
red staining was seen in all three samples. This indicates more collagen matrix 
deposition on the 0% and 40% Bioglass
®
 samples. The 5% Bioglass scaffold, 
showed more blue staining, suggesting greater deposition of 
glycosaminoglycan/aggrecan, considered a precursor to cartilaginous tissue 
deposition. 
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Figure 23. Sirius Red/Alcian Blue staining of DPSCs on different 
concentrations of Bioglass
®
. 
A: 0% Bioglass scaffold; B: 5% Bioglass scaffold; C: 40% Bioglass 
scaffold. Red colour indicates presence of collagen as suggested by Sirius 
Red staining. Blue colouration indicates the presence of possible cartilage 
precursor material. 
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4.6 The viability of DPSCs grown on Osseoguard
®
 and BioGide
®
 
Type I and III collagen membranes 
In order to confirm the viability of DPSCs grown on the two Type I and III collagen 
membranes, DPSCs were seeded onto them as described in section 3.11.4 and 
labelled with 5-CMFDA after 7 days of culture. Figures 24 (A) and (B) show 
DPSCs (bright fluorescent green colour) at 7 days post-cell seeding on both 
membranes. Images were taken under a fluorescent inverted microscope, indicating 
strong uptake of 5-CMFDA representing their continuing viability and potential for 
proliferation, as non-vital cells do not take up the dye. The increased fluorescence at 
the lower edge of the scaffold in image (B) indicated DPSCs permeating through the 
thickness of scaffold and not just adherent to the seeded surface. There was no 
obvious difference in cell fluorescence between either scaffold, suggesting equal 
viability. 
  
Figure 24. Fluorescent images showing viable 5-CMFDA labelled DPSCs on 3D 
scaffolds. 
Following culture in DMEM/10% FCS for 7 days, both A: Osseoguard
®
 
and B: BioGide
®
 show good colonisation by the DPSCs. 
 112 
 
4.7 Examination of unseeded Osseoguard
®
 and BioGide
®
 Type I and 
III collagen membranes by SEM and FEGSEM imaging 
4.7.1 Osseoguard
®
 Type I and III collagen membrane 
Two Type I and III collagen based scaffold materials were examined as described in 
section 3.11.3, under SEM and FEGSEM to assess their suitability as the 
collagenous/fibrillar component of the ECM-type construct. Having been coated in 
gold (for SEM images) or platinum (for FEGSEM images) in an inert argon gas 
atmosphere, the samples of Osseoguard
®
 Type I and III collagen membrane were 
imaged to identify any pattern in their structure. The SEM image shown in Figure 25 
(A) shows the upper surface of a sample of Osseoguard
®
 membrane material with 
the characteristic embossed “zig-zag” pattern, designating the ‘open,’ ‘up’ or outer 
side of the membrane during clinical use (i.e. that which the cells would not be 
expected to directly colonise into, rather a surface which they would be expected to 
proliferate, populate and colonise over). There are also some pieces of extraneous 
unembossed material left behind during the manufacturing process seen in the 
image. Figure 25 (B) shows the cut edge of the Osseoguard
®
 Type I and III collagen 
material, showing the upper surface of the cut material off to the top right hand side 
with the interior of the material showing an unorganised, random spongiform-like 
appearance with niches potentially suitable for cell attachment, growth and 
proliferation. The higher magnification FEGSEM image (Figure 25 (C)) shows the 
ultrastructure of the Osseoguard
®
 Type I and III collagen membrane material with 
an apparently random arrangement of the collagen fibrils of varying size and degree 
of intertwining, which exhibited collagen banding at approximately 65 nm. 
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Figure 25. SEM images (A and B) and a FEGSEM image (C), showing the 
structure of Osseoguard
®
 Type I and III collagen membrane. 
 
A: gross low power view of the top surface of the Osseoguard
®
 membrane 
material. B: lateral view of the cut edge and upper surface of the 
Osseoguard
®
 membrane material and C: high resolution image of the 
Osseoguard
®
 membrane material showing cross banded collagen fibrils. 
Scale bars shown at the bottom of all the images. 
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4.7.2 BioGide
®
 Type I and III collagen membrane 
Figure 26 (A) shows the gross SEM appearance of the upper surface of the 
BioGide
®
 Type I and III collagen membrane sample with the cut edge visible at the 
top edge. The word ‘UP’ is embossed on the surface. This is an attempt by the 
manufacturer to make it ‘Dentist proof’ and designate the side of the membrane 
which goes towards the outer surface of any wound during normal surgical usage 
where the cells would be expected to gradually populate and colonise over should it 
be exposed to an open environment, as opposed to into, which is the behaviour that 
any cells within the closed wound environment would be expected to exhibit. Figure 
26 (B) shows a higher power view of the BioGide
®
 Type I and III collagen 
membrane material, demonstrating the random arrangement of collagen fibres with 
gaps and niches suitable for cell attachment, colonisation, proliferation and 
differentiation. Figure 26 (C) shows an ultra-high resolution image of the BioGide
®
 
Type I and III collagen membrane material with a random arrangement of the 
collagen fibrils which are exhibiting collagen banding at approximately 65 nm.  
The gross, micro- and ultrastructure of both Osseoguard
® 
and BioGide
®
 membranes 
were near-identical. Although Type III collagen might be expected to be obvious 
from its’ finer structure (smaller diameter fibrils), very few of its’ microfibrils were 
apparent in either membrane. Both membranes showed good pore size of between 
50 to 300 µm and porosity (Murphy et al., 2010, Murphy and O'Brien, 2010) which 
is essential for the dissemination of gases and nutrients as well as expulsion of waste 
products and providing suitable niches for cell binding, attachment, colonisation, 
migration, proliferation and differentiation, whilst at the same time avoiding the 
aggregations of cells at the scaffold edges, which can occur with smaller pore size 
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scaffolds (O'Brien, 2011). This indicates that both/either would be suitable for future 
investigation as biomimetic matrices for seeding, attachment and proliferation of 
DPSCs in this study.  
  
 
 
Figure 26. SEM images (A and B) and a FEGSEM image (C) showing the 
structure of BioGide
®
 Type I and III collagen membrane. 
 
A: shows the gross (low power) view of the top of the BioGide
®
 Type I and 
III collagen membrane, B: lateral view of the cut edge of the BioGide
®
 
material and C: high resolution image of the BioGide
®
 membrane 
material showing cross banded collagen fibrils (cf . Osseoguard
®
 Figure 
24 (C). Scale bars shown at the bottom of all the images. 
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4.8 Ultrastructural appearance of DPSCs grown in vitro on Type I 
and III collagen membranes in DMEM/10%FCS 
4.8.1 DPSCs grown on Osseoguard
®
 Type I and III collagen membrane in vitro 
DPSCs were cultured on 25mm
2
 Osseoguard
®
 membrane samples for 14 days in 
DMEM/10%FCS, as described in section 3.11.4 to ascertain the membrane’s 
suitability to facilitate DPSC attachment, colonisation, proliferation and 
differentiation, all of which would be necessary for success as a putative scaffold 
material. Figure 27 (A) shows an area of approximately 0.36 mm
2
 of the 
Osseoguard
®
 membrane as seen in the SEM. Elements of the gross structure of the 
membrane were visible with a background of DPSCs apparently embedded in matrix 
which they had produced. Several groups of cells were visible bridging across gaps, 
as indicated by the white arrows. Figure 27 (B) shows a high power view of the 
same area, approximately 0.046 mm
2
 showing the cell density more obviously than 
Figure 27 (A) but again with an extensive area of DPSCs embedded in their own 
matrix. Figure 27 (C) shows a close up of the cells from images (A) and (B), in an 
area of approximately 0.004 mm
2
. This shows the cells exhibiting a mixed 
fibroblast/myofibroblastic morphology with some structural features such as 
fenestrations, attachment ‘feet’ or focal adhesions and filopodia apparent. 
These images confirmed that the Osseoguard
®
 Type I and III collagen membrane 
was capable of supporting the attachment, colonisation and proliferation of DPSCs 
over a period of 14 days, enabling them to produce their own extracellular matrix 
materials with pores and gapping between the cells and cell layers to allow the 
through flow of nutrients and O2. 
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Figure 27. SEM images of DPSCs growth on Osseoguard
®
 Type I and III 
collagen membrane after 24 days of culture in DMEM/10%FCS. 
 
A: low power view of DPSCs on the Osseoguard
®
 membrane showing 
structural elements of the scaffold material indicated by the yellow arrows 
and various groupings of DPSCs, indicated by the white arrows. B: higher 
power image of the right side of the field in (A) with cells covered in 
matrix. C: further higher power image detailing individual DPSCs seen 
here bridging the gaps between scaffold fibres. DPSCs embedded in own 
matrix indicated by red arrows. Scale at the bottom of the images. 
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4.8.2 DPSCs grown on BioGide
®
 Type I and III collagen membrane in vitro 
To decide which Type I and III collagen membrane would be the final choice and as 
a comparator for Osseoguard
®
, DPSCs were also cultured on 25mm
2
 BioGide
®
 Type 
I and III collagen membrane samples as described in section 3.11.4. Figure 28 (A) 
shows an extended grouping of apparently less mature cells in area of cells 
embedded in their own extracellular matrix. These less mature or ‘new’ cells are 
most likely to have derived from other cells in situ or they could have migrated there 
from elsewhere on the scaffold material. They show little or no evidence of 
alignment with the other cells or matrix production. Figure 28 (B) shows detail of a 
cell indicated from the bottom centre of image (A), exhibiting an irregular cuboidal 
morphology with an approximate cell length of 10 µm. Immediately above it is 
another ‘new’ cell, this time showing a different ‘J’-shaped morphology and above 
that, a small clump of ‘new’ oval cells. None of these cells are exhibiting any 
evidence of any matrix deposition at this stage, although all the other established 
cells are, as can be seen elsewhere. Figure 28 (C) shows detail of a cell indicated in 
the top left region of image (A), apparently assuming a differing morphology and 
commencing matrix deposition as it gradually aligns with the adjacent cells. The 
outline of the cells in the background can be seen through their blanket of matrix. 
Figure 28 (D) shows a colony of cells. The cell to the left of the central pair 
(indicated by the white arrows) exhibits less matrix deposition. The cell on the right 
of the pair exhibits more matrix deposition and both this cell and another third cell 
to the left of this pair (lower to the left in the image) can be seen to be extruding 
some material (indicated by the yellow arrows) through a pore in the cell membrane. 
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Overall, these images appear to show that DPSCs can attach, colonise, proliferate, 
align and thrive sufficiently over the duration of the culture period to produce their 
own matrix on BioGide
®
 Type I and III collagen membrane with pores and gapping 
between the cells and cell layers that would allow the permeation of nutrients and O2 
as well as the dispersal of waste products. Their colonisation can be compared with 
the unseeded material in Section 4.7.2 and also the image in Figure 28 (E). 
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Figure 28. SEM images showing DPSCs growth on BioGide
®
 Type I and III 
collagen membrane after 14 days of culture in DMEM/10% FCS. 
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4.9 Appearance of DPSCs grown on Osseoguard
®
 and BioGide
®
 
Type I and III collagen membranes in the confocal microscope 
4.9.1 DPSCs examined at 7 days post seeding 
After 7 days of attachment and culture, Figure 29 (A and B) shows DPSCs with 
strong uptake of 5-CMFDA and TOPRO indicating their continuing viability at the 
time of staining and presumed potential for proliferation had culture been allowed to 
continue. The images show snapshots of z-stacks taken on the confocal microscope 
to show the depth of penetration of the DPSCs after 7 days in culture in 
DMEM/10% FCS. There appeared to be no obvious differences seen between the 
scaffolds, with both scaffolds showing cells several layers deep, confirming that 
cells survival in the deeper, potentially nutrient poor parts of the scaffold material.  
  
Figure 29. Confocal laser scanning microscope images of DPSCs on (A) 
Osseoguard
®
 and (B) BioGide
®
 Type I and III collagen membranes. 
Both images show viable DPSCs penetrating towards the deeper parts of 
each membrane. Scale at the bottom of each image. 
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4.9.2 DPSCs examined at 28 days post seeding 
Figure 30 (A and B) shows DPSCs cultured in DMEM/10% FCS in 3D 
Osseoguard
®
 and BioGide
®
 Type I and III collagen membrane scaffolds at 28 days 
post-seeding with viable cells being stained with Acridine Orange and HCS 
CellMask
™
 Deep Red dye, showing strong uptake of these stains and the extent of 
colonisation and proliferation in both scaffold materials. Both images are from a 
series of z-stacks taken on the confocal microscope to show the depth of penetration 
of the DPSCs within both scaffolds after 28 days culture. Both scaffolds exhibited 
cells several layers deep, confirming that cells could survive in the deeper, 
potentially nutrient poor parts of the scaffold. It was noted that there were many 
fewer (if any) gaps between the DPSCs on both scaffolds at this stage of the 
experiment as the culture period had gone on for 21 days longer than the seven days 
in Section 4.9.1, Figure 29, where larger numbers of gaps were seen. There were 
also DPSCs out of focus in parts of both images which are not able to be shown in a 
snapshot image (areas seen as dark patches). Also, the cells appeared to be  more 
aligned on the Osseoguard
®
 sample compared with the BioGide
®
 although there is 
apparently an area of uncolonised BioGide
®
 scaffold (the green mesh-like region) in 
Figure 30 (B). This could be down to one of several reasons such as failure of stain 
uptake or non-attachment and proliferation of the DPSCs during the seeding 
procedure, although close examination of Figure 30 (B) does show Acridine Orange 
stained nuclei within the centre of the green mesh field, indicating failure of stain 
uptake as the more likely cause. 
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Figure 30. Confocal laser scanning microscope images showing DPSCs growth 
on (A) Osseoguard
®
 and (B) BioGide
®
 Type I and III collagen membranes 
after 28 days of culture. 
 
(A) and (B) show extensive colonisation of both scaffolds. Scale shown at 
the bottom right of each image. 
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4.10 Measurement of DPSC proliferation on BioGide
®
 Type I and 
III collagen scaffold membranes using the PicoGreen
®
 method 
In order to quantitatively determine DPSC proliferation on BioGide
® 
Type I and III 
collagen scaffolds, DNA was measured using a PicoGreen
®
 assay at a range of time 
points, as described in section 3.13. Statistical analysis was carried out by a 1-way 
ANOVA calculation using Microsoft Excel software. Figure 31 shows the DNA 
standard calibration curve. 
This type of standard curve shown in Figure 31 was used to quantify DNA 
recovered from DPSCs seeded onto 25 mm
2
 sections of BioGide
®
 Type I and III 
collagen membrane at days 5, 10 and 15 following seeding, as a measure of cell 
numbers. 
Figure 31. Calibration curve for DNA quantification. 
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The bar chart in Figure 32 shows that the numbers of cells present in the scaffold 
increased progressively with time, indicating that the membrane supported DPSCs 
growth, allowing them to proliferate throughout the time period examined. 
However, statistical analysis showed that although there was an apparent increase 
between day 5 and day 10, it was not statistically significant, with p = 0.102. The 
increase in detectable DNA between day 5 and day 15 was statistically significant, 
with p ˂ 0.0001 and the increase in measurable DNA between days 10 and day 15 
was statistically significant with p˂0.0001. 
The more precise values obtained by the calculations are displayed in table 4. 
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Figure 32. Bar chart showing total of measurable DNA obtained from DPSCs 
grown on BioGide
® 
Type I and III collagen scaffolds. 
DNA was measured at days 5, 10 and 15 using a PicoGreen assay. NS: p ˃ 
0.05; ***: p ≤ 0.001. n=9 
 
TABLE 4: Statistical analysis of measurable DNA at days 5, 10 and 15. 
Table showing the precise values obtained by statistical analysis. 
Groups Adjusted p value 
Day 5 compared with day 10 0.101712 
Day 5 compared with day 15 0.000047 
Day 10 compared with day 15 0.000195 
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4.11 H&E Histological staining of DPSCs on BioGide
® 
Type I and 
III collagen membranes in DMEM/10% FCS 
Given the data shown in sections 4.8 and 4.9, it was decided that as neither scaffold 
material showed any discernible difference from the other and that both had shown 
good support for DPSCs attachment, colonisation and some evidence of 
proliferation, further work would proceed using BioGide
®
 Type I and III collagen 
membrane as there were fewer issues with supply since the material was available 
cheaply, at short notice and could be both stored and sterilised easily after opening. 
Figure 33 (A) shows a histological section, stained with H&E, of BioGide
® 
Type I 
and III membrane scaffold (white arrows) with DPSC ingrowths (yellow arrows) 
showing cell attachment and colonisation. The matrix deposited by the DPSCs 
stained pale purple-pink with the scaffold material staining a darker shade of the 
same colour and showing a coarser-structured ribbon-like appearance. 
Figures 33 (B and C) revealed what appeared to be deposition of an extracellular 
matrix material within the scaffold and attachment of DPSCs to the membrane itself 
(Figure 33 (D). 
A higher power oil immersion image revealed  nuclei around circular/oval regions as 
shown in Figure 33 (D). Taken together, these data suggest that DPSCs can attach to 
the membrane, continue to grow and to successfully proliferate over a period of 28 
days producing a fine extracellular matrix material (see areas indicated by yellow 
arrows in Figure 33 (A)). 
Of particular interest were the areas where small irregular and sometimes oval void 
areas had formed. These superficially resembled vascular structures in appearance, 
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with cell nuclei next to what would be the putative vessel lumen. These can be seen 
in all of the images, most commonly within areas of matrix deposition but also 
within the scaffold material itself and were more apparent in the higher 
magnification views. Their presence led to the next avenue of investigation in 
section 4.12. 
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Figure 33. H&E staining showing DPSC growth on BioGide
®
 Type I and III 
collagen membrane. 
 
A: DPSCs and matrix ingrowths (indicated by the yellow arrows) into the 
BioGide
®
 membrane. B: area with DPSCs surrounding an area of void or 
lumen (indicated by the white arrows)  with their nuclei prominent into 
the same. C: same region under higher power with the putative vascular 
areas indicated by the white arrows. D: oil immersion image showing 
DPSCs and their deposited matrix. The central void oval area indicated 
by the white arrow inside the area of deposited matrix would be 
approximately the size of a capillary. Scale bars in millimetres at the 
lower right corner of the images. 
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4.12 Immunolocalisation of angiogenic markers expressed by 
DPSCs on BioGide
® 
Type I and III collagen scaffolds 
Consequent to the findings in section 4.11. it was decided to investigate whether the 
oval and irregular lumen-like structures were actually neo-vascular. 
Immunohistochemistry was carried out to determine if they would stain positively 
for angiogenic markers. Figure 34 shows immunostaining of DPSCs cultured on 
Type I and III collagen membranes in αMEM/10% FCS, stained for CD31 and 
CD34 markers. There was no evidence of any positive staining on any of the 
sections or the negative control. In contrast, the positive control (dental pulp) 
sections (Figure 35 (B and C)) all showed positive staining for the markers. This 
suggests that there had been no early angiogenic change in the DPSCs cultured on 
the scaffolds at 14 days. However, there was evidence of some matrix deposition by 
the DPSCs (the fine hair-like strands). 
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Figure 34. CD31 and CD34 immunohistochemical staining of DPSCs on 
BioGide
®
 Type I and III collagen membrane. 
 
A: staining for CD31. B: staining for CD31 (magnified view of image A). 
C: negative control (no 1
st
 antibody). D: staining for CD34 of DPSCs on 
BioGide
®
 Type I and III collagen membrane after 14 days of culture in 
αMEM/10% FCS. No positive staining was detected in any of these 
samples. 
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Figure 35. Negative and positive controls used for immunohistochemical 
staining for CD31 and CD34 antibodies. 
 
A: CD31 negative control (no 1
st
 antibody) for DPSCs on BioGide
®
. B: 
positive control (dental pulp section) staining strongly for CD31. C: 
positive control (dental pulp section) staining strongly for CD34. D: CD34 
negative control dental pulp section without 1
st
 antibody. Scale bars at 
bottom of images. 
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4.13 Immunostaining of STRO-1 and CD34 staining cells 
The images in Figure 36 were taken from consecutive sections of the same dental 
pulp show the relative proximity of STRO-1 and CD34 positive staining cells. There 
is marked commonality of staining between the two biomarkers, with the staining 
patterns being almost identical. This correlates with CD34 being regarded as a 
marker for ‘precursor’ cells of various lineages as well as haematopoietic precursor 
cells. Note that despite the commonality of staining pattern between the two 
biomarkers, there is no evidence of any CD34 staining away from the immediate 
blood vessel vicinity, but there is definite evidence of positive staining to STRO-1 
seen in image A in the surrounding perivascular tissue niche. 
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Figure 36. Staining of three consecutive control sections of dental pulp with 
STRO-1 stain (A), CD34 stain (B) and H&E stain (C). 
A: blood vessel in dental pulp indicated by the blue arrow with cells 
staining strongly positive for STRO-1 antibody (in the perivascular niche, 
indicated by the red arrows in the top left of the image. The endothelial 
vessels have also stained strongly for STRO-1. The perivascular tissues 
are indicated by the yellow arc in each image. 
B: consecutive microtome section to (A), immuno-stained for CD34 
indicated by the black arrow. The endothelial cells stained strongly 
positive for CD34 antibody. Note no perivascular staining, with the 
perivascular tissues indicated by the yellow arc. 
C: conventional H&E staining of next consecutive microtome section with 
blue arrow indicating the blood vessel. 
Image C shows another section from the same blood vessel stained for 
H&E with the vessel walls staining strongly positive for H&E as indicated 
by the light blue arrow and the region of the perivascular tissues indicated 
by the yellow arc. 
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4.14 The effect of added rhVEGF165 on the expression of angiogenic 
markers by DPSCs and HUVECs on 1% collagen gels 
As the DPSCs cultured on BioGide
® 
Type I and III collagen scaffolds had not shown 
any evidence of markers for angiogenic change, it was decided to investigate if the 
presence of rhVEGF165 would have any effect on the expression of angiogenic 
markers in a collagen gel culture as can be seen in the following images comprising 
Figure 37. Collagen gel was chosen for these experiments in order to approximate 
more closely the culture conditions of the HyA gel component of the intended Type 
I and III collagen/HyA construct. EGM was chosen as the culture medium as it is 
recommended for cells expressing angiogenic markers e.g. HUVECs. HUVECS 
were chosen as a comparator cell line as they express angiogenic markers such as 
CD31, CD34 and Von Willebrand Factor (vWF). 
 
As can be seen in Figure 37, following culture in the presence of rhVEGF165 on 1% 
collagen gels for 48 hours, DPSCs showed minimal positive immunostaining for 
either CD31 (Figure 37 (A)) or CD34 (Figure 37 (B)) angiogenic markers, similar to 
the dental pulp positive and negative controls (Figure 35 (B), (C) and (D)). This 
indicates no, or very slight, differentiation along an angiogenic lineage for DPSCs 
under these conditions. 
In contrast, the HUVEC positive control cell line (Figure 38(A and B)) showed 
strong positive staining for both CD31 and CD34. 
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Figure 37. CD31 and CD34 immunohistochemical staining of DPSCs cultured 
on 1% collagen I gels in EGM with 5 ng/mL rhVEGF165 for 48 hours. 
 
A and B: weakly positive immunostaining staining of DPSCs to the target 
antigens, CD31 and CD34 respectively. C and D: negative controls (no 1
st
 
antibody). All images show evidence of annular configuration, suggestive 
of monolayer vascular structures (gold arrows). 
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Figure 38. Immunohistochemical staining for CD31 and CD34 of HUVECs 
cultured for 48 hours on 1% collagen I gel in EGM with 5 ng/mL 
rhVEGF165. 
 
A and B: HUVECs (positive control cell line), showed strong positive 
immunostaining for CD31 and CD34 markers, respectively. C and D: 
negative controls, (no 1
st
 antibody) showed minimal staining. Monolayer 
vascular-like  structures indicated by gold arrows. 
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4.15 Comparison of cells cultured on 1% HyA ± rhVEGF165 
4.15.1 DPSCs 
Cells were cultured on 1% HyA gel with or without rhVEGF165 to see if a 1% HyA 
gel could induce angiogenic change in the absence of rhVEGF165. Figure 39 shows 
strong positive immunostaining for both CD31 and CD34 markers when DPSCs 
were cultured in 1% HyA in EGM for 48 hours with and without the addition of 5 
ng/mL of rhVEGF165 to the culture medium. All of the samples exhibited small 
circular or irregular collections of DPSCs suggestive of vascular structures in 
monoculture. This suggests that a 1% HyA gel on its own can act as a biomimetic 
matrix to initiate angiogenic change in DPSCs without needing the addition of 
rhVEGF165 when cultured for 48 hours and is discussed more fully in the discussion, 
Section 5.4.4. 
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Figure 39. CD31 and CD34 immunohistochemical staining of DPSCs grown on 
1%HyA ± 5 ng/mL of rh VEGF165
 
 after 48 hours of culture in EGM 
 
A: DPSCs cultured on 1% HyA in EGM for 48 hours showed strongly 
positive immunostaining for CD31. B: as A, but stained for CD34 antigen 
also with strong positive staining evident. C and D: DPSCs cultured under 
the same conditions but with the addition of 5 ng/mL of rhVEGF165. Strong 
positive staining was seen for both CD31 and CD34 markers, with the 
blue arrows indicating cells arranged in a vascular-like configuration. 
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4.15.2 HUVECs 
HUVECs were used as the positive control for these experiments investigating the 
effect of culture conditions on angiogenic marker expression. Figure 40 shows 
strong positive staining for both CD31 and CD34 when HUVECS were cultured in 
1% HyA in EGM for 48 hours with and without the addition of 5 ng/mL of 
rhVEGF165 to the culture medium, similar to the observations for DPSCs cultured 
under the same conditions. This further suggests that a 1% HyA gel on its own can 
act as a biomimetic matrix and can enhance angiogenesis in HUVECs without 
needing the presence of rhVEGF165 when cultured for 48 hours. 
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Figure 40. CD31 and CD34 immunohistochemical staining of HUVECs 
cultured for 48 hours in 1%HyA ± 5 ng/mL of rhVEGF165 in EGM. 
 
A: strong CD31 positive immunostaining for HUVECs cultured on 1% 
HyA gel only. B: similar intense positive staining for HUVECs was seen 
for CD34 expression, again cultured on 1% HyA gel only. C and D: 
similar results for HUVECs cultured on 1% HyA gel + 5 ng/mL 
rhVEGF165 and immunostained for CD31 and CD34 respectively. Blue 
arrows indicate circularly arranged cells. 
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4.16 Immunohistochemical staining of G292 cells and HPDLCs 
cultured on 1% HyA in EGM with 5 ng/mL of rhVEGF165 
4.16.1 G292 cells 
G292 cells were used as a negative control and cultured under identical conditions to 
those described above with no expectation of any sign of early angiogenic change. 
Figure 41 shows that no obvious positive staining for either CD31 or CD34 was 
evident in any of the sections, indicating little or no propensity for angiogenic 
change in the G292 cells cultured on 1% HyA gel in EGM with 5 ng/mL of 
rhVEGF165. 
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Figure 41. CD31 and CD34 immunohistochemical staining of G292 cells as 
control, cultured in EGM on 1% HyA with 5 ng/mL of rhVEGF165. 
 
A: CD31 immunohistochemistry showed no positive staining. B: CD34 
immunohistochemistry also showed no positive staining. C: negative 
control (no 1
st
 antibody). All images × 100 mag. 
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4.16.2 HPDLCs 
HPDLCs were used as a separate negative control and cultured under identical 
conditions to those described above as they are derived from a similar embryological 
source to DPSCs and might be expected to show similar angiogenic change under 
the same stimuli. Figure 42 (A) and (B) show no definite positive staining for either 
CD31 or CD34 in any of the sections, probably indicating limited or no propensity 
for angiogenic change in the HPDLCs cultured on 1% HyA gel in EGM without 5 
ng/mL of rhVEGF165. 
These results are indicative of little or no early angiogenic change. The more 
pronounced change being in Figure 42 (C), the HPDLCs which were stained for 
CD31 antibody and which were cultured on 1% HyA gel in the presence of 5ng/mL 
of rhVEGF165, suggesting that rhVEGF165 enhances their potential for angiogenic 
change. There was minimal change in Figure 42 (D). These are cells deriving from a 
similar embryonic source as DPSCs and given their proximity to the dental pulp 
organ needing to be regenerated and their already documented pluripotency, they 
could become a potential recruit cell source for a suitable matrix to repopulate a 
sterile, prepared root canal and ultimately regenerate a dental pulp. 
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Figure 42. CD31 and CD34 immunohistochemical staining of HPDLCs cultured 
for 48 hours in 1%HyA ± 5ng/mL of rhVEGF165 in EGM. 
 
Images A and B were of cells cultured without rhVEGF165, whereas C and 
D were cultured with rhVEGF165. A and C: stained for CD31 antigen. B 
and D: stained for CD34 antigen. All images show weak staining for both 
markers but the cells cultured in the presence of rhVEGF165 showing 
stronger staining. Image C showing prominent nuclei and nucleoli. 
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4.17 Cold stage SEMs of DPSC-scaffold constructs in situ within 
endodontically prepared tooth slices 
Tooth slices containing BioGide
®
/HyA/DPSC constructs were prepared as described 
in sections 3.16.1 and 3.16.2. They were stopped after two weeks culture in EGM as 
described in section 3.16.2.1. They were then imaged in the SEM at minus 20 °C. 
The ultrastructural appearance of DPSC-scaffold constructs in situ within the 
endodontically prepared tooth slices is shown in Figure 43. The tooth slice cracked 
following exposure to the minus 20°C temperature in the SEM chamber, probably as 
a result of insufficient moisture removal and consequent ice crystal formation and 
expansion within the sample. Nevertheless, Figure 43 (C) shows DPSCs apparently 
bridging the space between scaffold and dentine with cells arranged in a layer 
covering the inside of the endodontically prepared dentine surface. Figure 43 (D) 
shows a prominent hour-glass shaped cell (see the white arrow) with an obvious 
nucleus, in a field of several other cells, all exhibiting prominent  cytoskeletal 
features. 
These results showed that despite the difficulties encountered in obtaining intact 
tooth sections for immunostaining, the tooth slice/ BioGide
®
/HyA/DPSC construct 
successfully maintained DPSCs over the two week period of this experiment (see 
Section 4. 18). 
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Figure 43. SEM images showing a tooth slice with DPSCs/BioGide
®
/scaffold in 
situ after 14 days of culture in EGM. 
 
A and B: low power view of the sample. Fracture of the dentine slice due 
to the minus 20°C temperature is obvious. C: dentine slice on left of field; 
BioGide
®
 membrane with 1% HyA gel on the right, with cells bridging the 
space (indicated by the white arrows). D: accumulation of cells including 
hour-glass shaped cell (indicated by the white arrow) exhibiting 
prominent cytoskeletal elements amongst the BioGide
®
 membrane fibres. 
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Further ultrastructural examination of more samples of the DPSC-constructs in situ 
within the endodontically prepared tooth slices showed similar but not identical 
interesting features. For example, Figure 44 (A) shows a different sample with a 
DPSC bridging between the scaffold and dentine (see white arrow) with DPSCs 
growing on the dentine wall to the right of the image showing obvious dentine 
tubule structure and DPSCs populating the instrumented lumen of the dentine slice. 
Figure 44 ((B), (C) and (D)) shows DPSCs within the scaffold material with other 
DPSCs in the field of view and good evidence of cytoskeletal elements and nuclei. 
All of the samples examined showed similar results confirming uniformity of results 
from the experimental protocol. 
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Figure 44. Cold stage SEM images of tooth slice/DPSC/BioGide
®
/HyA construct 
samples. 
 
These images appear to show cell groups proliferating within the 
BioGide
®
 membrane and 1% HyA gel matrices. Cell groups and 
individual cells indicated by the white arrows. 
 
 
 
 
 150 
 
4.18 Expression of angiogenic markers by DPSC-scaffold constructs 
in situ within endodontically prepared tooth slices 
Tooth slices containing DPSC constructs were prepared as described in sections 
3.16.1 and 3.16.2. Following preparation for histology and microtomy, sections were 
immuno-stained for CD31 and CD34 markers to investigate their expression  
following culture of the slices + constructs as a whole. Figure 45 shows DPSCs 
cultured in EGM in vitro on 1% HyA and BioGide
® 
Type I and III collagen 
membrane inside a tooth slice. Cells showed positive staining for CD31 and CD34 
markers, with blue-staining ribbon-like structures representing fragments of 
BioGide
®
 Type I and III collagen membrane which had fractured during cutting. 
Neither this membrane, nor the honeycombed structure representing the dentine of 
the tooth were positively stained for CD31 or CD34 and had only picked up the 
counter-staining from the Harris haematoxylin and Scotts tap water. Fragmentation 
of the BioGide
®
 Type I and III collagen membrane during histological procedures 
was a constant finding throughout the study. 
 
 
 
 
 
 151 
 
  
 
Figure 45. CD31 and CD34 immunohistochemical staining of DPSCs cultured 
on 1% HyA and BioGide
®
 in EGM in a tooth slice in vitro for two weeks. 
 
A: positive staining for CD31. B: positive staining for CD34. Note that in 
both images, the DPSCs appear to locate in small ‘lacunar-shaped’ areas 
off the main endodontically prepared tooth slice lumen. 
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4.19 Expression of angiogenic marker genes by human dental pulp 
stromal cells 
Quantitative RT-PCR (qRT-PCR) was used to determine gene expression of the 
angiogenic genes, CD31 and CD34 by DPSCs under different culture conditions. 
Cells were cultured either in 1% hyaluronic acid gels or as monolayers and in either 
EGM or basal medium (see Methods section 3.18). qRT-PCR was carried out at two 
and five days after culture using TaqMan gene expression assays for the angiogenic 
marker genes CD31 and CD34 as described in section 3.18. Results are shown 
relative to the housekeeping gene YWHAZ and were analysed using the comparative 
cycle threshold method (ΔCT). Bar charts of the mean ± standard error were plotted 
in Microsoft Excel. Statistical analysis between groups was carried out using an 
ANOVA one way test followed by Bonferroni multiple comparison tests. The 
analysis of statistical significance was carried out using SPSS version 21. The data is 
shown in Figure 46 and Tables 5 and 6. 
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Figure 46. qRT-PCR data showing changes in CD31 and CD34 expression by 
DPSCs under different culture conditions at different time points relative 
to the housekeeping gene YWHAZ. 
 
H = DPSCs cultured on 1% HyA gel; M = DPSCs cultured as monolayers; 
E = EGM used as culture medium; A = αMEM/10%FCS used as culture 
medium. Numeric value is the time in days (2 or 5) elapsed since day zero 
(D0). Bars show mean values ± SE, with n=1. Statistical comparison of 
data is shown in Tables 5 and 6 below. 
 
  
 154 
 
 
TABLE 5: Comparison of CD31 gene expression between the various cell/culture 
condition groups at days 0, 2 and 5. 
H = DPSCs cultured on 1%HyA gel; M = DPSCs cultured as monolayers; E = 
EGM used as culture medium; A = αMEM/10%FCS used as culture medium. 
Statistically significant change is shown by p≤0.05; NS = not significant; N/A 
= not applicable. 
 Day 0 HE2 HA2 ME2 HE5 HA5 ME5 MA5 
Day 0 N/A NS p≤0.05 NS NS NS NS NS 
HE2 NS N/A p≤0.05 NS NS NS NS NS 
HA2 p≤0.05 p≤0.05 N/A p≤0.05 p≤0.05 p≤0.05 p≤0.05 p≤0.05 
ME2 NS NS p≤0.05 N/A NS NS NS NS 
HE5 NS NS p≤0.05 NS N/A NS NS NS 
HA5 NS NS p≤0.05 NS NS NA NS NS 
ME5 NS NS p≤0.05 NS NS NS N/A NS 
MA5 NS NS p≤0.05 NS NS NS NS N/A 
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TABLE 6: Comparison of CD34 gene expression between the various cell/culture 
condition groups at days 0, 2 and 5. 
H = DPSCs cultured on 1%HyA gel; M = DPSCs cultured as monolayers; E = 
EGM used as culture medium; A = αMEM/10%FCS used as culture medium.  
Statistically significant change is shown by p≤0.05; NS = not significant; N/A 
= not applicable. 
 Day 0 HE2 HA2 ME2 HE5 HA5 ME5 MA5 
Day 0 N/A NS NS NS NS p≤0.05 NS p≤0.05 
HE2 NS N/A NS NS NS p≤0.05 NS p≤0.05 
HA2 NS NS N/A NS NS NS NS NS 
ME2 NS NS NS N/A NS p≤0.05 NS p≤0.05 
HE5 NS NS NS NS N/A p≤0.05 NS p≤0.05 
HA5 p≤0.05 p≤0.05 NS p≤0.05 p≤0.05 N/A NS NS 
ME5 NS NS NS NS NS NS N/A NS 
MA5 p≤0.05 p≤0.05 NS p≤0.05 p≤0.05 NS NS N/A 
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Effect of culture medium on changes in CD31 gene expression 
Comparing CD31 expression between days 0, 2 and 5 for DPSCs cultured on HyA 
in EGM showed an apparent upregulation between day 0 and day 2 and day 0 and 
day 5 but neither of these were statistically significant. In contrast, when DPSCs 
were grown on HyA in basal medium, there was a significant upregulation in CD31 
expression between days 0 and 2, followed by a significant down regulation between 
days 2 and 5, with CD31 expression at day 5 being similar to that at day 0 (NS). 
When DPSCs were grown in monolayer culture in EGM, there were also no 
significant differences in CD31 expression between days 0 and 5. Unfortunately, 
data for DPSCs grown in monolayers in basal medium for 2 days was not obtained, 
so there is no possibility of comparing expression at day 2 with day 0 or at day 5. 
 
Effect of culture medium on changes in CD34 gene expression 
Comparing CD34 expression between days 0, 2 and 5 for DPSCs cultured on HyA 
in EGM showed no significant changes with time. When DPSCs were grown on 
HyA and cultured in basal medium, there were no significant changes to CD34 gene 
expression at day 2 but a significant upregulation in CD34 expression was seen at 
day 5 compared with day 0. 
When DPSCs were grown as monolayers and cultured in EGM, CD34 expression 
was unaffected at days 2 and 5 of culture compared with day 0.  Unfortunately, data 
for DPSCs grown in monolayers in basal medium for 2 days was not obtained, so 
there is no way of comparing CD34 expression at day 2 with day 0 or at day 5. 
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Taken together, these data suggest that growth of DPSCs on HyA in EGM did not 
affect the expression of wither angiogenic marker. However, in basal medium, both 
gene markers were significantly upregulated in culture, with CD31 being greatly 
upregulated by day 2 and then returning to baseline values and CD34 being 
upregulated by day 5. 
 
Effect of 3D culture on HyA scaffolds on CD31 gene expression: 
The effect of growing DPSCs on HyA scaffolds compared with monolayer culture 
on angiogenic marker gene expression was also determined for each time point and 
in both culture mediums. CD31 expression in EGM was similar at both day 2 and 
day 5 (NS) irrespective of whether cells were cultured on HyA scaffolds or as 
monolayers. In basal medium, at day 5, there was also no significant differences in 
CD31 expression either between DPSCs grown on HyA scaffolds and those grown 
as monolayers. 
Effect of 3D culture on HyA scaffolds on CD34 gene expression: 
In the case of CD34 expression, DPSCs grown in EGM also had similar levels of 
gene expression at days 2 and 5 of culture (NS). In basal medium, CD34 expression 
was also similar irrespective of whether the cells were grown on HyA scaffolds or in 
monolayers at day 5. 
These data together suggest that the effect of HyA scaffolds in the expression of 
angiogenic markers was minimal under the conditions described here. 
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 Figure 47. Bar chart showing DPSCs expression of CD31 and CD34 when 
cultured in EGM either with 1% HyA gel or in monolayer relative to 
YWHAZ housekeeping gene. 
 
Comparing CD31 expression between days 0 and 2 in the HE2 and ME2 groups: 
although the bar chart shows there was just over a three-fold increase between days 
0 and 2, this was not calculated to be statistically significant, with a value of p = 1 
between day 0 and the HE2 group. In comparing change between day 0 and the ME2 
group, although there was again a more than doubling of CD31 expression, it wasn’t 
calculated as statistically significant with p = 1. 
Comparing CD34 expression between days 0, and day 2 for the HE2 and ME2 
groups again shows no statistically significant difference with p = 1 although there is 
an apparent change in expression shown on the bar chart. 
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Figure 48. Bar chart showing changes in CD31 and CD34 expression from day 
0 to days 2 and 5 in DPSCs cultured in 1% HyA with αMEM/10%FCS 
relative to YWHAZ housekeeping gene. 
 
Comparing CD31 expression between day 0 and the HA2 and HA5 groups: from 
day 0 to day 2 in the HA2 group showed an extremely significant up regulation of 
CD31 expression, with p ˂ 0.001. Between day 0 and day 5 the up regulation was 
much lower with p = 1. The difference between day 2 and 5 showed a significant 
down-regulation with p ˂ 0.001. 
Comparing CD34 expression between days 0, 2 and 5 for the HA group: the change 
in expression between days 0 and 2 wasn’t statistically significant with a calculated 
value of p = 0.432. The change in expression between days 0 and 5 was statistically 
significant with a value of p = 0.003. The difference in expression between days 2 
and 5 wasn’t statistically significant with a value of p = 0.702. 
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Figure 49. Bar chart showing changes in CD31 and CD34 expression in DPSCs 
at 2 and 5 days cultured on monolayer in EGM relative to YWHAZ 
housekeeping gene. 
 
Comparing CD31 expression between days 0, 2 and 5 in the ME group; There is no 
statistically significant change in CD31 expression between days 0 and 2, or 
between days 0 and 5 in this group. There is also no statistically significant change 
in expression between days 2 and 5 with p = 1 in all cases. 
Comparing the change in CD34 expression between days 0, 2 and 5 for the ME 
group: there was no statistically significant change in expression between day 0 and 
day 2, with p = 1. There was statistically significant change between days 0 and 5 
with p = 0.005. There was no statistically significant change in expression between 
days 2 and 5 with p = 1. 
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Figure 50. Bar chart showing changes in CD31 and CD34 expression in DPSCs 
at 2 days cultured on 1% HyA in αMEM/10%FCS or EGM relative to 
YWHAZ housekeeping gene. 
 
Comparing CD31 expression between day 0 and the HA2 and HE2 groups: the 
change in CD31 expression between day 0 and the HA2 group is very statistically 
significant with p ˂ 0.001. Between day 0 and the HE2 group it isn’t statistically 
significant and the p value was calculated to be p = 1. Between the HA2 and the 
HE2 groups the difference is statistically very significant with a calculated value of 
p ˂ 0.001. 
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Comparing CD34 expression between day 0 and day 2 in the HA and the HE2 
samples: the difference in expression between day 0 and HA2 wasn’t statistically 
significant with a value of p = 0.432. The difference in expression between day 0 
and HE2 wasn’t statistically significant with p = 1. The difference between HA2 and 
HE2 wasn’t statistically significant with p = 0.351. 
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Figure 51. Bar chart showing changes in CD31 and CD34 expression in DPSCs 
at 5 days cultured on 1% HyA gel in EGM or on monolayer in 
αMEM/10%FCS relative to YWHAZ housekeeping gene. 
Comparing CD31 expression between day 0 and days 5 in the HE5 and MA5 
groups: although a slight increase is shown in the chart, there is no statistically 
significant difference in CD31 expression between day 0 and day 5 in the HE group, 
with a calculated value of p = 0.419. There is also no statistically significant 
difference in CD31 expression between day 0 and day 5 in the MA group with a 
calculated value of p = 1. 
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Comparing CD34 expression between day 0 and day 5 in the HE5 and MA5 groups: 
there was no statistically significant difference between day 0 and HA5 with p = 1. 
There was a statistically significant difference between day 0 and MA5 with p = 
0.005. There was also a statistically significant difference between HE5 and MA5 
with p = 0.005. 
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Figure 52. Bar chart showing changes in CD31 and CD34 expression in DPSCs 
at 5 days cultured on 1% HyA gel in EGM or on 1% HyA gel in 
αMEM/10%FCS relative to YWHAZ housekeeping gene. 
Comparing the CD31 expression between day 0 and day 5 in the HE and HA group: 
there is no statistically significant difference in CD31 expression between day 0 and 
day 5 in the HE group with a calculated value of p = 0.419. there is no statistically 
significant difference between day 0 and day 5 of the HA group with a calculated 
value of p = 1 and the same for the HA5 group compared to the HE5 group. 
Comparing CD34 expression between day 0 and the H5 and HA5 groups: there is no 
significant difference between day 0 and HE5 with p = 1. There is a significant 
difference between day 0 and HA5 with p = 0.003. There is also a significant 
difference between HE5 and HA5 with p = 0.003. 
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4.20 Retrieval of in vivo samples 
After being euthanized at 28 days, the samples were dissected out from the animals 
and prepared for decalcification and sectioning (see section 3.17.2). 
 
 
 
Figure 53. Euthanized mouse ready for dissection and retrieval of samples. 
 
Image showing euthanized mouse with samples b, (right front, Type I and 
III collagen membrane with DPSCs) and c, (right rear, HyA with DPSCs) 
visible through the skin, indicated by the black arrows. The mouse seems 
to have been fighting with its siblings as can be seen from the scabs and 
scars on its back and right haunch. The red arrow indicates the single 
punched out hole in the ear, indicating that this is mouse number 1. 
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At dissection, all of the tooth slice constructs could be seen to have been 
encapsulated in fibrous tissue with a soft tissue pedicle attached. 
  
  
Figure 54. Dissected tooth slice samples from in vivo study. 
A (sample a) shows the soft tissue pedicle attachment indicated by the 
gold arrow near the top of the image. The tooth enamel is indicated by the 
light green arrows, the dentine by the light blue arrow, the blood vessels 
of the capsule are indicated by the red arrow and the protuberance of the 
BioGide
®
/1% HyA central construct, with no seeding DPSCs is indicated 
by the black arrow. B (sample b) shows the same, the central construct 
being BioGide
®
 with DPSCs. All coloured arrows indicating their 
respective structures, except there is no pedicle in the image. C (sample c), 
central construct being 1% HyA and DPSCs, again shows the same 
structures indicated by their respective coloured arrows, with the central 
construct appearing vascular in appearance. D (sample d) again shows 
enamel, dentine, blood vessels, central construct of BioGide
®
/1% HyA gel 
and DPSCs with an attachment pedicle, all indicated by their respective 
coloured arrows. Samples a,b,c and d correspond with the implantation 
sites in Figure 16, section 3.17.2. 
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4.21 Angiogenic change in tooth slice / DPSC-scaffold constructs 
following in vivo implantation 
Previously (section 4.17), in vitro and in situ data suggested that a combination of 
DPSCs and BioGide
®
 infiltrated with HyA supported cell growth and expression of 
angiogenic markers by DPSCs. 
The four sets of tooth slices were prepared as described in section 3.16.1 and 3.16.2 
containing 1) BioGide
®
/HyA only, with no DPSCs; 2) BioGide
®
 and DPSCs; 3) 1% 
HyA plus DPSCs; 4) BioGide
®
/HyA plus DPSCs. Each tooth slice containing the 
constructs was implanted sub-cutaneously into Nu/Nu mice. After four weeks, the 
slices with constructs in situ were recovered, decalcified and tissue processed. The 
expression of angiogenic markers and evidence of early vasculature was assessed 
using immunohistochemistry. 
4.21.1 BioGide
®
/HyA only 
Figure 55 (A) (BioGide
®
/HyA only – no additional DPSCs seeded) shows evidence 
of cell ingrowth (white arrow) in to the BioGide
®
/HyA scaffold with BioGide
®
 
fragments (blue arrow). Dark brown staining tubule-like structures resembling 
predentine or dentine were seen, with a defined demarcation line between them and 
the dentinal tubules of the tooth slice. These tubules were contiguous with the 
dentine tubules of the endodontically prepared tooth slice which appeared to have 
picked up background staining. Cell bodies with dark blue staining cell nuclei (from 
the Harris Haematoxylin counter stain) were seen in intimate contact with the 
tubule-like material front, with cell processes visibly traversing through both the 
darker-staining tubule-like material and into the pre-existing dentinal tubules. This 
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suggested successful colonisation of the endodontically prepared space and 
continued cell growth enabling deposition of the tubule-like material. These samples 
were intended to provide negative controls and were not seeded with DPSCs, so the 
cells seen in the sections must have come from the host animal itself. This suggests 
the construct either having a passive role, allowing colonisation by the murine cells 
or an angio-dentinal inductive/conductive property for the tooth slice/combined 
scaffold material potentially affecting any cells allowed to colonise the prepared root 
canal within the tooth slice construct. Given that the only cells available for 
colonisation of these matrices must be murine, this would suggest that in a clinical 
application, other cells, not necessarily DPSCs, could potentially colonise from 
other tissues such as the periodontal ligament, which is anatomically adjacent to the 
tooth apex. As PDLCs are embryologically very close to DPSCs, this would be an 
interesting hypothesis to further explore. 
Figure 55 (B) shows a higher power image of the same section as (A) revealing a 
close up of the cell ingrowth described previously. This showed that the cellular 
ingrowth did not only colonise the prepared root canal space but also began to grow 
cell processes along the existing dentinal tubules of the tooth slice. In (C) there was 
also evidence of cell ingrowth with the same tubule-like material contiguous with 
the dentine tubules of the tooth slice and cells in intimate contact with and arranged 
along the deposition front of the tubule-like material as described previously in the 
absence of pre-seeding with DPSCs. Finally, Figure 55 (D) demonstrates the 
arrangement of some cells within the construct in to a circular pattern, similar to 
vascular configuration (indicated by the white arrow). There was however, no 
evidence of any newly deposited tubule-like material in this particular section. 
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Figure 55. Immunohistochemical staining for CD31 and CD34 expression in 
sections of tooth slices containing constructs (without pre-seeding with 
DPSCs) in vivo. 
 
A and B: Tooth slice containing BioGide
®
/1% HyA only (no DPSCs 
seeded on to the scaffold pre-implantation), with white arrows indicating 
cell accumulations, red arrows indicating new tubule-like material and 
blue arrows indicating BioGide
®
 remnants. C and D: Tooth slice 
containing BioGide
®
 membrane, with the white arrows indicating cell 
accumulations, red arrows indicating new tubule-like structure and blue 
arrows indicating BioGide
®
 remnants. A, B and D were immunostained 
for CD31 antibody, C was stained for CD34 antibody. Positive staining 
appears brown, as does the new tubule-like material. A circular 
arrangement of cells, reminiscent of vascular structures is seen in image 
D, indicated by the white arrow. 
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4.21.2 BioGide
®
 and DPSCs 
When the combination of BioGide
®
 and DPSCs (no HyA) were used, similar 
results were obtained as were found in the HyA/BioGide
®
 (no DPSCs) samples 
as described previously. 
Figure 56 (A) shows the same evidence of soft tissues ingrowth, new tubule-like 
material and cells in intimate contact with the same layer as that described and 
illustrated in Figure 55. Circular vascular structures were present showing brown 
positive staining to CD34. Figure 56 (B) shows a soft tissue ingrowth staining 
positively for CD31, detached from the dentine during processing, containing 
vascular structures with BioGide
®
 fragments nearby and new tubule-like 
material contiguous with the tooth slice dentinal tubules. A magnified view of 
this is shown in Figure 56 (C), with the cells being arranged in an odontoblast-
like fashion, with one cell in particular indicated by the purple arrow obviously 
running its process into an adjacent dentinal tubule. 
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Figure 56. Immunohistochemical staining for CD34 and CD31 expression in 
tooth slices containing BioGide
®
 and DPSCs only (no HyA). 
 
A: staining for CD34. Green arrow shows dentine surface, red arrows 
show new material and cell processes at tooth slice margin, white arrows 
show soft tissue ingrowth, blue arrows indicate BioGide
® 
fragments, 
yellow arrows indicate vascular structures. B: Staining for CD31. Green 
arrow shows dentine surface, red shows new tubular material, yellow 
shows vascular ingrowth, white shows soft tissue ingrowth, blue shows 
BioGide
®
 fragments. C: Staining for CD31, magnified view. Same colour 
coding for arrows as before, but the purple arrow is to highlight a cell 
with its process running into the dentinal tubule. 
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4.21.3 1%HyA and DPSCs 
When 1% HyA gel was used with DPSCs in the constructs to fill the prepared root 
canal 
 
within the tooth slices, results were similar to those described in the preceding 
sections, with evidence of soft tissue ingrowth staining positively for CD34 (see 
Figure 57). There was also a deposit of brown-staining tubule-like material with the 
tubules contiguous with the dentinal tubules of the tooth slice. Cell bodies appeared 
to be in intimate contact with the new material, with their processes transiting into 
the dentinal tubules of the tooth slice and a defined demarcation line between the 
new material and the dentine tubules of the tooth slice.  
This soft tissue ingrowth was strongly positive for CD34 as evidenced by the brown 
colouration particularly towards its central region when stained using immuno-
histochemistry. It also appeared to be attached to the dentine of the tooth slice by a 
pedicle-like structure (see Figure 57 (B and C)). There was also evidence (Figure 57 
(B)) of a tubule-like material that stained a darker brown than the dentine of the 
tooth slice itself. These dark staining tubules were contiguous with the pre-existing 
dentinal tubules of the endodontically prepared tooth slice and exhibited dark blue 
staining nuclei of cells that appeared to be in intimate contact with the “deposition 
front” of the material. Evidence of vascular-like structures could also be seen, with 
some cells present within the lumen of the vascular structure exhibiting a biconcave 
disc morphology, strongly suggestive of a vascular structure containing 
erythrocytes. 
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Figure 57. CD34 immunohistochemical staining of tooth slice containing 1% 
HyA gel and seeded with DPSCs following recovery from in vivo 
incubation for 28 days. 
 
A: white arrow shows soft tissue ingrowth in to tooth slice lumen, staining 
strongly for CD34 marker, green arrow shows dentine slice. B: soft tissue 
attachment to tooth slice showing strong immunostaining for CD34 
marker. Small box is enlarged in (C), large box is enlarged in (D). C: 
white arrow shows soft tissue staining strongly for CD34 marker, red 
arrow shows cell front and cell processes, transiting the darker staining 
tubule-like material, into the dentine tubules of the tooth slice. D: shows a 
vascular-like structure staining positively for CD34 marker with some 
pale-staining, non-nuclear cells present in the lumen. Positive 
immunostaining for CD34 (brown colour) was apparent in soft tissue 
ingrowth and new tubule-like structure formation. 
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When the tooth slices containing 1% HyA seeded with DPSCs were immune-stained 
using antibodies to the angiogenic marker CD31 after recovery from the animals 
following 28 days in vivo culture, cells staining with dark blue nuclei were seen to 
be in intimate contact with the instrumented canal lumen (Figure 58 (A)). Cell 
ingrowth was clearly apparent with strongly positive staining for the CD31 marker. 
The cells were apparently aligned along the deposition front of the new tubule-like 
material, contiguous with the dentinal tubules of the instrumented tooth slice (Figure 
58 (B)). Cell processes were seen to be transiting the new tubule-like material and 
continuing through into the dentinal tubules of the tooth slice itself. 
Figure 59 (A) is a negative control section of dental pulp (no first antibody). This 
showed no evidence of staining for the marker even in blood vessels while the 
corresponding positive control confirmed strong immunostaining for CD31 and 
CD34 (Figure 59 (B) and (C). 
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Figure 58. CD31 immunohistochemical staining of tooth slice containing 1% 
HyA gel and seeded with DPSCs. 
 
A - D: soft tissue ingrowth indicated by the white arrows, positive staining 
for CD31 (brown colour) indicated by the yellow arrows and new tubule-
like material deposited contiguous with the tooth slice dentine, indicated 
by the red arrows. The dark blue cell bodies can clearly been seen in 
intimate contact with the deposition front of the new material and there is 
a demarcation line between the same and the dentine of the tooth slice. 
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The following dental pulp sections were stained for each biomarker with a control 
section not being stained for either, thereby acting as a negative control. 
  
 
 
Figure 59. Dental pulp control sections immunostained for CD31 and CD34 
marker. 
 
A: no dark brown staining was seen for CD31/CD34 when the first 
antibody was omitted even around vascular structures (yellow arrows); 
(negative control dental pulp section). B: strong brown immunostaining 
for CD31 was seen in the positive control (dental pulp) including around 
the vessels (yellow arrows). C: strong brown immunostaining for CD34 is 
obvious in this positive control dental pulp section as indicated by the 
yellow arrows. 
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4.21.4 BioGide
®
/ 1% HyA with DPSCs 
The final combination of constructs consisted of a combination of BioGide
®
 
collagen membrane plus 1% HyA gel seeded with DPSCs and was used as a within 
tooth slices followed by implantation in vivo and recovery after 28 days. Immuno-
histochemistry to determine CD31 expression again revealed new tubule-like 
material with cells in intimate contact with the deposition front of the material and 
cell processes passing via the material into the dentinal tubules of the tooth slice 
(Figure 60 (A and B)). The BioGide
®
 fragments appeared blue following staining 
and there was also extensive background staining over the dentine of the tooth slice. 
At higher magnification, cell ingrowth could be seen following the contour of the 
endodontically prepared tooth slice lumen with CD31 positively stained nuclei 
apparent (Figure 60 (B)). A region of tubule-like material (marked with a red arrow) 
with dark CD31 positive staining cell nuclei was seen in intimate contact with the 
deposition front of the tubule-like material which was in turn contiguous with the 
dentinal tubules of the tooth slice. 
When immuno-histochemistry was repeated, this time using antibodies to CD34, 
similar results were seen (Figure 60 (C and D)).  
The results indicate that a combination of BioGide
® 
and 1% HyA gel plus DPSCs 
can lead to colonisation of the prepared root canal space, with new tubule-like 
material laid down contiguous with the dentinal tubules and with the cell layer 
responsible for elaborating this new material in intimate contact with the front of 
that newly laid down material. Positive staining with both CD31 and CD34 within 
this neo-tissue suggests early angiogenesis. 
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Figure 60. Immunohistochemical staining of in vivo samples of BioGide
®
 
membrane, 1% HyA and DPSCs stained for CD31 marker. 
 
Images A, B, C and D: BioGide
®
/1%HyA/DPSCs. Images A and B: 
stained for CD31 antibody marker with soft tissue ingrowth indicated by 
the white arrows, BioGide
®
 fragments indicated by the blue arrows and 
new, material with a visible demarcation line contiguous with the dentinal 
tubules indicated by the red arrows. Images C and D: stained for CD34 
marker with soft tissue ingrowth indicated by white arrows, new material 
with a visible demarcation line contiguous with the dentinal tubules, by 
the red arrows. 
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5.Discussion 
5.1 Introduction 
5.1.1 Vasculogenesis and angiogenesis 
During embryonic growth blood vessels develop through one of two processes; 
Vasculogenesis where endothelial cells develop from progenitor cells and: 
Angiogenesis where new vessels sprout from existing vessels (Risau, 1995, Risau 
and Flamme, 1995). Therefore in the adult all blood vessel production is a result of 
angiogenesis (Hanahan and Folkman, 1996). Outside of the nervous system 
endothelial cells are amongst the longest lived cells in the human body (as are 
odontoblasts) with a very low turnover of 1 in 10,000 of them being in cell division 
at any one time (Hobson and Denekamp, 1984), but given the appropriate 
stimulation a vasculature can become very active and start to grow new capillaries. 
Thus, the process of angiogenesis is very complex (Auerbach and Auerbach, 1994, 
Cockerill et al., 1995) which in turn implies there being multiple controls to oversee 
it. 
5.1.2 Dental pulp regeneration 
Dental pulp regeneration in endodontics has been the Holy Grail of Dentistry, and 
more recently the specialisation of Endodontics, for over half a century (Nygaard-
Ostby, 1961, Nygaard-Ostby and Hjortdal, 1971). The American Association of 
Endodontists Glossary of Endodontic Terms (Endodontists, 2015) has defined 
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regenerative endodontics as ‘biologically based procedures designed to 
physiologically replace damaged tooth structures, including dentine and root 
structures, as well as cells of the pulp-dentine complex’. This started with 
histological investigations into tissue formation following dental pulp removal and 
apical ingrowth inside the root canal, initially following blood clot ingress and 
usually as sequelae of over-instrumentation during endodontic preparation 
(Nygaard-Ostby, 1961). Some tissue formation had also been seen inside root canals 
following pulp removal and filling of the root canal with a resorbable material 
(Engel, 1950, Erausquin and Muruzabal, 1968, Matsumiya and Kitamura, 1960, 
Stromberg, 1969). Studies in both animals and humans showed that such 
occurrences only happened if the root canal was allowed to fill with clotted blood 
from the adjacent instrumented periapical area (Erausquin and Muruzabal, 1968, 
Nygaard-Ostby, 1961). However, a separate study reported that following deliberate 
instrumentation beyond the apices of the teeth (admittedly by several millimetres), 
areas of periapical granulomas persisted and that granulomatous tissue was 
pervasive within the apical foramen (Seltzer et al., 1968) although this could well 
have been a consequence of the crude techniques employed, the resultant apical 
trauma sequelae and consequent compromised healing into an already fibrotic area. 
More recently, these principles have been put to use in establishing a methodology 
to improve the treatment outcomes of immature teeth with open apices which have 
necrotic dental pulps. Historically, teeth like this have undergone apexification 
therapy where the treatment protocol entails root canal instrumentation along with 
periodic application and changes of Ca(OH)2 to remove any necrotic or infected 
tissues until a calcific tissue barrier develops at the tooth apex (Banchs and Trope, 
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2004, Damle et al., 2012, Diogenes et al., 2013, Iwaya et al., 2001, Rule and Winter, 
1966). Although successful in many cases, this protocol involves multiple surgery 
visits, thereby incurring higher clinical costs along with the potential for reinfection 
and consequent patient morbidity. An alternative to this is the application of an 
apical plug of mineral trioxide aggregate (MTA) which has the advantage of only 
one or two visits (Damle et al., 2012). However, like apexification, this procedure 
only promotes apical closure and doesn’t allow for continuing root development or 
continued radicular dentine deposition within the lumen of the root canal to increase 
the strength of the tooth (Jadhav et al., 2012, Shivashankar et al., 2012). Hence, the 
current ‘gold standard’ treatment for immature open-apex teeth is a strategy of 
revascularisation which has been proven to induce both root extension (i.e. 
completion of root growth to the anatomically ideal correct length with a fully 
formed apex) and radicular strengthening by circumferential deposition of dentine 
inside the root canal lumen (Diogenes et al., 2013). When comparing the two 
methods, root extension does increase the survival rate of revascularised teeth when 
compared to apexified teeth by 100% v 77.2%, (Jeeruphan et al., 2012) and so can 
be regarded as an improvement. 
Dental pulp survival following injury is an important aspect of dentistry and 
successful pulp capping with calcium hydroxide eventually results in pulp cells 
adhering to an osteodentine layer before differentiation into odontoblasts and 
production of dentine (Schroder, 1985). Long term studies have shown that success 
rates for this vary dramatically, with one long term study giving results of 80.1% 
after one year, tapering down to 58.7% after nine years (Willershausen et al., 2011). 
Although calcium hydroxide has been the accepted gold standard material of choice 
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for many years, a Cochrane review has revealed that there is limited evidence as to 
the most appropriate pulp capping material (Miyashita et al., 2007). With such a lack 
of common thought amongst the profession, brought about by both the limitations of 
the current techniques and materials in use, along with blinkered attitudes amongst 
practitioners, tissue engineering (provided it is properly thought through and 
applied) is ideally placed to provide a definitive answer to problems which have 
bedevilled the profession for decades such as bone loss around post/crown restored 
anterior teeth (Eliasson et al., 1995) and their premature loss (Aptekar and Ginnan, 
2006, Murray et al., 2007). 
The traditional tissue engineering triad of cells, scaffold and morphogens or growth 
differentiation signals (Alsberg et al., 2001) will invariably be different for dental 
pulp regeneration of immature teeth with open apices and those with complete 
apices, given their likely age groups of application. Both will have devitalised or 
necrotic tissues to contend with, where exposure to inflammatory cytokines such as 
tumour necrosis factor alpha (TNF-α) will cause loss of differentiation and 
mineralisation abilities in DPSCs (Boyle et al., 2014) which in turn interferes with 
the odontogenic differentiation of apical cells in developing teeth which is necessary 
for root formation (Sonoyama et al., 2008). Hence, root canal debridement is 
achieved by a combination of intracanal medicaments and chemomechanical means. 
Revascularisation protocols only employ mechanical instrumentation in about a 
third of cases (Kontakiotis et al., 2015), showing the importance and necessity of 
endodontic irrigation and medicaments. To preserve apical papilla cells, lower 
strength 1.5% sodium hypochlorite solution is used and 17% EDTA has been shown 
to promote release of growth factors resulting in hard tissue formation (Becerra et 
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al., 2014, Galler et al., 2015, Martin et al., 2014). Disinfection is achieved by 
Ca(OH)2 or triple antibiotic paste (TAP) with the latter being most commonly used, 
although Ca(OH)2 also gives successful results (Chen et al., 2012) as it appears to 
aid proliferation of periapical cells whereas TAP, in high concentrations shows 
detrimental effects (Ruparel et al., 2012). Failure to revascularise has been attributed 
to persistence of post canal debridement bacterial biofilms and smear layer, 
indicating inadequate infection control (Lin et al., 2014). 
To date, no combination of Type I and III collagen membrane material with a 1% 
HyA gel has been used in any study or protocol to revascularise an immature open 
apex tooth, as reported in the literature. In this current study, a novel but everyday 
combination of ‘High Street’ materials, with their concomitant advantages of 
already being commercially licenced, ready availability, cost benefit and 
comparative ease of possible clinical use was investigated to determine their 
potential for use in tissue engineering a new dental pulp with potential applications 
in this particular sphere. 
In a clinical setting, dental pulp revascularisation of a mature adult tooth with a fully 
formed apex in a patient has yet to be achieved (Albuquerque et al., 2014) although 
evidence of both the safety and efficacy of one treatment modality necessary for 
clinical use has been presented (Nakashima and Iohara, 2014) as a prerequisite to the 
initiation of a clinical trial. Almost every investigator and publication reports the use 
of a different combination of scaffold material, cells and/or morphogens to achieve 
their end results, both in vivo or in vitro as the following selection of citations 
shows: (Akkouch et al., 2014, Bottino et al., 2013 (a), Bottino et al., 2013 (b), 
Cavalcanti et al., 2013, Cordeiro et al., 2008, Coyac et al., 2013, Dobie et al., 2002, 
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Feng et al., 2010, Galler et al., 2008, Galler et al., 2011(a), Galler et al., 2011(b), 
Galler et al., 2012, Huang et al., 2010, Iohara et al., 2014, Iohara et al., 2013, 
Ishimatsu et al., 2009, Ishizaka et al., 2012, Murakami et al., 2013, Nakashima and 
Iohara, 2011, Nakashima and Iohara, 2014, Rosa et al., 2013, Wang et al., 2011, 
Yang et al., 2012, Yang et al., 2010, Zhang et al., 2012). This makes meaningful 
direct peer to peer comparisons impossible and is reminiscent of the debate 
surrounding what might be the best endodontic filling material at the beginnings of 
the twentieth century (Gethro, 1919) before the dental profession finally settled on a 
3-D gutta-percha condensation in combination with a sealant paste (Schilder, 1967). 
There have been moves to at least rationalise the cell types used in these 
investigations with the suggestion that they be fully characterised to provide the 
knowledge of candidate cell gene expression to avoid spurious comparisons and 
ensure that everyone is ‘singing from the same hymn sheet’ (Ruparel et al., 2013) 
and also to inform good manufacturing processes for DPSC sourcing and 
proliferation (La Noce et al., 2014). 
 
5.2 Study overview 
The current study used a mixed tissue engineering scaffold material consisting of a 
combination of a commercially available BioGide
® 
Type I and III collagen 
membrane combined with a commercially available hyaluronic acid product which 
has never before been reported as having been used experimentally in dental pulp 
tissue engineering, although each separate component has been used in differing 
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combinations in other applications and for different tissues. HyA has been used to 
investigate angiogenic change and cell attachment whilst cross-linked to Type I 
collagen derived from bovine Achilles tendon (Perng et al., 2009) in a study 
examining new blood vessel development. This study also showed that short chain 
HyA of low Molecular Weight (MW) 6.5 kDa, or oligosaccharide (o-HyA) was 
better at generating a higher density of new blood vessels than its longer chain high 
MW comparator (MW 220 kDa). HyA has also been investigated for its material 
properties of mechanical degradation whilst cross-linked to Type I collagen as a 
component of cartilage tissue engineering using human Mesenchymal Stem Cells 
(hMSCs) (Kim et al., 2012) and for compression, swelling and degradation 
properties whilst cross-linked to collagen as a scaffold for use in brain tissue 
engineering using neural stem cells (Wang and Spector, 2009). A cross-linked 
sponge collagen/HyA construct has been shown to have improved dissolution 
qualities and higher elastic collapse stress and compressive modulus than collagen-
only controls when used to support the proliferation of 3T3-L1 pre-adipocytes in 
adipose tissue engineering for use in mammary tissues (Davidenko et al., 2010) and 
it has also been used in an in vitro study in conjunction with collagen combined with 
chondroitin sulphate as a potential cartilage tissue engineering scaffold (Zhang et al., 
2010). If anything, the diversity of these studies highlights both the ubiquity and 
importance of the collagen/HyA combination in nature and as a potentially essential 
and desirable combination in any future tissue engineering clinical protocol. 
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5.3 Choice of cell procurement 
Dental pulp cell harvesting 
The dental pulp explant method is based on the outgrowth of DPSCs from sectioned 
pieces of dental pulp and their adherence to tissue culture plastic (Hilkens et al., 
2013, La Noce et al., 2014, Spath et al., 2010). In this study, the dental pulp explant 
method (Park et al., 2004) proved to be both unpredictable and time-consuming in 
procuring adequate cell numbers for experimentation. The cell numbers required for 
experimental use also meant that there was a real potential that the results could be 
affected by cell senescence by the time sufficient DPSCs had been accumulated. 
Whilst quantitative data showing the comparative cell numbers obtained at set time 
points might have been useful to compare their doubling times, the obvious huge 
superiority of the collagenase digest method in obtaining DPSCs rendered this 
unnecessary. This was supported by data from other authors (Gronthos et al., 2000, 
Huang et al., 2006). 
When comparing site-specific characteristics of dental pulp, the ALP activity (used 
as an early marker of osteogenic potential) was consistent in all of the three donor 
samples tested in that highest activity was seen in the coronal pulp explants with 
minimal activity in the radicular and apical pulp explant samples. This runs contrary 
to other authors (Liu et al., 2004, Sun et al., 2004) who found that the pulp explant 
method was better at harvesting DPSCs and that ALP activity was higher in root 
canal DPSCs compared with coronal DPSCs. However, the culture conditions were 
not identical as no mineralisation induction agents were used in this study, whereas 
theirs had included dexamethasone. This would thus reflect differences in inherent 
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ALP activity such as in this study and induced ALP activity as in the previous two 
studies just mentioned. 
Several different types of cells have been used to investigate potential strategies in 
dental pulp tissue engineering. These include DPSCs (Yang et al., 2010), Stem cells 
from Human Exfoliated Deciduous teeth (SHED) (Cordeiro et al., 2008) both 
DPSCs and SHEDs together (Galler et al., 2008) DPSCs and SCAPs (Huang et al., 
2010), canine dog pulp CD105
+
/CD31
-
 side population cells (Nakashima and Iohara, 
2011), HPDLSCs (Galler et al., 2011(a)) and BMSCs (Galler et al., 2011(a)). In 
particular, CD31
+
 BMSCs (i.e. non-endothelial cells) have recently been shown to 
possess better vasculogenic and angiogenic properties than their CD31
-
 counterparts. 
In a recent review article (Albuquerque et al., 2014) of the studies examined, 18 out 
of the 27 used DPSCs and a total of 21 used some form of either DPSCs, SHEDs or 
SCAP cells either on their own or in combination. Hence, the logical choice of cells 
for this study were DPSCs, based upon their availability and comparability to other 
studies in the established literature. It is worthwhile noting that other authors have 
noted that DPSCs have a predilection towards angiogenic differentiation, which 
would also make them suitable for this study (d'Aquino et al., 2007, Ishizaka et al., 
2013, Laino et al., 2005, Trubiani et al., 2003). 
 In addition, as they are derived from the tissue which is the object of the intended 
regeneration process, it should follow that any successful scaffold construct used 
would have a better chance of success in dente. At the initial stage of the study, 
DPSCs were cultured from dental pulp explants and the resultant DPSCs harvested 
and passaged on for experimental use. As previously noted in the results section 
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(4.1.1 and 4.1.2) this gave very variable results, concurring with the findings of 
Moule et al., 1995 and so was abandoned for a modification of the enzymatic digest 
method adopted by Gronthos et al., 2000, which gave consistently better cell 
proliferation. Whilst it would have been useful to have obtained quantitative data to 
support this, the obvious inter-donor variability plus the marked difference in cell 
numbers derived from each method showed the obvious superiority of the 
collagenase digest method. During this study the DPSCs generated using the 
collagenase digestion method showed the ability to proliferate on the BioGide
® 
Type 
I and III collagen scaffold material and showed their ability to both colonise onto 
and undergo early angiogenic change on the 1% HyA scaffold. 
 
 
5.4 Choice of scaffold materials and investigative model 
As any scaffold material can have an effect on the eventual outcomes and findings 
of the study, it was important to choose that which, after an investigation of the 
literature, would be suitable but without unduly adversely affecting the outcome in 
any particular direction. This concurs with the findings of other investigators (Smith 
et al., 2015) who found that DPSCs cultured on elements of the ECM maintained 
their phenotype better, compared with those cultured on normal tissue culture 
plastic. 
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5.4.1 Tooth slice model 
The tooth slice model (Goncalves et al., 2007, Magloire et al., 1996, Mullane et al., 
2008, Sloan et al., 1998) is a well-established investigative protocol and the results 
obtained in this thesis broadly concur with those obtained immunohistochemically 
by other authors, where CD31 was identified in a tooth slice culture of SHED cells 
albeit following culture with rhVEGF165 (Sakai et al., 2010). In this thesis, the use of 
EGM as a culture medium was consistent with minimising the potentially random 
effects of FCS as well as its successful use in other studies culturing such diverse 
endothelial cell types such as 1° human iliac artery endothelial cells (Riessen et al., 
2001), endothelial cells from the corpus cavernosum of the human penis (Pilatz et 
al., 2005(a), Pilatz et al., 2005(b)) and 1° human corneal endothelial cells (Schulz et 
al., 2013), although in this latter study, the EGM was modified by supplementing it 
with 10% FCS. 
The in vivo experiment results obtained in this thesis were more definitive and 
stronger than the in vitro experiments, probably because the living organism is a 
better bioreactor than a tissue culture plastic 6 well plate and the animal has a much 
more subtly responsive physiology and microecology than the (relatively speaking) 
crude environment of the laboratory. Notwithstanding the last sentence, the 
experiment was carried out upon an animal with a minimally functioning immune 
system and so any positive results should be viewed with a degree of caution and not 
extrapolated directly to humans. The in vitro culture of DPSCs, seeded onto a 
combined Type I and III collagen membrane infiltrated with 1% HyA gel (described 
in the in vitro materials and methods and the results sections, 3.16 and 4.18 
respectively) showed cells which stained positively for both CD31 and CD34, but 
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with less evidence of residual scaffold material than was expected due to Type I and 
III collagen scaffold loss during floating out and mounting of the cut 
immunohistochemical sections. This technical problem was an issue throughout and 
unfortunately reduced the number of useful sections available for full interpretation. 
All four variants of scaffold used in the in vivo results (Type I and III collagen 
membrane plus 1% HyA with no DPSCs; Type I and III collagen membrane plus 
DPSCs: 1% HyA gel plus DPSCs; Type I and III collagen membrane infiltrated with 
1% HyA plus DPSCs) showed much better cell proliferation, along with deposition 
of material exhibiting a tubular structure contiguous with the pre-existing dentinal 
tubules than was seen in vitro. The newly deposited tubular-structured material was 
in intimate contact with an overlying cell layer and had cell processes transiting the 
new material into the dentinal tubules of the surrounding prepared tooth slice. 
Perhaps the most interesting result was that from the Type I and III collagen 
membrane/1% HyA only sample which showed the same result as the others but 
with no seeding cells having been added. This would imply that a cell-free 
procedure could be a possibility in the future with the scaffold itself exerting both an 
angioinductive and proliferative effect on any cells populating it. The possibility of a 
scaffold-inducing angiogenic effect was further supported by the qRT-PCR data 
shown here, which demonstrated CD31/34 upregulation in basal medium in the 
absence of additional angiogenic cues provided by EGM. An angioinductive 
scaffold would negate the need for cell-seeding and the associated difficulties as is 
more fully expounded in the Future Work section. The findings in this study were 
consistent with the findings of other investigators (Cordeiro et al., 2008, Sakai et al., 
2010), although both of these investigators only removed the pulp tissue from the 
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tooth slice leaving the predentine untouched and uninstrumented by files, a situation 
with potential to leave necrotic debris behind in the clinical setting, although each 
tooth slice was treated with EDTA. Any blood vessels in the soft tissues deposited 
within the tooth slice lumen stained positively to CD31 and CD34. There was also 
evidence of blood vessel-like structures, possibly containing red blood cells and 
closely resembling dental pulp both in architecture and immunohistological findings. 
These findings are consistent with those from previous studies (Cordeiro et al., 
2008, Sakai et al., 2010) although the scaffolds involved in the current study differed 
from those in the cited studies which were poly-L-lactic acid (PLLA) and cast into 
the pulp space in situ. Also, there was obvious visual evidence of a definite 
demarcation line between the newly laid down tubule-like material and the pre-
existing dentine of the tooth slice, consistent with the findings of other investigators 
(Huang et al., 2010). 
 
5.4.2 CD31 and CD34 biomarkers 
As already stated in sections 1.15.1.and 1.15.2 respectively, CD31 and CD34 are 
important biomarkers for angiogenesis and neovascularisation (Pinter et al., 1997). 
As a bioactive molecule, CD31 has been shown to be involved in numerous 
biological processes such as platelet aggregation and homeostasis, thrombosis, 
maintenance of the vascular endothelial barrier function, mechanosensing of 
endothelial cell response to fluid shear stress (Woodfin et al., 2007), leucocyte 
migration during the inflammatory response to sites of injury and bacterial ingress 
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and development of the vasculature (DeLisser et al., 1997, Ferrero et al., 1995, 
Thompson et al., 2001). 
CD34 has been used for the isolation of haematopoietic stem and progenitor cells 
and as a marker to identify some tissue specific stem cells such as muscle satellite 
cells and epidermal cell precursors. In these capacities it has been widely used both 
as a haematopoietic stem cell marker and a vascular endothelial cell marker (Fina et 
al., 1990, Hristov and Weber, 2008, Sato et al., 1999). In this study CD31 and CD34 
stained well both in experimental samples and for control sections of dental pulp 
tissues, with the only shortcomings being down to handling/storage errors and 
operator error. The qRT-PCR data presented in this thesis showed interesting 
significant differences in the timing of expression of CD31 and CD34, with CD31 
expression apparently occurring earlier during the culture conditions compared with 
CD34. This would need further work to investigate whether such changes are 
relevant in vivo. 
 
5.4.3 OsseoGuard
®
 and BioGide
®
 Type I and III collagen membranes scaffold 
material 
In selecting an appropriate scaffold, the ultimate decision to proceed with BioGide
®
 
as a source of collagen scaffold was primarily based on ease of acquisition. 
OsseoGuard
®
 is a highly purified bovine Type I collagen membrane derived from 
Achilles tendon whereas BioGide
®
 is a veterinary-certified porcine sourced pure 
Type I and III collagen membrane (Almazrooa et al., 2014, Willershausen et al., 
2014). BioGide
®
 is obtained following inactivation of all potential microorganisms 
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and removal of any fatty and other tissue residues before being sterilised by gamma 
irradiation. BioGide
®
 is FDA approved and CE marked (as is OsseoGuard
®
) and 
consists of Types I and III collagen without further cross-linking or chemical 
treatment (Ghanaati, 2012). Results for BioGide
®
 obtained under SEM investigation 
of its structure, are consistent with those obtained by other investigators (Li, 2015, 
Schlegel et al., 1997). It (BioGide
®
) has been shown to be less susceptible to 
proliferation of three different strains of bacteria than OsseoGuard
®
 (Slutzkey et al., 
2015) although neither membrane has any definitive antibacterial properties nor are 
they marketed as possessing any. BioGide
®
 also showed better results in an 
attachment assay at 24 hours and 5 days when compared to OsseoGuard
®
 in a study 
examining attachment and proliferation of human osteoblast-like cells (Papaioannou 
et al., 2011). Both materials showed suitable pore size and interconnectivity for cell 
attachment, colonisation and proliferation (see section 4.7). This corresponds well 
with the findings of other authors (Loh and Choong, 2013, Yang et al., 2002). 
BioGide
®
 also exhibits surface roughness due to not being cross-linked in any way, 
and the randomness of its structure also promotes better cell adhesion than an 
aligned structure (Zhong et al., 2006). Being of a ‘fabric’ construction, it keeps its 
size and shape and doesn’t shrink, which can be a problem with collagen gels 
(Huang et al., 2006). 
Both of these membranes are primarily comprised of Types I and III collagen. Type 
I collagen is a major structural protein of the ECM where it supports the growth of a 
wide variety of tissues and provides properties such as mechanical strength (Harley 
et al., 2007). In hydrogel form it has also been shown to align and stabilise collagen 
fibrils and DPSCs differentiating into Schwann cells in neural tissue engineering 
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(Georgiou et al., 2013, Martens et al., 2014). Type III collagen is co-expressed with 
Type I collagen and is deficient in the tissues of patients with Ehlers-Danlos 
syndrome type IV (Pope et al., 1975). It is widespread among the body’s tissues, 
both elastic and skeletal, such as bone (Keene et al., 1991) in the epineurium along 
with collagens Type I and II (Platt et al., 2003) and also in the tympanic membrane 
where Type III collagen is the predominant type, giving the tympanic membrane its’ 
elasticity and contributes to the healing response of that organ along with Type II 
collagen (Lim, 1995, Stenfeldt et al., 2013). Type III collagen has been shown to be 
present in early wound repair at a detectable level 48 hours after healing 
commenced, when only procollagen of Type I collagen was found, with Type I 
collagen only being detectable at 72 hours and increasingly thereafter until at day 9 
when it was the predominant collagen being synthesised (Gay et al., 1978). Thus, 
the presence of Type III collagen in BioGide
®
 could have an effect on the early 
establishment of nascent neo-pulpal tissues, paving the way for the later onset of a 
more fibroblastic morphology prior to the shift to predominantly collagen Type I 
expression. In the dental field, BioGide
®
 collagen Type I and III membrane has 
shown itself capable of maintaining dental pulp vitality and supporting an increased 
number of blood vessels when used as a pulp-capping agent (Marsan et al., 2003). 
Other investigators have used collagen impregnated with antibiotics (Biofil-AB™) 
as a pulpotomy capping agent in deciduous teeth where it was found to be a 
potential alternative to the current ‘gold standard’ material formocresol, showing 
itself to be biologically compatible with deciduous dental pulp tissue, increased pulp 
healing capacity and promoting better vascularisation where it showed better 
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biocompatibility than the other material being studied - Pulpotec cement (Kakarla, 
2013). 
In this study, BioGide
®
 collagen Type I and III membrane was also seen to be 
compatible with DPSC attachment over a 15 day period as seen when measuring 
DNA content using the PicoGreen
®
 assay (section 4.10) and for longer periods of up 
to 28 days, as shown by the confocal microscopy images (section 4.9.2) and also by 
the SEMs taken on BioGide
®
 and Osseoguard
®
 membranes at 28 days of culture 
(sections 4.8.1 and 4.8.2). This is consistent with findings of other investigators who 
cultured DPSCs and oral fibroblasts for 14 days in Type I collagen gels (Lee et al., 
2004). 
 
5.4.4 Hyaluronic Acid as a scaffold material 
As an important part of the ECM, HyA plays a pivotal role both in signal 
transduction and cell instruction (DeAngelis, 2008, Toole, 2001). It has been mooted 
that there are two distinct but continuous forms of ECM, the widespread general 
intercellular ECM and another more closely cell-associated ECM called the 
glycocalyx, first imaged using electron microscopy (Luft, 1966) and since then 
subjected to widespread investigation for its influence on endothelial and 
pathophysiological processes (Arkill et al., 2011, Erickson and Stern, 2012, Reitsma 
et al., 2007, Rola, 2013). The endothelial glycocalyx is predominantly localised on 
the luminal (i.e. inward-facing) surface of the endothelium where it interacts directly 
with passing blood flow. It has important roles in mediation of leucocyte adhesion 
(Lipowsky, 2011, Tarbell, 2010), vascular permeability (Curry and Adamson, 2012, 
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Tarbell, 2010) and endothelial mechanotransduction (Fu and Tarbell, 2013, Pries et 
al., 2000, Tarbell and Ebong, 2008). This extension of the HyA into the vascular 
lumen also enables it to control the diffusion of low MW solutes and permeability 
(Gao and Lipowsky, 2010, Henry and Duling, 1999, Henry and Duling, 2000). It is 
an extremely versatile molecule and can be chemically modified (Schalte et al., 
2011), enabling it at a high molecular weight of 1.6 × 10
6
 Da to support Schwann 
cells for neural tissue regeneration (Suri and Schmidt, 2010), made into 
microspheres for sustained gene delivery with site-specific targeting (Yun, 2004), 
electrospun into nanofibrous scaffolds (Ji et al., 2006), and used as a delivery 
vehicle for growth factor complexes (Xie et al., 2011). It also has the advantage of 
complete degradation by the body’s cells following use as a scaffold material 
(Solchaga et al., 1999) and may reduce postsurgical inflammation when added to a 
surgical site thereby improving treatment outcomes (Jentsch et al., 2003, Peattie et 
al., 2004, Prato et al., 2003). HyA has also been shown to have some limited 
bacteriostatic activity (Pirnazar et al., 1999). HyA usually occurs as a high 
molecular-mass glycosaminoglycan, widely found in mammalian tissues and of 
sizes between 6 x 10
5
 to 1 x 10
6
 Daltons (Da) and is a component in the 
haematopoietic stem cell (HSC) niche in the bone marrow where it not only 
provides a support or physical scaffold within the marrow to facilitate retention and 
localisation of HSCs to the stem cell niche but is also able to affect the cellular 
functions of HSCs through ligation with its counter receptors (Haylock and Nilsson, 
2006). Whereas high molecular weight HyA is found in many biological contexts, 
much lower molecular weight HyA is easily detectable in many cancers where it is 
thought to aid in tumour angiogenesis and also assist cell motility and invasion 
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(Lokeshwar and Selzer, 2000). HyA degradation products have been shown to have 
different biological properties and functions depending on their chain length (Stern 
et al., 2006). o-HyAs are short chains or oligomers of HyA most often with a weight 
of ≤104 Da, which corresponds to between 2 to 40-mers (Cui et al., 2009). These o-
HyAs have been shown to initiate gene activation and expression affecting cell 
function, proliferation, and migration (Entwistle et al., 1996, Noble, 2002, Sherman 
et al., 1994) with differing functions from those found in the normal, more usual 
high molecular mass HyA polymer. Short chain HyA is also involved in 
angiogenesis with o-HyAs of between 4-25 disaccharides (approximately 1 x 10
4
 to 
1.6 x 10
6 
Da) exhibiting angiogenic effects on endothelial cells (West and Kumar, 
1989) and so should probably be worthy of further investigation re dental pulp 
revascularisation as more specific angiogenic agents. Their proliferative effects on 
endothelial cells are thought to be mediated by action on two of the ERM (Ezrin, 
Radixin and Moesin) group proteins ezrin and merlin, where HUVECs treated with 
o-HyA showed an increase in the expression and activation of ezrin but treatment 
with native high MW HyA (n-HyA) gave no significant change in ezrin expression 
or activation. Conversely, treatment with n-HyA gave no increase in ezrin 
expression and activation but did give increase that of merlin (Mo et al., 2011). 
Whereas longer chain HyA has a tendency to inhibit angiogenesis, it can also 
enhance the production of Type I and Type VIII collagens by endothelial cells 
(Rooney et al., 1993). More defined investigation of narrower ranges of o-HyAs 
have shown short chains of 3-10 disaccharide units (but not greater than 10 units) to 
have the ability to stimulate endothelial cells’ proliferation, migration and sprout 
formation resulting in angiogenesis when used in the chicken chorioallantoic 
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membrane (CAM) model (Toole et al., 2008) and also in infarction of the 
myocardium (Slevin et al., 2002). Following depolymerisation into o-HyAs, 
common or garden ‘native’ HyA may show different novel functions or bioactive 
behaviour (Cui et al., 2009). It has been shown that o-HyAs compete with higher 
molecular weight HyA at cell surface receptors such as CD44 (Misra et al., 2005) 
and the receptor for HyA-mediated motility (RHAMM) (Slevin et al., 2007). Native 
high molecular weight HyA has an important role in inhibiting endothelial cell 
proliferation and migration, as shown in a three-dimensional collagen gel model 
(Lokeshwar and Selzer, 2000, West et al., 1985) and it is thought that o-HyAs acting 
in an antagonistic fashion may inhibit many of these interactions via differing 
pathways (Gao et al., 2008, Slevin et al., 2004). The specificity of o-HyA chain size 
has been shown by Cui et al., 2009, who synthesised o-HyAs of 4, 6, 8 and 10 
disaccharide fragment lengths. The 4 o-HyA chain length had no statistically 
significant effects on either HUVECs proliferation (which were being used as 
controls during this experiment) or chicken CAM angiogenesis, whereas the 6, 8 and 
10 o-HyA significantly stimulated both HUVEC proliferation and chicken CAM 
angiogenesis. This was in agreement with previous studies which had shown that 
oligosaccharides of between 6 – 20 disaccharides could both bind to the CD44 
receptor site on endothelial cells and also promote angiogenesis there once in situ 
(Stern et al., 2006) and in a study which showed that o-HyA complexes promote 
wound healing in the murine wound healing model at twice the rate of nHyA 
complexes (Gao et al., 2010), this study also found that compared to nHyA, o-HyA 
promoted the up-regulation of endothelial nitric oxide synthase expression; also E-
selectin, integrin β3, procollagen-1 and procollagen-3. Matrix metalloproteinase-9 
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(MMP-9) and MMP-13 were downregulated. One further advantage of HyA over 
rhVEGF165 is that its physiological effects can continue for an extended period of 
several days, whereas the half-life of rhVEGF165 is between 3 to 6 minutes in vivo 
(George et al., 2000) and about one hour in vitro (Shi et al., 2001). 
In vivo experimentation using HyA has shown that it can potentially have a role to 
play in pulp capping and reparative dentinogenesis either alone, using MW 1500-
2000 kDa or in combination with other biomaterials (Bogovic et al., 2011, Inuyama 
et al., 2010, Kuo et al., 2008, Sasaki and Kawamata-Kido, 1995). An in vitro study 
has recently shown a construct of HyA seeded with DPSCs to be able to develop a 
dental pulp-like tissue and also aid in the repair of calvarial defects in rats when 
used in vivo (Ferroni et al., 2015). 
As already shown in the results section (Section 4) GenGiGel
®
-derived HyA can 
support cell growth of DPSCs (section 4.4; section 4.15), G292 cells (sections 4.4; 
4.16.1), HUVECs (section 4.15.2) and HPDLCs (section 4.16.2) so it can support 
more than one type of cell, which is important but unsurprising given its ubiquity 
throughout the ECM and the fact that almost every cell type expresses its most 
common receptor, CD44. The HyA powder supplied by OralDent
®
 for this study is 
available commercially as GenGiGel
®
 in several concentrations. On the company’s 
website, it is listed as being of patented high molecular weight and is commonly 
used in periodontal therapies and for mouth ulceration. It therefore has a track record 
of use in the oral cavity but the reported high MW would appear to be less than ideal 
given the enhanced angiogenic properties associated with o-HyAs and described 
above. This high versus low molecular weight could account for the limited 
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angiogenic change seen experimentally and in the qRT-PCR results in this thesis 
when using the GenGiGel
® 
powder. However, the high MW of the HyA used here 
could also be an explanation for the dentine-like deposition seen in all of the 
immunohistochemistry samples described in section 4.21 and as this phenomenon 
has previously been documented in the literature in the direct pulp-capping model 
(Sasaki and Kawamata-Kido, 1995) in association with high MW HyA. It would 
provide an explanation as well, for the nodule-like formation seen in the cultures of  
G292 cells with HyA described in section 4.3.1. Previous tooth slice models have 
dwelt on angiogenesis as their main result and don’t seem to have reported any 
dentine-like deposition as a finding for whatever reason (Goncalves et al., 2007, 
Mullane et al., 2008), although maintenance of the pulpal soft tissues was confirmed 
and evidence of continued ECM production and tooth slice dental pulp homeostasis 
has been seen (Sloan et al., 1998). 
The 1% HyA gel used in the study has shown itself to be able to initiate early 
angiogenic change in DPSCs as indicated by positive immunohistochemical staining 
for CD31 and CD34 markers both in the presence and absence of rhVEGF165 (section 
4.16) and also weakly to CD31 marker in HPDLCs under identical culture 
conditions (section 4.16). This is perhaps surprising given its high MW, although the 
high MW chains could have been degraded to smaller fragments during the 
autoclaving process used for sterilisation. In addition, the qRT-PCR data showed an 
upregulation in gene expression for CD31 and CD34 which may also explain the 
level of angiogenic change sufficient to increase angiogenic marker activity as seen 
in the immunohistochemical results (section 4.18) but show no evidence of budding 
or sprouting in the in vitro DPSC cultures as seen in the low MW studies (Cui et al., 
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2009). This would suggest that a more precise mixture of high and low MW HyA 
could be a more clinically applicable, appropriate and ultimately successful scaffold 
material for dental pulp tissue engineering, potentially able to give suitable cues for 
both angiogenesis and hard tissue formation in a single material. As well as HyA, 
there are other examples of tissue culture scaffolds which can show angiogenic 
change in DPSCs, without the necessity of adding rhVEGF165 (El-Gendy et al., 
2015). 
 
5.4.5 Collagen/HyA in combination as scaffold material 
HyA has been used in combination with collagens in other investigative areas and 
other tissues such as the brain (Wang and Spector, 2009) and in cartilage tissue 
engineering (Liao et al., 2007, Pfeiffer et al., 2008). The combination has not, 
however, been used in dental pulp engineering to date and particularly as a 
membrane and gel combination. The natural presence of the two materials in the 
majority of tissues in the body combined with the biocompatibility of the two 
materials and their biodegradability makes them particularly favourable as potential 
scaffolds both for the delivery of cells, and as building blocks for new tissues and 
consequently for tissue reconstruction in three-dimensions (Vickers et al., 2006, 
Wang et al., 2006). 
As shown in the in vitro results, section (Section 4.12), Type I and III collagen 
membranes on their own were unable to initiate early angiogenic change in DPSCs 
seeded and grown on them for a period of several days. However, the in vitro results 
(section 4.19) shows that early angiogenic change for DPSCs was induced by 
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culture in a relatively non-molecular weight-specific gel matrix of 1% HyA in the 
presence of an endothelial culture medium without rhVEGF165. The in vivo tooth 
slice results (section 4.21) showed that DPSCs seeded onto Type I and III 
collagen/1% HyA and also Type I and III collagen/1% HyA on its own can result in 
a soft tissue ingrowth staining positively for CD31 and CD34, markers of 
angiogenic change and also give rise to a newly deposited, organised, tubule-like 
tissue contiguous with the original dentinal tubules of the endodontically prepared 
tooth slice along with formation of a layer of cells in intimate contact with the new 
organised tubule-like material boundary, similar to the layer of odontoblasts 
anatomically and histologically found at the pulpo-dentine interface of the normal 
healthy tooth (Goncalves et al., 2007, Mullane et al., 2008, Sakai et al., 2011). They 
also showed that similar results could be obtained in the absence of seeded DPSCs. 
This must mean that as a sub-cutaneous model had been used where the tooth 
slice/scaffold material/seeding cell construct is inserted into a pocket beneath the 
cutaneous layer (Goncalves et al., 2007, Mullane et al., 2008) and without resorting 
to implantation in intra-peritoneally placed diffusion chambers, any cells found in 
the BioGide
®
/HyA cohort of results had to be derived from the animal host, there 
being no other source for them. This in turn means that there is potential for a 
successful therapeutic protocol based on a ‘no implanted or seeded cells’ basis, 
leading back to the possibility of recruiting adjacent HPDLCs or other cells 
migrating along the blood stream via an opened up or expanded apical orifice with 
all of the potential advantages expounded in Section 7: Future Work, the least of 
which would be not needing to negotiate many of the regulatory difficulties involved 
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in current cell-based therapies. It would also lessen the inherent difficulties of donor 
cell collection, isolation, proliferation and placement. 
Previous studies have used species-specific antibodies to differentiate between cells 
and tissues derived from the seeding cells and those from the host animal. 
Preliminary work was begun on this but wasn’t continued due to constraints on 
antibody optimisation and time available. 
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6. Conclusion 
To summarise, this study has shown that: 
1. It is possible to induce changes commensurate with early angiogenesis in 
an unselected population of DPSCs by the application of a broad, non-
specific but predominantly high MW commercially available HyA gel. 
2. Type I and III commercially available collagen membrane materials can 
support DPSCs, allowing them to attach and colonise and then proliferate 
over an extended period of time, but not induce angiogenic change. 
3. A combination of these two commercially available materials, ± DPSCs 
can promote the growth of CD31/CD34 positive vascular-like structures 
within an experimental tooth slice model without recourse to expensive 
or customised scaffold materials and without a specifically selected i.e. 
an intentionally broad DPSC population. They have also shown similar 
results when used unseeded, which means that the cells therein observed 
had to be host-derived, implying an inductive/conductive property to the 
scaffold materials. 
4. The results obtained here using this novel scaffold combination correlate 
with those obtained by previous investigators of dental pulp 
revascularisation using alternative strategies but in addition, show that 
the deposition of a tubular material which was contiguous with the 
dentinal tubules of the tooth slice in situ, with a layer of cells in intimate 
contact with that tubular material whose cell processes transit the new 
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material and run into the dentinal tubules of the tooth slice. As such, this 
newly deposited material was strongly reminiscent of dentine or 
predentine in histological appearance. 
5. The results obtained in this study provide a basis for future work 
focussing upon the definitive goal of tissue engineering a dental pulp in 
situ. 
 207 
 
7 Future work 
The results of the present study have highlighted several main areas of investigation 
deserving of further study: 
1. As the PCR results were fragmentary and n only equalled 1, more detailed 
PCR investigation would give better insight as to the exact nature of the 
angiogenic change achieved by the 1% HyA scaffold material. 
2. Further immunohistochemical investigation of the tubule-like material laid 
down in the tooth slice samples during the in vivo experiment by specific 
markers such as those for DSPP could elicit a more definitive answer as to 
its’ exact composition, as would investigation of the adjacent cell layer for 
evidence of enamelysin, a marker for odontoblasts. 
3. Given the proximity of an easily available source of stromal cells in the 
periodontal ligament, the predictable success of apexification procedures and 
the probable hierarchy of other therapeutic loci in which cell sources such as 
DPSCs are much more likely to be utilised for major organ repair, 
regeneration or replacement, not to mention the costs and possible risks 
involved in harvesting, expanding and storing DPSCs, it would be logical to 
evaluate in situ HPDLCs as a potential source of new cells to repopulate an 
engineered dental pulp. This would require further investigation into the best 
method of accessing them using some modified form of Patency Filing via 
the tooth apex to ensure optimal preservation of their survivability and 
proliferation in situ but would make sense as the periodontal ligament is a 
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self-renewing source of cells with a rapid natural turnover, it has a healthy 
vascular supply provided there are no perio/endo or other dental 
complications and would require no further harvesting of cells from other 
donor sources. In turn, this would minimise the amount of time taken to 
acquire cells, reduce the potential risks of laboratory contamination and 
problems from senescence during proliferation, lessen patient morbidity 
consequent to harvesting donor cells from other sites and at the same time 
maximise use of the ‘patient as the bioreactor’. As apexification or 
revitalisation often leads to a fibro-osseous deposition inside the root canal 
lumen, further investigation would be needed to elucidate the optimal 
scaffold material instead of the current blood clot which takes the entire 
process along a repair pathway, not a regenerative one. In a mature tooth, 
this would probably involve opening up i.e. widening the tooth apex, but as 
has been seen in the case of apexification and other occurrences, not only 
soft tissues but also hard tissues can be deposited given the appropriate 
stimulation and conditions (see Figure below). 
4. Optimisation of HyA chain length needs to be carried out to improve and 
optimise the vascular and proliferation response from any cell source used 
for dental pulp regeneration. The size of o-HyA required for dermal and 
other wound healing has already been expounded and although they might be 
predicted to behave in the same way, any cells used in dental pulp 
regeneration will need a more specifically optimised scaffold to proliferate 
rapidly to repopulate an instrumented root canal before the onset of bacterial 
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ingress. This would also fit in with more accurately establishing the 
temporality of CD31 and CD34 expression during culture. 
5. There is a probable role for collagen Type I and III possibly in endodontic 
point form or gel-supported fibrils as opposed to membrane form. This could 
originate from decellularised dental pulp from bovine or porcine origin 
which would furnish both the necessary fibrillar tissue clues as well as 
provide a template in situ from the various collagen types necessary for any 
cell ingrowth to tissue engineer a new dental pulp. 
It could also have potential (a) as a carrier for attached or sequestered 
morphogens or morphogen precursors, or (b) as an easily-degraded source of 
scaffold material for the regenerating dental pulp. Overall, this would mean 
it is based primarily on an organic (i.e. in the classical organic chemistry 
definition such as predominantly oxygen/carbon/nitrogen based materials 
and biologically resorbable scaffold materials) as opposed to an inorganic 
(i.e. in the classical chemistry definition such as predominantly 
calcium/silicon/sodium/phosphorous materials) basis. 
6. Finally as the following Figure shows, it is possible to stimulate growth of 
hard tissues (in the presence of orthodontic forces and tooth movement) 
down a root canal with an open apex which has been appropriately prepared 
by adequate filing and disinfection followed by insertion of a suitable 
nucleating scaffold material such as Ca(OH)2 as in the clinical example 
shown below. 
A soft tissue should not lie beyond the abilities of dental science and future 
application as a clinical endodontic dental pulp regenerative therapy. 
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Figure 61. Image of bone deposition inside the root canal of an open apex, 
orthodontically repositioned upper right central incisor. 
The above incisor was partially endodontically treated when this patient 
was 8-9 years old. A: in her early twenties it was repositioned 
orthodontically following removal of the single gutta percha point (which 
doesn’t even touch the sides) then endodontic instrumentation, 
disinfection with sodium hypochlorite, drying, then application of 
Ca(OH)2 paste and the access cavity sealed. B: several millimetres of bone 
have been deposited inside the root canal lumen during orthodontic 
movement as can be seen by the trabecular structure of the bone in the 
apical portion of the root canal, limiting the extent of the new gutta 
percha root canal filling. Note the absence of any periodontal structures 
inside the root canal, such as lamina dura, periodontal ligament, or 
periodontal ligament space, where the bone deposition has occurred. This 
would imply ankylosis, although there is still radiographic evidence of 
periodontal structure on the external root surface. 
(Images courtesy of L.D.I.). 
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List of Abbreviations 
5-CMFDA 5-chloromethylfluorodiacetate 
ABI Applied Biosystems 
ALP Alkaline phosphatase 
APES 3-aminopropyltriethoxysilane 
BDNF Brain derived neurotrophic factor 
BMPs Bone morphogenic proteins 
BMSCs Bone marrow stem cells 
BSP Bone sialoprotein 
CAM Chorioallantoic membrane 
CD Cluster of differentiation 
CGRP Calcitonin gene-related peptide 
DMEM Dulbecco’s modified Eagle’s medium 
DMP1 Dentine matrix protein-1 
DMSO Dimethyl sulphoxide 
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DNA Deoxyribonucleic acid 
DPSCs Dental pulp stromal cells 
DPX Dibutylphthalate 
DSPP Dentine sialophosphoprotein 
ECACC European collection of cell cultures 
ECM Extra Cellular Matrix 
EDTA Ethylenediaminetetracetic acid 
EGFIR Epidermal growth factor 
EGM Essential growth medium 
FCS Foetal calf serum 
FEGSEM Field emission gun scanning electron microscope 
FN Fibronectin 
GAG Glycosaminoglycan 
GDNF Glial derived neurotrophic factor 
H&E Haematoxylin and Eosin 
HIV Human Immunodeficiency Virus 
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hMSCs Human Mesenchymal Stem Cells 
HPDLC Human Periodontal Ligament Cells 
HRP Horseradish Peroxidase 
HSC Haematopoietic Stem Cell 
HUVECs Human umbilical vein endothelial cells 
HyA Hyaluronic Acid 
IGFIR Insulin-like growth factor 1 
ITIMs Immunoreceptor tyrosine inhibitory motifs 
kDa kilo Dalton 
LDI Leeds Dental Institute 
LOX Lysil oxidase 
LOXL Lysil oxidase-like 
MEPE Matrix extracellular phosphoglycoprotein 
MHCs Major histocompatibility complexes 
mRNA  Messenger Ribonucleic Acid 
MTA Mineral trioxide aggregate 
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MW Molecular weight 
NBF Neutral buffered formaldehyde 
NCPs Non collagenous proteins 
NGF Nerve growth protein 
NGS Normal goat serum 
n-HyA Native High Molecular weight Hyaluronic Acid. 
o-HyA Oligo- Hyaluronic Acid 
OP Osteopontin 
PBS Phosphate buffered saline 
PDLLA Poly (DL-lactic acid) 
PG Proteoglycan 
PLLA Poly-L-lactic acid 
PTPs Protein-tyrosine phosphates 
RER Rough endoplasmic reticulum 
RHAMM Receptor for Hyaluronan Mediated Motility 
rhVEGF165 Recombinant human VEGF 165 
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SCAP Stem Cells from the Apical Papilla 
SCID Severe Combined Immunodeficient 
SEM Scanning electron microscope 
SHED Stem cells from Human Exfoliated deciduous 
Teeth 
SHPs Src homology region 2 domain-containing 
phosphates 
SIBLINGS Small integrin binding ligand N-linked 
glycoproteins 
SLRPS Small leucine rich proteins 
STRO-1 Stromal Cell Surface Marker 1 
TE Trizema hydrochloride ethylenediaminetetracetic 
acid 
TGFβ Transforming growth factor Beta 
TOPRO TOPRO-3 iodide 
TRIS Tris(hydroxymethyl)aminomethane 
UV Ultra Violet 
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vWF Von Willebrand Factor 
YWHAZ Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta 
polypeptide 
αMEM Alpha modified essential media 
 
 251 
 
Appendix A Histology protocols 
 
1.1 Alkaline Phosphatase staining. 
Positive alkaline phosphatase stain produces a strong dark red-purple 
colouration indicative of a tissues’ or cells’ ability to form mineralised tissue 
under the appropriate culture conditions. 
1) The cell explants were first stopped in 98% ethanol overnight in their 6 
well plate. 
2) Next day the ethanol is drained off and replaced with PBS for 10 
minutes. 
3) Add 0.4mL of Naphthol A5-MX solution to 9.6 mL of distilled water. 
4) To this mixture add 2.4mg of Fast Violet B salt and mix thoroughly. 
5) Remove the PBS from the samples and add sufficient reagent mixture to 
cover the samples. 
6) Leave with lid on for at least 30 minutes or longer if necessary until no 
further colour change is apparent. 
7) Take images. 
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1.2 Alcian Blue/Sirius Red Staining. 
Alcian blue positive cells produce the proteoglycan aggrecan, a component of 
cartilage. 
1. Stain the sections on the slides with Weigart haematoxylin. Using a plastic 
Pasteur pipette, gently wash the Weigart haematoxylin over each section and 
leave for 10 minutes. 
2. Take each slide and rinse gently through a water bath then replace the slides 
in the staining tray. 
3. Place the tray into the water bath and rinse for 10 minutes. 
4. Dip the slides 3x in acid/alcohol(20mL HCl + 2litres 50% methanol). 
5. Rinse slides in water bath for 1 minute. 
6. Stain slides in molybdophosphoric acid for 20 minutes. 
7. Rinse in water bath for 1 minute. 
8. Stain with Sirius red for 60 minutes. 
9. Rinse in water 1 minute. 
10. Dip tray in 100% ethanol 1 for 30 minutes then 100% ethanol 2 for 30 
minutes. 
11. Mount in DPX. 
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1.3 CD31/34 staining for formalin fixed paraffin embedded dental pulp sections 
and in vitro and in vivo samples. 
For CD31: AbCam ab28364. CD34: AbCam ab 81289. STRO-1: AbCam ab102969. 
1. Place slides in staining tray and place in Xylene 1 for 20 minutes. 
2. Place in Xylene 2 for 20 minutes. 
3. Place in alcohol 1 for 5 minutes. 
4. Place in alcohol 2 for 5 minutes. 
5. Tap water wash for 5 minutes minimum. 
6. Place in 2% hydrogen peroxide/methanol solution for 20 minutes 
7. Wash in PBS in washbox with magnetic stirrer for 5 minutes minimum. 
8. For antigen retrieval, place slides in a plastic coplin jar containing 10mM 
sodium citrate buffer (pH6) and place coplin jar(s) in a water bath preheated 
to 65°C. Cover the water bath and leave for 1 hour. 
9. Replace slides in staining racks and wash in PBS in washbox with stirrer for 
minimum of 5 minutes. 
10. Quickly load slides into Shandon 67650002 Sequenza developer and top up 
well at top of each coverplate slide holder with PBS. N.B. if PBS drains 
through rapidly, slide is not seated properly. 
11. Add 1/5 normal goat serum (NGS) for 5 minutes. 
12. Add primary antibody at desired concentration (usually 1:100) and leave 
overnight at room temperature, with box cover on and some PBS in bottom 
of container to prevent drying out. 
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13. Top up coverplate well with PBS and leave for 5 minutes minimum. 
14. Add 2 drops of EnVision solution A from Dako kit K5007 per slide and 
leave for 30 minutes. 
15. Quickly unload the slides and place into a humidity chamber and add 120µL 
of EnVision solution (1mL of solution B plus 20µL of solution C) to each 
slide. After 5 minutes check staining under microscope. Repeat if necessary. 
16. Was in PBS/washbox for 5 minutes minimum. 
17. Counterstain in Harris haematoxylin for 1 minute. 
18. Wash in tap water for 5 minutes minimum until water runs clear. 
19. Immerse in Scott’s tap water for 1 minute. 
20. Wash in tap water for 5 minutes. 
21. Dehydrate in alcohol 3 & 4 for 5 minutes each. 
22. Clear in xylene 1 & 2 for 5 minutes each. 
23. Mount slides under appropriate sized coverslip in DPX (DibutylPhthalate in 
solution with Xylene). 
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1.4 Haematoxylin and Eosin (H&E) staining. 
1. Place sections in a slide rack and immerse in xylene for 5 minutes. 
2. Immerse sections in absolute ethyl alcohol 1 for 5 minutes. 
3. Immerse sections in absolute alcohol 2 for 5 minutes. 
4. Wash under running tap water for 5 minutes. 
5. Stain with Harris’ haematoxylin solution for 3 minutes. 
6. Wash under running tap water for 5 minutes. 
7. Differentially stain the nuclei by dipping the sections in 1% acid alcohol for 
(literally) 3 quick dips. Check under the light microscope for contrast and repeat 
if necessary. 
8. Wash under running tap water for 5 minutes. 
9. ‘Blue’ the sections by immersion in Scott’s tap water for 2 minutes. 
10. Wash under running tap water for 5 minutes. 
11. counterstain by immersing the sections in 1% aqueous Eosin for 30 seconds. 
12. Wash under running tap water for 5 minutes. 
13. Dehydrate in absolute alcohol 3 for 5 minutes. 
14. Dehydrate in absolute alcohol 4 for 5 minutes. 
15 Clear the alcohol by immersion in xylene for 5 minutes 
16. Mount the sections in DPX, under a coverslip. 
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1.5 DPSCs, HUVECs and G292 cells cultured on collagen I gel, 1% HyA gel in 
12 well plates or on coverslips. CD31 AbCam ab28364. CD34 AbCam ab 81289. 
Use a new disposable plastic Pasteur pipette for each stage and do not mix them 
up between stages to avoid reagent contamination. 
1 Remove culture medium and wash in PBS for 5 minutes. 
2.Remove PBS and fix cells in 10% NBF for 30 minutes. 
3. Remove NBF and wash gel with 3 x 5 minutes tap water. 
4. Remove tap water and immerse in 2% hydrogen peroxide/methanol for 20 
minutes. 
5. Remove H2O2/methanol and wash with PBS 3 x 5 minutes. 
6. Apply 20% NGS in PBS for 5 minutes. 
7. Remove excess NGS but do not wash (for negative control leave covered with 
NGS overnight. 
8. Add primary antibody at desired concentration (usually 1:100) and seal the 
plate around with parafilm, placing PBS in any unused wells to prevent 
desiccation. 
9. Add 2 drops EnVision solution A for 30 minutes at room temperature. 
10. Wash with PBS for 3 x 5 minutes. 
11. Add EnVision solution (1mL of B with 20µL of C) 150µL per well for 2 x 5 
minutes. 
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12. Wash thoroughly with tap water for at least 2 x 10 minutes. Tap water should 
be clear at last wash. 
13. Counterstain with Harris haematoxylin for 1 minute. 
14. Wash thoroughly with tap water and repeat until clear. 
15. Immerse with Scott’s tap water for 1 minute. 
16. Wash with tap water 3 x 5 minutes. 
17. If cells cultured on a cover slip, mount face down onto a slide with aqueous 
mounting medium then seal edges with nail varnish. If cultured in a 12 well 
plate, seal lid with PARAFILM® “M” laboratory film and record images as soon 
as possible. 
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1.6 RNA Isolation and Reverse Transcription 
Each 6 well plate was stopped at the appropriate time point by draining the media 
and washed twice with 3 mL of PBS for 20mins each. It was then drained and 1 mL 
of trypsin/EDTA reagent (Invitrogen, UK) was added then the plates were placed in 
a tissue culture incubator until the cells had detached or in the case of those cultured 
on HyA, until they had visibly shrunken under microscope examination. Then each 
well was scoured with a disposable cell scraper (Fisherbrand
®
 Scientific) to ensure 
maximal cell harvest. The contents of each group of wells (monolayer or HyA) were 
then moved into a 50 mL test tube, topped up with PBS to 30 mL, vortexed for 1 
minute and then spun down for 10 minutes at 2000 rpm. The supernatant was then 
removed and the resealed tubes were stored at minus 80°C until RNA extraction. 
The RNA was obtained from the cells in accordance with the instructions found in 
the Qiagen RNeasy
®
 Mini Kit (50) (Cat. No. 74104) as follows: 
The cell pellet was defrosted in 1 × PBS at room temperature then agitated to mix 
the contents. It was then centrifuged at 2000 rpm for ten minutes, the supernatant 
was aspirated and cells were disrupted by adding 1.5 mL of RLT buffer, to which 
had previously been added β-mercaptoethanol at a concentration of 10µL per mL. 
As the cells had been pelleted the cell pellet was pipetted up and down to loosen it 
up and aid cell lysis during mixing. The mixture was transferred to a 2 mL tube and 
vortexed for 1 minute at 1400. 350 µL of 70% ethanol was added to the tube and the 
mixture pipetted to mix. 700µL of each sample (including any precipitate) was 
transferred to a labelled RNeasy spin column, placed in a 2mL spin column which is 
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then spun at 10000 rpm for 15 seconds. The flow-through is discarded, then to 
remove any potential genomic DNA, an on-column DNase digestion is performed: 
350µL of Buffer RW1 is added to each spin column and centrifuged at 10000 rpm 
for 15 seconds and the flow-through is discarded. 10µL of DNase stock solution 
(DNase 1 kit, Invitrogen, UK) is added to 70µL of RDD buffer for each sample 
(i.e.80µL per sample), added to each spin column centrifuged very briefly and left 
for 20 minutes at room temperature. 350 µL of Buffer RW1 is then added to each 
spin column and centrifuged at 10000 rpm for 15 seconds. Discard the flow-through. 
500µL of Buffer RPE is added to each column and spun for 2 minutes at 10000 rpm. 
Using a new collection tube, 50µL of RNase free water is added to each column and 
spun for 1 minute at 10000rpm to elute the RNA. Discard the follow-through and 
repeat. 
The RNA quality was checked using a Thermo Scientific NanoDrop 2000 machine 
which measured the quantity and purity of the RNA obtained. A 2 µL sample of the 
extracted mRNA is quantified by measuring the 260/280 ratios, which were all 
found to be between 1.8 and 2, indicating acceptable purity. 
The RNA obtained is then processed into cDNA using a High Capacity RNA-to-
cDNA Kit (applied Biosystems, Carlsbad, USA) to obtain 200ng of cDNA in 20 µL 
reaction volumes in accordance with the manufacturer’s instructions. These were 
then run on a MJ Research PTC-100 Thermo Cycler for 1 hour at 37°C and then at 
95°C for five minutes. 
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Appendix B List of Conferences Attended 
 
7
th
 April 2007  BSDR Annual General Meeting, Durham (Poster). 
27
th
 June 2007  White Rose Health Innovation Partnership – Dentistry 
Workshop (Oral Presentation). 
16
th
 October 2008 2
nd
 Leeds-Michigan Tissue Engineering Symposium. 
19
th
 November 2008 Leeds Dental Institute postgraduate student annual meeting. 
18
th
 November 2009 Leeds Dental Institute postgraduate student annual meeting. 
17
th
 November 2010 Leeds Dental Institute postgraduate student annual meeting 
(Poster). 
27
th
 July 2011  Leeds Dental Institute postgraduate annual meeting. 
11
th
 July 2012  Leeds Dental Institute postgraduate annual meeting (oral 
presentation). 
10
th
 July 2013  Leeds Dental Institute postgraduate annual meeting. 
9
th
 July 2014  Leeds Dental Institute postgraduate annual meeting. 
10
th
 July 2015  Leeds Dental Institute postgraduate annual meeting. 
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Appendix C List of Courses Attended 
 
26
th
 January 2011  Human Tissue Ethics Training Workshop. 
10
th
 February 2011 Protecting your ideas – Understanding the process. 
16
th
 March 2013  University Research Ethics Workshop. 
1
st
 May 2013 How to write a great research paper and get it accepted 
by a good journal. 
28
th
 January 2015  Preparing for your viva. 
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Appendix E Publications 
Automated electrophysiological and pharmacological evaluation of human 
pluripotent stem cell-derived cardiomyocytes. Denning, C. et al. Submitted to Stem 
Cells and development, subject to corrections and revision. 
